<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Selenium micronutrient network" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The selenium-centred micronutrient biological network. The most relevant biochemical processes related to selenium in the context of metabolism, oxidation and inflammation are represented. Also, the compartmental separation (intracellular vs. plasma) is presented, identifying the selenium centred plasma metabolome. A selenoprotein database exists at:  http://www.selenodb.org.

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP15 CPTAC Assay Portal]</Comment>
  <Graphics BoardWidth="3725.9999999999995" BoardHeight="2671.0"/>
  <DataNode TextLabel="Lipoxin A4" GraphId="a438a" Type="Metabolite">
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGD2" GraphId="a79b9" Type="Metabolite">
    <Comment>Prostaglandin D2</Comment>
    <BiopaxRef>f03</BiopaxRef>
    <BiopaxRef>c9c</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Arachidonic acid" GraphId="a7bc6" Type="Metabolite">
    <BiopaxRef>b30</BiopaxRef>
    <BiopaxRef>fcb</BiopaxRef>
    <BiopaxRef>e68</BiopaxRef>
    <BiopaxRef>d00</BiopaxRef>
    <BiopaxRef>bc2</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="FGA" GraphId="ae014" Type="Protein" GroupRef="e46d6">
        </DataNode>
  <DataNode TextLabel="PGE1" GraphId="ae558" Type="Metabolite">
    <Comment>Prostaglandin E1</Comment>
    <BiopaxRef>e06</BiopaxRef>
    <BiopaxRef>b1f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Thromboxane B2" GraphId="b71db" Type="Metabolite">
    <BiopaxRef>f21</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Lipoxin B4" GraphId="b8717" Type="Metabolite">
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Thromboxane A2" GraphId="b948f" Type="Metabolite">
    <BiopaxRef>f21</BiopaxRef>
    <BiopaxRef>f03</BiopaxRef>
    <BiopaxRef>d18</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Linoleic acid" GraphId="bb33d" Type="Metabolite">
    <BiopaxRef>fcb</BiopaxRef>
    <BiopaxRef>e68</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="a-Tocopherol" GraphId="bc4fd" Type="Metabolite">
    <BiopaxRef>c52</BiopaxRef>
    <BiopaxRef>ed9</BiopaxRef>
    <BiopaxRef>b39</BiopaxRef>
    <BiopaxRef>fb3</BiopaxRef>
    <BiopaxRef>fb5</BiopaxRef>
    <BiopaxRef>caf</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Arachidonic acid" GraphId="c2c40" Type="Metabolite">
    <BiopaxRef>b30</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Lipoxin A4" GraphId="c358a" Type="Metabolite">
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="F2-Isoprostane" GraphId="c38a5" Type="Metabolite">
    <BiopaxRef>bc2</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="DHA" GraphId="c468d" Type="Metabolite">
    <Comment>Docosahexaenoic acid</Comment>
    <BiopaxRef>f8d</BiopaxRef>
    <BiopaxRef>fe6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="8-Isoprostaglandin F2a" GraphId="c75f4" Type="Metabolite">
    <BiopaxRef>bc2</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGI2" GraphId="c8082" Type="Metabolite">
    <Comment>Prostaglandin I2</Comment>
    <BiopaxRef>f03</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGE2" GraphId="c8c2d" Type="Metabolite">
    <Comment>Prostaglandin E2</Comment>
    <BiopaxRef>f03</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Thromboxane B2" GraphId="cb799" Type="Metabolite">
    <BiopaxRef>f21</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="RELA" GraphId="cbb48" Type="GeneProduct" GroupRef="c57bc">
    <Comment>nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65</Comment>
    <Graphics Color="ff00ff"/>
    </DataNode>
  <DataNode TextLabel="MDA" GraphId="cda46" Type="Metabolite">
    <Comment>Malondialdehyde</Comment>
    <BiopaxRef>d63</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGE2" GraphId="ce534" Type="Metabolite">
    <Comment>Prostaglandin E2</Comment>
    <BiopaxRef>f03</BiopaxRef>
    <BiopaxRef>eb6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="a-Tocopherol" GraphId="ce5f2" Type="Metabolite">
    <BiopaxRef>c52</BiopaxRef>
    <BiopaxRef>ed9</BiopaxRef>
    <BiopaxRef>b39</BiopaxRef>
    <BiopaxRef>fb3</BiopaxRef>
    <BiopaxRef>fb5</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="PGI2" GraphId="ceac0" Type="Metabolite">
    <Comment>Prostaglandin I2</Comment>
    <BiopaxRef>f03</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGF2a" GraphId="d16da" Type="Metabolite">
    <Comment>Prostaglandin F2a</Comment>
    <BiopaxRef>f03</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="DHA" GraphId="d3705" Type="Metabolite">
    <Comment>Docosahexaenoic acid</Comment>
    <BiopaxRef>f8d</BiopaxRef>
    <BiopaxRef>fe6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="COX2" GraphId="d63c5" Type="Protein">
    <Comment>EC 1.14.99.1</Comment>
    <Comment>Cyclooxygenase 2</Comment>
    <Comment>COX-2 inducible</Comment>
    <BiopaxRef>d00</BiopaxRef>
    <BiopaxRef>f8c</BiopaxRef>
    <BiopaxRef>ad3</BiopaxRef>
    <BiopaxRef>ade</BiopaxRef>
    <BiopaxRef>eec</BiopaxRef>
    <BiopaxRef>c8e</BiopaxRef>
    <BiopaxRef>b39</BiopaxRef>
    <BiopaxRef>fb3</BiopaxRef>
    <BiopaxRef>bc2</BiopaxRef>
    <BiopaxRef>eb5</BiopaxRef>
    <BiopaxRef>b1f</BiopaxRef>
    <Graphics Color="999996"/>
    </DataNode>
  <DataNode TextLabel="COX1" GraphId="d657b" Type="Protein">
    <Comment>EC 1.14.99.1</Comment>
    <Comment>Cyclooxygenase 1</Comment>
    <Comment>COX-1 constitutive</Comment>
    <BiopaxRef>d00</BiopaxRef>
    <BiopaxRef>f8c</BiopaxRef>
    <BiopaxRef>c8e</BiopaxRef>
    <BiopaxRef>eb5</BiopaxRef>
    <Graphics Color="999996"/>
    </DataNode>
  <DataNode TextLabel="ALA" GraphId="d6ac0" Type="Metabolite">
    <Comment>Alpha-Linolenic acid</Comment>
    <BiopaxRef>f8d</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGF2a" GraphId="d78db" Type="Metabolite">
    <Comment>Prostaglandin F2a</Comment>
    <BiopaxRef>f03</BiopaxRef>
    <BiopaxRef>add</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="EPA" GraphId="d832d" Type="Metabolite">
    <Comment>Eicosapentaenoic acid</Comment>
    <BiopaxRef>c8e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGD2" GraphId="d8720" Type="Metabolite">
    <Comment>Prostaglandin D2</Comment>
    <BiopaxRef>f03</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Linoleic acid" GraphId="dc083" Type="Metabolite">
    <BiopaxRef>fcb</BiopaxRef>
    <BiopaxRef>e68</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGE1" GraphId="dc9f7" Type="Metabolite">
    <Comment>Prostaglandin E1</Comment>
    <BiopaxRef>e06</BiopaxRef>
    <BiopaxRef>b1f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="DGLA" GraphId="de8da" Type="Metabolite">
    <Comment>Dihomo-gamma-linolenic acid</Comment>
    <Comment>8,11,14-Eicosatrienoic acid</Comment>
    <BiopaxRef>e06</BiopaxRef>
    <BiopaxRef>b1f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NFkB1" GraphId="dee1e" Type="GeneProduct" GroupRef="c57bc">
    <Comment>nuclear factor NF-kappa-B p50 subunit</Comment>
    <Graphics Color="ff00ff"/>
    </DataNode>
  <DataNode TextLabel="F2-Isoprostane" GraphId="e3d61" Type="Metabolite">
    <BiopaxRef>bc2</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="DPA" GraphId="e6845" Type="Metabolite">
    <Comment>Docosapentaenoic acid</Comment>
    <BiopaxRef>fe6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Lipoxin B4" GraphId="e6f1f" Type="Metabolite">
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGH3" GraphId="e848a" Type="Metabolite">
    <Comment>Prostaglandin H3</Comment>
    <BiopaxRef>c8e</BiopaxRef>
    <BiopaxRef>d9c</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGG2" GraphId="e92a2" Type="Metabolite">
    <Comment>Prostaglandin G2</Comment>
    <BiopaxRef>eb5</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="8-Isoprostaglandin F2a" GraphId="e93f4" Type="Metabolite">
    <BiopaxRef>bc2</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="DPA" GraphId="ea849" Type="Metabolite">
    <Comment>Docosapentaenoic acid</Comment>
    <BiopaxRef>fe6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="EPA" GraphId="f3cc5" Type="Metabolite">
    <Comment>Eicosapentaenoic acid</Comment>
    <BiopaxRef>c8e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ALA" GraphId="f7a72" Type="Metabolite">
    <Comment>Alpha-Linolenic acid</Comment>
    <BiopaxRef>f8d</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NFkB2" GraphId="f9052" Type="GeneProduct" GroupRef="c57bc">
    <Comment>nuclear factor of kappa light polypeptide gene enhancer in B-cells 2</Comment>
    <Graphics Color="ff00ff"/>
    </DataNode>
  <DataNode TextLabel="MDA" GraphId="fd626" Type="Metabolite">
    <Comment>Malondialdehyde</Comment>
    <BiopaxRef>d63</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGH2" GraphId="feb41" Type="Metabolite">
    <Comment>Prostaglandin H2</Comment>
    <BiopaxRef>d00</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PGE3" GraphId="ffaea" Type="Metabolite">
    <Comment>Prostaglandin E3</Comment>
    <BiopaxRef>c8e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Kynurenine" GraphId="bc30c" Type="Metabolite">
    <BiopaxRef>bf9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="MTR" GraphId="fba72" Type="Protein">
    <Comment>EC 2.1.1.13</Comment>
    <Comment>5-methyltetrahydrofolate-homocysteine methyltransferase</Comment>
    <BiopaxRef>fe7</BiopaxRef>
    <BiopaxRef>c2d</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="TRXR1" GraphId="e3880" Type="Protein" GroupRef="e0614">
    <Comment>EC 1.8.1.9</Comment>
    <Comment>Selenoprotein-thioredoxin reductase 1</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="CBS" GraphId="c4433" Type="Protein">
    <Comment>EC 4.2.1.22</Comment>
    <Comment>cystathionine-beta-synthase</Comment>
    <BiopaxRef>cb6</BiopaxRef>
    <BiopaxRef>fe7</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Iodine" GraphId="c80df" Type="Metabolite">
    <BiopaxRef>e0b</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Iodine" GraphId="df988" Type="Metabolite">
    <BiopaxRef>e0b</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="KMO" GraphId="cc807" Type="Protein">
    <Comment>EC 1.14.13.9</Comment>
    <Comment>kynurenine 3-hydroxylase</Comment>
    <BiopaxRef>bf9</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="R-Triiodothyronine (rT3)" GraphId="a5609" Type="Metabolite">
    <Comment>Reverse triiodothyronine</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>c37</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Triiodothyronine (T3)" GraphId="af9f8" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="15-HETE" GraphId="b2775" Type="Metabolite">
    <Comment>15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid</Comment>
    <BiopaxRef>b30</BiopaxRef>
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Thyroxine (T4)" GraphId="c4512" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5-HPETE" GraphId="ce455" Type="Metabolite">
    <Comment>5(S)-Hydroperoxyeicosatetraenoic acid</Comment>
    <BiopaxRef>e7f</BiopaxRef>
    <BiopaxRef>fad</BiopaxRef>
    <BiopaxRef>b30</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5,6-Epoxytetraene" GraphId="cfc2b" Type="Metabolite">
    <BiopaxRef>d95</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="R-Triiodothyronine (rT3)" GraphId="d8e2a" Type="Metabolite">
    <Comment>Reverse triiodothyronine</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="15-HETE" GraphId="d985f" Type="Metabolite">
    <Comment>15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid</Comment>
    <BiopaxRef>b30</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Triiodothyronine (T3)" GraphId="e744d" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>c37</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5-HETE" GraphId="e8b87" Type="Metabolite">
    <Comment>5-hydroxyeicosatetraenoic acid</Comment>
    <BiopaxRef>e7f</BiopaxRef>
    <BiopaxRef>fad</BiopaxRef>
    <BiopaxRef>b30</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Thyroxine (T4)" GraphId="ea35e" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>c37</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5-HETE" GraphId="eea23" Type="Metabolite">
    <Comment>5-hydroxyeicosatetraenoic acid</Comment>
    <BiopaxRef>e7f</BiopaxRef>
    <BiopaxRef>fad</BiopaxRef>
    <BiopaxRef>b30</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NADP+" GraphId="fbaf7" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="MPO" GraphId="c7ac2" Type="Protein">
    <Comment>EC 1.11.1.7</Comment>
    <Comment>Myeloperoxidase</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <BiopaxRef>aac</BiopaxRef>
    <BiopaxRef>c51</BiopaxRef>
    <BiopaxRef>ceb</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Catalase" GraphId="cf958" Type="Protein">
    <Comment>EC 1.11.1.6</Comment>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>de0</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="MPO" GraphId="faa3d" Type="Protein">
    <Comment>EC 1.11.1.7</Comment>
    <Comment>Myeloperoxidase</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Uric acid" GraphId="e6791" Type="Metabolite">
    <BiopaxRef>f84</BiopaxRef>
    <BiopaxRef>f4e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Cysteine" GraphId="e5057" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Factor VII" GraphId="a2e9b" Type="Protein">
    <Comment>EC 3.4.21.21</Comment>
    <Comment>coagulation factor VII (serum prothrombin conversion accelerator)</Comment>
    <BiopaxRef>cc7</BiopaxRef>
    <BiopaxRef>d29</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Thrombin" GraphId="a85a9" Type="Protein">
    <Comment>EC 3.4.21.5</Comment>
    <Comment>coagulation factor II (thrombin)</Comment>
    <BiopaxRef>f17</BiopaxRef>
    <BiopaxRef>cc7</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="tPA" GraphId="bd650" Type="Protein">
    <Comment>EC 3.4.21.68</Comment>
    <Comment>plasminogen activator, tissue</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="tPA" GraphId="bf4fe" Type="Protein">
    <Comment>EC 3.4.21.68</Comment>
    <Comment>plasminogen activator, tissue</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="PAI-1" GraphId="d6714" Type="Protein">
    <Comment>Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="PLG" GraphId="e063c" Type="Protein">
    <Comment>EC 3.4.21.7</Comment>
    <Comment>Plasminogen</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Thrombin" GraphId="e223c" Type="Protein">
    <Comment>EC 3.4.21.5</Comment>
    <Comment>coagulation factor II (thrombin)</Comment>
    <BiopaxRef>f17</BiopaxRef>
    <BiopaxRef>cc7</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Factor VII" GraphId="e887f" Type="Protein">
    <Comment>EC 3.4.21.21</Comment>
    <Comment>coagulation factor VII (serum prothrombin conversion accelerator)</Comment>
    <BiopaxRef>cc7</BiopaxRef>
    <BiopaxRef>d29</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="PLG" GraphId="ea7fa" Type="Protein">
    <Comment>EC 3.4.21.7</Comment>
    <Comment>Plasminogen</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="PAI-1" GraphId="f4722" Type="Protein">
    <Comment>Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="GGT1" GraphId="f74ca" Type="Protein">
    <Comment>EC 2.3.2.2</Comment>
    <Comment>gamma-glutamyltransferase 1</Comment>
    <BiopaxRef>cf6</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="GPX 4" GraphId="fd41c" Type="Protein" GroupRef="afe71">
    <Comment>EC 1.11.1.12</Comment>
    <Comment>Selenoprotein-glutathione peroxidase 4</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="TRXR2" GraphId="adb0f" Type="Protein" GroupRef="e0614">
    <Comment>EC 1.8.1.9</Comment>
    <Comment>Selenoprotein-thioredoxin reductase 2</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Xantine oxidase" GraphId="d17e4" Type="Protein">
    <Comment>EC 1.17.3.2</Comment>
    <Comment>http://en.wikipedia.org/wiki/Xanthine_oxidase</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <BiopaxRef>e0f</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="PRDX5" GraphId="cb3e2" Type="Protein" GroupRef="c1ae6">
    <Comment>EC 1.11.1.15</Comment>
    <Comment>peroxiredoxin 5</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="H2O2" GraphId="e47b0" Type="Metabolite">
    <Comment>Hydrogen peroxide</Comment>
        </DataNode>
  <DataNode TextLabel="ALOX5" GraphId="aaa29" Type="Protein">
    <Comment>EC 1.13.11.34</Comment>
    <Comment>arachidonate 5-lipoxygenase</Comment>
    <BiopaxRef>f43</BiopaxRef>
    <BiopaxRef>a4c</BiopaxRef>
    <BiopaxRef>d95</BiopaxRef>
    <BiopaxRef>ade</BiopaxRef>
    <BiopaxRef>fb5</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="ALOX15B" GraphId="b544e" Type="Protein">
    <Comment>EC 1.13.11.33</Comment>
    <Comment>arachidonate 15-lipoxygenase, type B</Comment>
    <BiopaxRef>b30</BiopaxRef>
    <BiopaxRef>c82</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Copper" GraphId="db9da" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Uric acid" GraphId="ab5b9" Type="Metabolite">
    <BiopaxRef>f84</BiopaxRef>
    <BiopaxRef>f4e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Vitamin B12" GraphId="dbe9f" Type="Metabolite">
    <BiopaxRef>c7a</BiopaxRef>
    <BiopaxRef>a64</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="5,10-Methylene-THF" GraphId="d35e0" Type="Metabolite">
    <Comment>5,10-Methylenetetrahydrofolate</Comment>
        </DataNode>
  <DataNode TextLabel="SelR" GraphId="c4fa0" Type="Protein">
    <Comment>EC 1.8.4.-</Comment>
    <Comment>Selenoprotein-selenoprotein X</Comment>
    <BiopaxRef>aff</BiopaxRef>
    <BiopaxRef>af9</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Tryptophan" GraphId="eb9ae" Type="Metabolite">
    <BiopaxRef>d0b</BiopaxRef>
    <BiopaxRef>bf9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="5-methyl-THF" GraphId="c6bbe" Type="Metabolite">
    <Comment>5-methyltetrahydrofolate</Comment>
        </DataNode>
  <DataNode TextLabel="SOD3" GraphId="cecee" Type="Protein" GroupRef="ae815">
    <Comment>EC 1.15.1.1</Comment>
    <Comment>superoxide dismutase 3, extracellular</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="PRDX1" GraphId="ad556" Type="Protein" GroupRef="c1ae6">
    <Comment>EC 1.11.1.15</Comment>
    <Comment>peroxiredoxin 1</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="RFK" GraphId="faed3" Type="Protein">
    <Comment>EC 2.7.1.26</Comment>
    <Comment>riboflavin kinase</Comment>
    <BiopaxRef>a22</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="H2O" GraphId="ad687" Type="Metabolite">
    <Comment>Glutathione disulfide</Comment>
        </DataNode>
  <DataNode TextLabel="GPX 3" GraphId="cfea7" Type="Protein" GroupRef="afe71">
    <Comment>EC 1.11.1.9</Comment>
    <Comment>Selenoprotein-glutathione peroxidase 3</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Niacinamide" GraphId="cc97b" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="CTH" GraphId="bed9f" Type="Protein">
    <Comment>EC 4.4.1.1</Comment>
    <Comment>cystathionase</Comment>
    <BiopaxRef>fe7</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="PNPO" GraphId="cbf20" Type="Protein">
    <Comment>EC 1.4.3.5</Comment>
    <Comment>pyridoxamine 5'-phosphate oxidase</Comment>
    <BiopaxRef>ddc</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Heme" GraphId="ca7e6" Type="Metabolite">
    <BiopaxRef>de0</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>cb6</BiopaxRef>
    <BiopaxRef>d18</BiopaxRef>
    <BiopaxRef>b53</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NADPH" GraphId="ca100" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Lipoic acid" GraphId="c8e06" Type="Metabolite">
    <BiopaxRef>abc</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Manganese" GraphId="a37df" Type="Metabolite">
    <Graphics Color="009833"/>
    </DataNode>
  <DataNode TextLabel="FAD" GraphId="bb0ab" Type="Metabolite">
    <Comment>Flavin adenine dinucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Methionine sulfoxide" GraphId="af991" Type="Metabolite">
    <BiopaxRef>aff</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Dehydroascorbic acid" GraphId="a473b" Type="Metabolite">
    <BiopaxRef>f97</BiopaxRef>
    <BiopaxRef>ec4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Leukotriene A4" GraphId="d431b" Type="Metabolite">
    <BiopaxRef>e71</BiopaxRef>
    <BiopaxRef>f5f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NADPH" GraphId="b96ba" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="FAD" GraphId="fd89b" Type="Metabolite">
    <Comment>Flavin adenine dinucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="THF" GraphId="e2c9a" Type="Metabolite">
    <Comment>Tetrahydrofolic acid</Comment>
        </DataNode>
  <DataNode TextLabel="Hydroxykynurenine" GraphId="fa566" Type="Metabolite">
    <BiopaxRef>bf9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Folic acid" GraphId="aa67f" Type="Metabolite">
    <BiopaxRef>c2d</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="NADP+" GraphId="c9ee6" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="NADPH" GraphId="f48db" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Selenium" GraphId="ac66d" Type="Metabolite">
    <BiopaxRef>e72</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Selenium" GraphId="ea38d" Type="Metabolite">
    <BiopaxRef>e72</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="SelK" GraphId="b3ed6" Type="Protein">
    <Comment>Selenoprotein-selenoprotein K</Comment>
    <BiopaxRef>af0</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Sep15" GraphId="fca10" Type="Protein">
    <Comment>Selenoprotein-15 kDa selenoprotein</Comment>
    <BiopaxRef>db9</BiopaxRef>
    <BiopaxRef>a89</BiopaxRef>
    <BiopaxRef>f4c</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="GPX 6" GraphId="b59a0" Type="Protein" GroupRef="afe71">
    <Comment>EC 1.11.1.9</Comment>
    <Comment>Selenoprotein-glutathione peroxidase 6</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="GSH" GraphId="a9d07" Type="Metabolite">
    <Comment>Glutathione</Comment>
    <BiopaxRef>bc0</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Nicotinamidase" GraphId="d1714" Type="Protein">
    <Comment>Catalysis of the reaction: nicotinamide + H2O = nicotinate + NH3 GO:0008936</Comment>
    <BiopaxRef>d0b</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Calcium" GraphId="b044b" Type="Metabolite">
    <BiopaxRef>f5f</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Methionine" GraphId="e297e" Type="Metabolite">
    <BiopaxRef>aff</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Manganese" GraphId="c2267" Type="Metabolite">
    <Graphics Color="009833"/>
    </DataNode>
  <DataNode TextLabel="NADPH" GraphId="c0b2d" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Folic acid" GraphId="c7921" Type="Metabolite">
    <BiopaxRef>c2d</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="FMN" GraphId="a0653" Type="Metabolite">
    <Comment>Flavin Mononucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Selenocysteine" GraphId="cc5e0" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>a3f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Selenide" GraphId="e5648" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>a3f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Selenophosphate" GraphId="f4293" Type="Metabolite">
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>a3f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Cysteine" GraphId="bc332" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Leukotriene C4" GraphId="c28d2" Type="Metabolite">
    <BiopaxRef>f5f</BiopaxRef>
    <BiopaxRef>cf6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Leukotriene C4" GraphId="ff750" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="GPX 3" GraphId="c10cb" Type="Protein">
    <Comment>Selenoprotein-glutathione peroxidase 3</Comment>
    <BiopaxRef>f4a</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Dehydroascorbic acid" GraphId="f14eb" Type="Metabolite">
    <BiopaxRef>f97</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="GPX 2" GraphId="b036c" Type="Protein" GroupRef="afe71">
    <Comment>EC 1.11.1.9</Comment>
    <Comment>Selenoprotein-glutathione peroxidase 2</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelP" GraphId="d929a" Type="Protein">
    <Comment>Selenoprotein-selenoprotein P</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Trx-S2" GraphId="b3e60" Type="Protein">
    <Comment>oxidized thioredoxin</Comment>
    <BiopaxRef>abc</BiopaxRef>
    <BiopaxRef>f1f</BiopaxRef>
    <BiopaxRef>f97</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Ascorbic acid" GraphId="fca86" Type="Metabolite">
    <BiopaxRef>ec4</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Lipoic acid" GraphId="a81a0" Type="Metabolite">
    <BiopaxRef>abc</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PRDX4" GraphId="d85f9" Type="Protein" GroupRef="c1ae6">
    <Comment>EC 1.11.1.15</Comment>
    <Comment>peroxiredoxin 4</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="GPX 1" GraphId="ef54e" Type="Protein" GroupRef="afe71">
    <Comment>EC 1.11.1.9</Comment>
    <Comment>Selenoprotein-glutathione peroxidase 1</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="NADP+" GraphId="cc501" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Homocysteine" GraphId="a4680" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="ROS" GraphId="bed05" Type="Metabolite">
    <Comment>reactive oxygen species</Comment>
    <Comment>http://en.wikipedia.org/wiki/Reactive_Oxygen_Species</Comment>
    <BiopaxRef>a46</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>aff</BiopaxRef>
    <BiopaxRef>fb6</BiopaxRef>
    <BiopaxRef>af0</BiopaxRef>
    <BiopaxRef>c68</BiopaxRef>
    <BiopaxRef>ec4</BiopaxRef>
    <BiopaxRef>a2e</BiopaxRef>
    <BiopaxRef>f4e</BiopaxRef>
    <BiopaxRef>e0f</BiopaxRef>
    <BiopaxRef>c52</BiopaxRef>
    <BiopaxRef>bc2</BiopaxRef>
    <BiopaxRef>c83</BiopaxRef>
    <BiopaxRef>d6f</BiopaxRef>
    <BiopaxRef>a4a</BiopaxRef>
    <BiopaxRef>fb2</BiopaxRef>
    <BiopaxRef>ae3</BiopaxRef>
    <BiopaxRef>ffd</BiopaxRef>
    <BiopaxRef>a05</BiopaxRef>
    <BiopaxRef>ce6</BiopaxRef>
    <BiopaxRef>e3f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="RNS" GraphId="c0e80" Type="Metabolite">
    <Comment>reactive nitrogen species</Comment>
    <Comment>http://en.wikipedia.org/wiki/Reactive_nitrogen_species</Comment>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>f11</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="NADPH" GraphId="d3a67" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Vitamin B12" GraphId="f28e8" Type="Metabolite">
    <BiopaxRef>c7a</BiopaxRef>
    <BiopaxRef>a64</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="MTHFR" GraphId="ef1e3" Type="Protein">
    <Comment>EC 1.5.1.20</Comment>
    <Comment>5,10-methylenetetrahydrofolate reductase</Comment>
    <BiopaxRef>c2d</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Homocysteine" GraphId="ec17c" Type="Metabolite">
    <BiopaxRef>d29</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SelH" GraphId="b83ab" Type="Protein">
    <Comment>Selenoprotein-selenoprotein H-chromosome 11 open reading frame 31</Comment>
    <BiopaxRef>ae3</BiopaxRef>
    <BiopaxRef>ffd</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SPS2" GraphId="c35a9" Type="Protein">
    <Comment>EC2.7.9.3</Comment>
    <Comment>Selenoprotein-selenophosphate synthetase 2</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>cbc</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelO" GraphId="d27a3" Type="Protein">
    <Comment>Selenoprotein-selenoprotein O</Comment>
    <Comment>Unknown function</Comment>
    <BiopaxRef>c06</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelN" GraphId="d86b0" Type="Protein">
    <Comment>Selenoprotein-selenoprotein N, 1</Comment>
    <BiopaxRef>c06</BiopaxRef>
    <BiopaxRef>b76</BiopaxRef>
    <BiopaxRef>d6f</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="DIO2" GraphId="d9bd5" Type="Protein">
    <Comment>EC 1.97.1.10</Comment>
    <Comment>Selenoprotein-deiodinase, iodothyronine, type II</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
    <BiopaxRef>f5c</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelT" GraphId="da423" Type="Protein">
    <Comment>Selenoprotein-selenoprotein T</Comment>
    <BiopaxRef>c06</BiopaxRef>
    <BiopaxRef>c83</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelM" GraphId="de905" Type="Protein">
    <Comment>Selenoprotein-selenoprotein M</Comment>
    <BiopaxRef>bf2</BiopaxRef>
    <BiopaxRef>a4a</BiopaxRef>
    <BiopaxRef>fb2</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelP" GraphId="e3718" Type="Protein">
    <Comment>Selenoprotein-selenoprotein P</Comment>
    <BiopaxRef>f1e</BiopaxRef>
    <BiopaxRef>c68</BiopaxRef>
    <BiopaxRef>e2d</BiopaxRef>
    <BiopaxRef>b77</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="DIO3" GraphId="e586f" Type="Protein">
    <Comment>EC 1.97.1.11</Comment>
    <Comment>Selenoprotein-deiodinase, iodothyronine type III</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="DIO1" GraphId="f09fb" Type="Protein">
    <Comment>EC 1.97.1.10</Comment>
    <Comment>Selenoprotein-deiodinase, iodothyronine, type I</Comment>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>e0b</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelV" GraphId="f8b44" Type="Protein">
    <Comment>Selenoprotein-selenoprotein V</Comment>
    <Comment>Unknown function</Comment>
    <BiopaxRef>c06</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelI" GraphId="fad0c" Type="Protein">
    <Comment>Selenoprotein-selenoprotein I</Comment>
    <Comment>Unknown function</Comment>
    <BiopaxRef>c06</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SelS" GraphId="fe319" Type="Protein">
    <Comment>Selenoprotein-selenoprotein S</Comment>
    <BiopaxRef>d09</BiopaxRef>
    <BiopaxRef>a05</BiopaxRef>
    <BiopaxRef>d42</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="SOD1" GraphId="e9bbd" Type="Protein" GroupRef="ae815">
    <Comment>EC 1.15.1.1</Comment>
    <Comment>superoxide dismutase 1, soluble</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="Pyridoxal 5'-phosphate" GraphId="ee8f2" Type="Metabolite">
    <BiopaxRef>bf9</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Serine" GraphId="b2e47" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Iron" GraphId="beae1" Type="Metabolite">
    <BiopaxRef>f5f</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Hypoxanthine" GraphId="b33c7" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="PRDX3" GraphId="e9631" Type="Protein" GroupRef="c1ae6">
    <Comment>EC 1.11.1.15</Comment>
    <Comment>peroxiredoxin 3</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="GSR" GraphId="d554b" Type="Protein">
    <Comment>EC 1.8.1.7</Comment>
    <Comment>glutathione reductase</Comment>
    <BiopaxRef>f38</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="APOA1" GraphId="a0196" Type="Protein">
    <Comment>apolipoprotein A-I</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="APOB" GraphId="a4395" Type="Protein">
    <Comment>apolipoprotein B</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="LDLR" GraphId="a53eb" Type="Protein">
    <Comment>low density lipoprotein receptor</Comment>
    <BiopaxRef>e9b</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="VLDL" GraphId="afaae" Type="Metabolite">
    <Comment>very-low-density lipoprotein</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>ba4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="LDL" GraphId="b142a" Type="Metabolite">
    <Comment>low-density lipoprotein</Comment>
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>aac</BiopaxRef>
    <BiopaxRef>a9f</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
    <BiopaxRef>caf</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SAA4" GraphId="b5726" Type="Protein">
    <Comment>serum amyloid A4, constitutive</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="SRB1" GraphId="b6a04" Type="Protein">
    <Comment>scavenger receptor class B, member 1</Comment>
    <BiopaxRef>c7d</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="ABCA1" GraphId="bb745" Type="Protein">
    <Comment>ATP-binding cassette, sub-family A (ABC1), member 1</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>c7d</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="bcf2e" Type="Metabolite">
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="APOA1-NO2Tyr" GraphId="c2d04" Type="Protein">
    <Comment>Nitrotyrosinated apolipoprotein A-I</Comment>
    <BiopaxRef>c65</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="ACT" GraphId="c4d7d" Type="Protein">
    <Comment>alpha-1-antichymotrypsin</Comment>
    <Comment>serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3</Comment>
    <BiopaxRef>e9b</BiopaxRef>
    <BiopaxRef>ce6</BiopaxRef>
    <BiopaxRef>e11</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HDL" GraphId="c57e3" Type="Metabolite">
    <Comment>high-density lipoprotein</Comment>
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="VLDL-TAG" GraphId="cb970" Type="Metabolite">
    <Comment>very-low-density lipoprotein-triglyceride</Comment>
    <Comment>Triglyceride transport</Comment>
    <BiopaxRef>de8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="FMN" GraphId="ce4a7" Type="Metabolite">
    <Comment>Flavin Mononucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SAA2" GraphId="ce7eb" Type="Protein">
    <Comment>serum amyloid A2</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HDL-C" GraphId="cf0a6" Type="Metabolite">
    <Comment>high-density lipoprotein cholesterol</Comment>
    <Comment>Cholesterol transport</Comment>
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="TAG" GraphId="d0575" Type="Metabolite">
    <Comment>Triglyceride</Comment>
    <Comment>Triacylglycerol</Comment>
    <BiopaxRef>de8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ACT" GraphId="d3b5a" Type="Protein">
    <Comment>alpha-1-antichymotrypsin</Comment>
    <Comment>serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3</Comment>
    <BiopaxRef>e9b</BiopaxRef>
    <BiopaxRef>ce6</BiopaxRef>
    <BiopaxRef>e11</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="APOA1" GraphId="d4079" Type="Protein">
    <Comment>apolipoprotein A-I</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HDL" GraphId="d595a" Type="Metabolite">
    <Comment>high-density lipoprotein</Comment>
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="HDL-C" GraphId="d5f27" Type="Metabolite">
    <Comment>high-density lipoprotein cholesterol</Comment>
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SAA1" GraphId="d7661" Type="Protein">
    <Comment>serum amyloid A1</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="SAA3" GraphId="da7bf" Type="Protein">
    <Comment>serum amyloid A3 pseudogene</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="APOB" GraphId="dd437" Type="Protein">
    <Comment>apolipoprotein B</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="VLDL" GraphId="dd4fd" Type="Metabolite">
    <Comment>very-low-density lipoprotein</Comment>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>ba4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="oxLDL" GraphId="de60a" Type="Metabolite">
    <Comment>oxidized low-density lipoprotein</Comment>
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>aac</BiopaxRef>
    <BiopaxRef>a9f</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="HDL/APOA1" GraphId="e97d6" Type="Metabolite">
    <Comment>high-density lipoprotein</Comment>
    <Comment>ApoA-I is present on the majority of HDL particles and constitutes aprox 70% of the apolipoprotein content of HDL particles</Comment>
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="HDL/SAA" GraphId="e9c9c" Type="Metabolite">
    <Comment>high-density lipoprotein</Comment>
    <Comment>SAA circulates in plasma as a constituent of high density lipoproteins (HDL).</Comment>
    <BiopaxRef>e99</BiopaxRef>
    <BiopaxRef>ea2</BiopaxRef>
    <BiopaxRef>c7d</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="eb3d6" Type="Metabolite">
    <BiopaxRef>e99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="oxLDL" GraphId="ee0d9" Type="Metabolite">
    <Comment>oxidized low-density lipoprotein</Comment>
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>aac</BiopaxRef>
    <BiopaxRef>a9f</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
    <BiopaxRef>caf</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="TAG" GraphId="f0bc8" Type="Metabolite">
    <Comment>Triglyceride</Comment>
    <Comment>Triacylglycerol</Comment>
    <BiopaxRef>de8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="LDL" GraphId="f2302" Type="Metabolite">
    <Comment>low-density lipoprotein</Comment>
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>aac</BiopaxRef>
    <BiopaxRef>a9f</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="VLDL-TAG" GraphId="f5683" Type="Metabolite">
    <Comment>very-low-density lipoprotein-triglyceride</Comment>
    <Comment>Triglyceride transport</Comment>
    <BiopaxRef>de8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="VLDL/APOB" GraphId="ff642" Type="Metabolite">
    <Comment>very-low-density lipoprotein</Comment>
    <Comment>The VLDL is produced in the liver, contains one molecule of apoB100</Comment>
    <BiopaxRef>de8</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="O2" GraphId="ba6f9" Type="Metabolite">
    <BiopaxRef>d63</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Pyridoxal 5'-phosphate" GraphId="c1b4b" Type="Metabolite">
    <BiopaxRef>bf9</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="8-OHdG" GraphId="affc1" Type="Metabolite">
    <Comment>8-Hydroxy-deoxyguanosine</Comment>
    <BiopaxRef>be4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="8-OHdG" GraphId="c5114" Type="Metabolite">
    <Comment>8-Hydroxy-deoxyguanosine</Comment>
    <BiopaxRef>be4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="FAD" GraphId="ff44e" Type="Metabolite">
    <Comment>Flavin adenine dinucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PRDX2" GraphId="afe0d" Type="Protein" GroupRef="c1ae6">
    <Comment>EC 1.11.1.15</Comment>
    <Comment>peroxiredoxin 2</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="ADP" GraphId="bfa7a" Type="Metabolite">
    <Comment>Adenosine diphosphate</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Leukotriene D4" GraphId="c48de" Type="Metabolite">
    <BiopaxRef>cf6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Leukotriene D4" GraphId="edda5" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Copper" GraphId="a1433" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Chlorine" GraphId="b5519" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Chlorine" GraphId="c6e4f" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Cystathionine" GraphId="bee4c" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="FAD" GraphId="d9733" Type="Metabolite">
    <Comment>Flavin adenine dinucleotide</Comment>
    <BiopaxRef>af3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SOD2" GraphId="af4b3" Type="Protein" GroupRef="ae815">
    <Comment>EC 1.15.1.1</Comment>
    <Comment>superoxide dismutase 2, mitochondrial</Comment>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="Dihydrolipoate" GraphId="ac3f4" Type="Metabolite">
    <BiopaxRef>abc</BiopaxRef>
    <BiopaxRef>a2e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Serine" GraphId="a7d41" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="NADP+" GraphId="b39da" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="ATP" GraphId="c50a9" Type="Metabolite">
    <Comment>Adenosine triphosphate</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Zinc" GraphId="d4f38" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="NADP+" GraphId="e0652" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="GSSG" GraphId="e48d3" Type="Metabolite">
    <Comment>Glutathione disulfide</Comment>
        </DataNode>
  <DataNode TextLabel="NADPH" GraphId="c15fb" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Reduced</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Zinc" GraphId="a48e8" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Niacin" GraphId="a602e" Type="Metabolite">
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Leukotriene B4" GraphId="a9b63" Type="Metabolite">
    <BiopaxRef>e71</BiopaxRef>
    <BiopaxRef>f5f</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Leukotriene B4" GraphId="f74e0" Type="Metabolite">
    <BiopaxRef>e71</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Quinolinic Acid" GraphId="a2e6b" Type="Metabolite">
    <BiopaxRef>d0b</BiopaxRef>
    <BiopaxRef>bf9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="PMP" GraphId="a9cb3" Type="Metabolite">
    <Comment>Pyridoxamine 5'-phosphate</Comment>
        </DataNode>
  <DataNode TextLabel="NO" GraphId="a760e" Type="Metabolite">
    <Comment>Nitric oxide</Comment>
    <BiopaxRef>ceb</BiopaxRef>
    <BiopaxRef>c51</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="O3" GraphId="da39a" Type="Metabolite">
    <Comment>ozone</Comment>
        </DataNode>
  <DataNode TextLabel="NO" GraphId="dbec3" Type="Metabolite">
    <Comment>Nitric oxide</Comment>
    <BiopaxRef>ceb</BiopaxRef>
    <BiopaxRef>c51</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="HNO2" GraphId="e2d67" Type="Metabolite">
    <Comment>Nitrous acid</Comment>
        </DataNode>
  <DataNode TextLabel="NO2" GraphId="ee480" Type="Metabolite">
    <Comment>Nitrogen dioxide</Comment>
        </DataNode>
  <DataNode TextLabel="HOCl" GraphId="f16d6" Type="Metabolite">
    <Comment>Hypochlorite</Comment>
        </DataNode>
  <DataNode TextLabel="NADP+" GraphId="cd332" Type="Metabolite">
    <Comment>Nicotinamide adenine dinucleotide phosphate-Oxidized</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="GSH" GraphId="e572e" Type="Metabolite">
    <Comment>Glutathione</Comment>
    <BiopaxRef>bc0</BiopaxRef>
    <BiopaxRef>e71</BiopaxRef>
    <BiopaxRef>ae3</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="sICAM-1" GraphId="a1471" Type="Protein">
    <Comment>soluble intercellular adhesion molecule 1</Comment>
    <BiopaxRef>e0e</BiopaxRef>
    <BiopaxRef>e34</BiopaxRef>
    <BiopaxRef>cd0</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="D-dimer" GraphId="a7107" Type="Protein">
    <Comment>http://en.wikipedia.org/wiki/Fibrin_degradation_product</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <BiopaxRef>a00</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IL10" GraphId="a8632" Type="Protein">
    <Comment>interferon, gamma</Comment>
    <BiopaxRef>b77</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="TNFa" GraphId="aa73c" Type="Protein">
    <Comment>tumor necrosis factor (TNF superfamily, member 2)</Comment>
    <BiopaxRef>d42</BiopaxRef>
    <BiopaxRef>da2</BiopaxRef>
    <BiopaxRef>e34</BiopaxRef>
    <BiopaxRef>e3f</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HbA1c" GraphId="ab76c" Type="Protein">
    <Comment>Glycated hemoglobin</Comment>
    <Comment>http://en.wikipedia.org/wiki/Glycated_hemoglobin</Comment>
    <BiopaxRef>cef</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IFNg" GraphId="abc88" Type="Protein">
    <Comment>interferon, gamma</Comment>
    <BiopaxRef>f5c</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="ALB" GraphId="ae520" Type="Protein">
    <Comment>albumin</Comment>
    <BiopaxRef>c31</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="INS" GraphId="b220a" Type="Protein">
    <Comment>Insulin</Comment>
    <BiopaxRef>b4a</BiopaxRef>
    <BiopaxRef>e66</BiopaxRef>
    <BiopaxRef>c53</BiopaxRef>
    <BiopaxRef>b59</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Fibrin" GraphId="b491c" Type="Metabolite">
    <BiopaxRef>f17</BiopaxRef>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="ffcc33"/>
    </DataNode>
  <DataNode TextLabel="IL1B" GraphId="b9f06" Type="Protein">
    <Comment>interleukin 1, beta</Comment>
    <BiopaxRef>d42</BiopaxRef>
    <BiopaxRef>da2</BiopaxRef>
    <BiopaxRef>e2d</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="INSR" GraphId="bddef" Type="Protein">
    <Comment>Insulin receptor</Comment>
    <BiopaxRef>b4a</BiopaxRef>
    <BiopaxRef>e66</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HBB" GraphId="bf8e2" Type="Protein">
    <Comment>hemoglobin, beta</Comment>
    <BiopaxRef>cef</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="TNFa" GraphId="c376b" Type="Protein">
    <Comment>tumor necrosis factor (TNF superfamily, member 2)</Comment>
    <BiopaxRef>d42</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="CRP" GraphId="c3834" Type="Protein">
    <Comment>C-reactive protein, pentraxin-related</Comment>
    <BiopaxRef>ed1</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
    <BiopaxRef>caf</BiopaxRef>
    <BiopaxRef>e0e</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Fibrin" GraphId="c4a3d" Type="Protein">
    <BiopaxRef>f17</BiopaxRef>
    <BiopaxRef>f7a</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IL1B" GraphId="c8c76" Type="Protein">
    <Comment>interleukin 1, beta</Comment>
    <BiopaxRef>d42</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IFNg" GraphId="caffc" Type="Protein">
    <Comment>interferon, gamma</Comment>
    <BiopaxRef>f5c</BiopaxRef>
    <BiopaxRef>e2d</BiopaxRef>
    <BiopaxRef>e34</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="sICAM-1" GraphId="cf4c8" Type="Protein">
    <Comment>soluble intercellular adhesion molecule 1</Comment>
    <BiopaxRef>e0e</BiopaxRef>
    <BiopaxRef>e34</BiopaxRef>
    <BiopaxRef>cd0</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="CCL2" GraphId="d147c" Type="Protein">
    <Comment>chemokine (C-C motif) ligand 2</Comment>
    <BiopaxRef>b77</BiopaxRef>
    <BiopaxRef>e3f</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="INS" GraphId="d58ca" Type="Protein">
    <Comment>Insulin</Comment>
    <BiopaxRef>b4a</BiopaxRef>
    <BiopaxRef>e66</BiopaxRef>
    <BiopaxRef>c53</BiopaxRef>
    <BiopaxRef>b59</BiopaxRef>
    <BiopaxRef>ba4</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IL10" GraphId="dd0e9" Type="Protein">
    <Comment>interferon, gamma</Comment>
    <BiopaxRef>b77</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="ALB" GraphId="e2257" Type="Protein">
    <Comment>albumin</Comment>
    <BiopaxRef>c31</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="FLAP" GraphId="e262a" Type="Protein">
    <Comment>arachidonate 5-lipoxygenase-activating protein</Comment>
    <BiopaxRef>f43</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IL6" GraphId="eaaa4" Type="Protein">
    <Comment>interleukin 6 (interferon, beta 2)</Comment>
    <BiopaxRef>f5c</BiopaxRef>
    <BiopaxRef>ed1</BiopaxRef>
    <BiopaxRef>af4</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="CCL2" GraphId="eb649" Type="Protein">
    <Comment>chemokine (C-C motif) ligand 2</Comment>
    <BiopaxRef>b77</BiopaxRef>
    <BiopaxRef>e3f</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="IL6" GraphId="ef76d" Type="Protein">
    <Comment>interleukin 6 (interferon, beta 2)</Comment>
    <BiopaxRef>f5c</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Fibrinogen" GraphId="f2509" Type="Protein">
    <BiopaxRef>af4</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="Fibrinogen" GraphId="f3dd1" Type="Protein" GroupRef="e46d6">
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="D-dimer" GraphId="f6b17" Type="Protein">
    <Comment>http://en.wikipedia.org/wiki/Fibrin_degradation_product</Comment>
    <BiopaxRef>f7a</BiopaxRef>
    <BiopaxRef>a00</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HBA1" GraphId="f710f" Type="Protein">
    <Comment>hemoglobin, alpha 1</Comment>
    <BiopaxRef>cef</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="HbA1c" GraphId="fcf18" Type="Protein">
    <Comment>Glycated hemoglobin</Comment>
    <Comment>http://en.wikipedia.org/wiki/Glycated_hemoglobin</Comment>
    <BiopaxRef>cef</BiopaxRef>
    <Graphics Color="ffcc00"/>
    </DataNode>
  <DataNode TextLabel="SelW" GraphId="a3dd8" Type="Protein">
    <Comment>Selenoprotein-selenoprotein W</Comment>
    <BiopaxRef>bc0</BiopaxRef>
    <BiopaxRef>dd0</BiopaxRef>
    <BiopaxRef>fb6</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Riboflavin" GraphId="d3307" Type="Metabolite">
    <BiopaxRef>ca9</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="SOD3" GraphId="c6bd2" Type="Protein">
    <Comment>EC 1.15.1.1</Comment>
    <Comment>superoxide dismutase 3, extracellular</Comment>
    <BiopaxRef>ae2</BiopaxRef>
    <Graphics Color="999998"/>
    </DataNode>
  <DataNode TextLabel="TRXR1" GraphId="b6504" Type="Protein">
    <Comment>Selenoprotein-thioredoxin reductase 1</Comment>
    <BiopaxRef>f1f</BiopaxRef>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="Ascorbate" GraphId="f643c" Type="Metabolite">
    <BiopaxRef>ec4</BiopaxRef>
    <BiopaxRef>f97</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="O2-&#195;&#8218;&#226;&#8364;&#339;" GraphId="d1e46" Type="Metabolite">
    <Comment>Superoxide</Comment>
        </DataNode>
  <DataNode TextLabel="Xanthine" GraphId="fbb37" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Calcium" GraphId="eddfc" Type="Metabolite">
    <BiopaxRef>f5f</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Kynureninase" GraphId="c9f82" Type="Protein">
    <Comment>EC 3.7.1.3</Comment>
    <BiopaxRef>bf9</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Methionine" GraphId="d77b8" Type="Metabolite">
    <BiopaxRef>aff</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ADP" GraphId="dcdd4" Type="Metabolite">
    <Comment>Adenosine diphosphate</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Trx-(SH)2" GraphId="aa8a1" Type="Protein">
    <Comment>reduced thioredoxin</Comment>
    <BiopaxRef>abc</BiopaxRef>
    <BiopaxRef>f1f</BiopaxRef>
    <Graphics Color="fccc00"/>
    </DataNode>
  <DataNode TextLabel="Nitrotyrosine" GraphId="a3827" Type="Metabolite">
    <BiopaxRef>f11</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ONOO-/ONOOH" GraphId="ed886" Type="Metabolite">
    <Comment>Peroxynitrite</Comment>
        </DataNode>
  <DataNode TextLabel="Nitrotyrosine" GraphId="f6e0b" Type="Metabolite">
    <BiopaxRef>f11</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="ATP" GraphId="cdd46" Type="Metabolite">
    <Comment>Adenosine triphosphate</Comment>
    <Graphics Color="ffff00"/>
    </DataNode>
  <DataNode TextLabel="Leukotriene E4" GraphId="a9427" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="Leukotriene E4" GraphId="b73ed" Type="Metabolite">
    <BiopaxRef>cf6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Leukotriene F4" GraphId="bb415" Type="Metabolite">
    <BiopaxRef>dd2</BiopaxRef>
    <BiopaxRef>cf6</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Glucose" GraphId="c8be1" Type="Metabolite">
    <BiopaxRef>b59</BiopaxRef>
    <BiopaxRef>cef</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Fructosamine" GraphId="ce144" Type="Metabolite">
    <BiopaxRef>c31</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Fructosamine" GraphId="ee4b4" Type="Metabolite">
    <BiopaxRef>c31</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Iron" GraphId="eaeb5" Type="Metabolite">
    <BiopaxRef>f5f</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="Hypoxanthine" GraphId="b91c3" Type="Metabolite">
        </DataNode>
  <DataNode TextLabel="TRXR3" GraphId="ab871" Type="Protein" GroupRef="e0614">
    <Comment>EC 1.8.1.9</Comment>
    <Comment>Selenoprotein-thioredoxin reductase 3</Comment>
    <Graphics Color="ff0000"/>
    </DataNode>
  <DataNode TextLabel="FLAD1" GraphId="f560b" Type="Protein">
    <Comment>EC 2.7.7.2</Comment>
    <Comment>FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae)</Comment>
    <BiopaxRef>a22</BiopaxRef>
    <BiopaxRef>b21</BiopaxRef>
    <Graphics Color="999999"/>
    </DataNode>
  <DataNode TextLabel="Ascorbic acid" GraphId="aafc3" Type="Metabolite">
    <BiopaxRef>ec4</BiopaxRef>
    <BiopaxRef>ed9</BiopaxRef>
    <BiopaxRef>c52</BiopaxRef>
    <Graphics Color="009933"/>
    </DataNode>
  <DataNode TextLabel="FGB" GraphId="f5caa" Type="Protein" GroupRef="e46d6">
        </DataNode>
  <DataNode TextLabel="FGG" GraphId="f281c" Type="Protein" GroupRef="e46d6">
        </DataNode>
  <Interaction GraphId="df2ef">
    <BiopaxRef>fec</BiopaxRef>
    <Graphics Color="0000ff">
      <Point GraphRef="e47b0"/>
      <Point GraphRef="ba6f9" ArrowHead="Arrow"/>
      <Anchor Position="0.27133158850744593" Shape="None" GraphId="a59f4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea08d">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="cecee"/>
      <Point GraphRef="c6bd2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f713a">
    <Graphics Color="ffff00">
      <Point GraphRef="c8d5c"/>
      <Point GraphRef="dcdd4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b7764">
    <Graphics Color="ffff00">
      <Point GraphRef="ff2aa"/>
      <Point GraphRef="b39da" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dc9f4">
    <Graphics Color="0000ff">
      <Point GraphRef="e572e"/>
      <Point GraphRef="e48d3" ArrowHead="Arrow"/>
      <Anchor Position="0.24845260071669079" Shape="None" GraphId="ef45b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4e13">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="c4fa0" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a0014">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="caffc" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a009c">
    <Graphics Color="0000ff">
      <Point GraphRef="c4512"/>
      <Point GraphRef="d8e2a" ArrowHead="Arrow"/>
      <Anchor Position="0.5329770681771955" Shape="None" GraphId="f8635"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a1109">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b5726"/>
      <Point GraphRef="e9c9c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a1da1">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e3d61"/>
      <Point GraphRef="d63c5" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a34bc">
    <Graphics>
      <Point GraphRef="dbe9f"/>
      <Point GraphRef="fba72" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a479c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="eaeb5"/>
      <Point/>
      <Point GraphRef="ca7e6" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a64ff">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c57e3"/>
      <Point/>
      <Point/>
      <Point GraphRef="b9ae9" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6568">
    <Graphics>
      <Point GraphRef="ae520"/>
      <Point GraphRef="ee4b4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6a9d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="a5004" ArrowHead="mim-stimulation"/>
      <Point/>
      <Point/>
      <Point GraphRef="bed05"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7b2a">
    <Graphics>
      <Point GraphRef="a0196"/>
      <Point GraphRef="e97d6" ArrowHead="Arrow"/>
      <Anchor Position="0.6342783505154639" Shape="None" GraphId="a7bf3"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a8080">
    <Graphics>
      <Point GraphRef="afaae"/>
      <Point GraphRef="a8e32" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a80d4">
    <Graphics>
      <Point GraphRef="f5c87"/>
      <Point GraphRef="bd96b" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a8eb8">
    <Graphics Color="0000ff">
      <Point GraphRef="a7bc6"/>
      <Point GraphRef="e92a2" ArrowHead="Arrow"/>
      <Anchor Position="0.8402154467350613" Shape="None" GraphId="d677d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9413">
    <Graphics>
      <Point GraphRef="c7ac2"/>
      <Point GraphRef="be1cb" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9633">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="d657b"/>
      <Point/>
      <Point/>
      <Point GraphRef="a79d6" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa190">
    <Graphics>
      <Point GraphRef="c57e3"/>
      <Point GraphRef="a7bf3" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa496">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d58ca"/>
      <Point/>
      <Point/>
      <Point GraphRef="afaae" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aad4a">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point/>
      <Point/>
      <Point GraphRef="d9bd5" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ab42f">
    <Graphics Color="0000ff">
      <Point GraphRef="ce455"/>
      <Point GraphRef="eea23" ArrowHead="Arrow"/>
      <Anchor Position="0.43916486681065514" Shape="None" GraphId="c347a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ac4fe">
    <Graphics ConnectorType="Elbow" Color="00cc00">
      <Point GraphRef="c38a5"/>
      <Point GraphRef="fb442" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ad2a5">
    <Graphics>
      <Point GraphRef="eb3d6"/>
      <Point GraphRef="c633e" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ad6b6">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c8be1"/>
      <Point GraphRef="f710f" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="add6e">
    <Graphics Color="0000ff">
      <Point GraphRef="c4512"/>
      <Point GraphRef="af9f8" ArrowHead="Arrow"/>
      <Anchor Position="0.559915164369034" Shape="None" GraphId="c03f1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ae427">
    <Graphics Color="0000ff">
      <Point GraphRef="e92a2"/>
      <Point GraphRef="feb41" ArrowHead="Arrow"/>
      <Anchor Position="0.6679629750299869" Shape="None" GraphId="a79d6"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="af337">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point/>
      <Point GraphRef="d147c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="af4a1">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point GraphRef="d147c" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b022d">
    <Graphics Color="0000ff">
      <Point GraphRef="b2775"/>
      <Point GraphRef="cfc2b" ArrowHead="Arrow"/>
      <Anchor Position="0.3260128051212053" Shape="None" GraphId="f8c27"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0857">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b9f06"/>
      <Point GraphRef="fe319" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0e2a">
    <Graphics>
      <Point GraphRef="cfc2b"/>
      <Point GraphRef="c358a" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b1da9">
    <Graphics Color="0000ff">
      <Point GraphRef="e47b0"/>
      <Point GraphRef="f16d6" ArrowHead="Arrow"/>
      <Anchor Position="0.48647661560312333" Shape="None" GraphId="b64d9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b4091">
    <Graphics>
      <Point GraphRef="df988"/>
      <Point GraphRef="af9f8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b4bcb">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bb33d"/>
      <Point/>
      <Point GraphRef="de8da" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b5b6b">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="eaaa4"/>
      <Point/>
      <Point/>
      <Point GraphRef="c3834" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b62b8">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e9c9c"/>
      <Point/>
      <Point GraphRef="cf0a6" ArrowHead="mim-conversion"/>
      <Anchor Position="0.04014571948998183" Shape="None" GraphId="dd209"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b69a4">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point GraphRef="fe319" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8948">
    <Graphics>
      <Point GraphRef="ff642"/>
      <Point GraphRef="f5683" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3990506329113924" Shape="None" GraphId="bfd89"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b904d">
    <Graphics>
      <Point GraphRef="b6a04"/>
      <Point GraphRef="dd209" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b9508">
    <Graphics>
      <Point GraphRef="eaeb5"/>
      <Point GraphRef="b544e" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd043">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d63c5" ArrowHead="mim-inhibition"/>
      <Point/>
      <Point GraphRef="bc4fd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd0fb">
    <Graphics Color="0000ff">
      <Point GraphRef="b491c"/>
      <Point GraphRef="a7107" ArrowHead="Arrow"/>
      <Anchor Position="0.45023696682464454" Shape="None" GraphId="ede30"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd197">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="dd0e9"/>
      <Point GraphRef="e3718" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="be5fd">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d58ca"/>
      <Point GraphRef="b35fd" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="be7ea">
    <Graphics>
      <Point GraphRef="fca10"/>
      <Point GraphRef="ae42a" ArrowHead="mim-cleavage"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c0315">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="df988"/>
      <Point GraphRef="c4512" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c2cca">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d7661"/>
      <Point GraphRef="e9c9c" ArrowHead="Arrow"/>
      <Anchor Position="0.8641113889849382" Shape="None" GraphId="b9ae9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c2e21">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="eaaa4"/>
      <Point/>
      <Point/>
      <Point GraphRef="d9bd5" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c31dd">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c8be1"/>
      <Point GraphRef="bf8e2" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c574b">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d71e9"/>
      <Point/>
      <Point/>
      <Point GraphRef="e3718" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6ff4">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff0000">
      <Point GraphRef="c10cb"/>
      <Point GraphRef="cf0a1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c7d1d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bed05"/>
      <Point GraphRef="bd96b" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c95be">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f710f"/>
      <Point GraphRef="fcf18" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c968d">
    <Graphics>
      <Point GraphRef="bb745"/>
      <Point GraphRef="dd209" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ca4e9">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ce7eb"/>
      <Point GraphRef="e9c9c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cab03">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point/>
      <Point GraphRef="eaaa4" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cc740">
    <Graphics>
      <Point GraphRef="e97d6"/>
      <Point GraphRef="cf0a6" ArrowHead="mim-conversion"/>
      <Anchor Position="0.41850455143763265" Shape="None" GraphId="c633e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cdef6">
    <Comment>inhibition through the reduction of lipid hydroperoxides  essential for the activation of COX-2</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b036c"/>
      <Point GraphRef="d63c5" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce2bc">
    <Graphics ConnectorType="Elbow">
      <Point/>
      <Point/>
      <Point/>
      <Point GraphRef="e5648" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cec29">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d147c"/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf2f7">
    <Graphics>
      <Point GraphRef="d0575"/>
      <Point GraphRef="bfd89" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cfe46">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bc4fd"/>
      <Point GraphRef="aaa29" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d1c75">
    <Graphics>
      <Point GraphRef="cfc2b"/>
      <Point GraphRef="b8717" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6622">
    <Graphics>
      <Point GraphRef="f4722"/>
      <Point GraphRef="bd650" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d67d8">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="aa73c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d72f7">
    <Graphics>
      <Point GraphRef="a0196"/>
      <Point GraphRef="c2d04" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8287522936857113" Shape="None" GraphId="fcb14"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d81ea">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e3718" ArrowHead="mim-inhibition"/>
      <Point/>
      <Point/>
      <Point GraphRef="b9f06"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="da59c">
    <Graphics>
      <Point GraphRef="b948f"/>
      <Point GraphRef="cb799" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db582">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="d63c5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db601">
    <Graphics Color="999999">
      <Point GraphRef="e586f"/>
      <Point GraphRef="f8635" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dcf2c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="eaaa4"/>
      <Point GraphRef="f3dd1" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd828">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point/>
      <Point GraphRef="b9f06" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="de148">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="cf4c8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e0a74">
    <Comment>nonenzymatic free radical-&#195;&#8218;&#226;&#8364;&#339;catalyzed reaction</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="a7bc6"/>
      <Point/>
      <Point GraphRef="e3d61" ArrowHead="mim-conversion"/>
      <Anchor Position="0.48623425966041767" Shape="None" GraphId="a5004"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e1ec2">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c8be1"/>
      <Point/>
      <Point GraphRef="d58ca" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e3272">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="caffc"/>
      <Point/>
      <Point/>
      <Point GraphRef="d9bd5" ArrowHead="mim-inhibition"/>
      <Anchor Position="0.036302552801578396" Shape="None" GraphId="d71e9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e381d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b56c2" ArrowHead="mim-binding"/>
      <Point/>
      <Point GraphRef="ca7e6"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e3da9">
    <Graphics Color="0000ff">
      <Point GraphRef="e5648"/>
      <Point GraphRef="f4293" ArrowHead="Arrow"/>
      <Anchor Position="0.506049802476703" Shape="None" GraphId="d31ab"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e53f3">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bf8e2"/>
      <Point GraphRef="fcf18" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e784e">
    <Graphics>
      <Point GraphRef="bd650"/>
      <Point GraphRef="ea7fa" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7c07">
    <Graphics>
      <Point GraphRef="bb745"/>
      <Point GraphRef="c633e" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9145">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b9f06"/>
      <Point/>
      <Point/>
      <Point GraphRef="fd41c" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e916e">
    <Graphics Color="0000ff">
      <Point GraphRef="b73ed"/>
      <Point GraphRef="bb415" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="fb7f1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9837">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="d9bd5"/>
      <Point GraphRef="c03f1" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea686">
    <Comment>inhibition through the reduction of lipid hydroperoxides  essential for the activation of COX-2</Comment>
    <Graphics>
      <Point GraphRef="e91c9"/>
      <Point GraphRef="d63c5" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eaabe">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c3834"/>
      <Point/>
      <Point/>
      <Point GraphRef="cf4c8" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eac16">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point/>
      <Point GraphRef="bddef" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb909">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ec17c"/>
      <Point/>
      <Point GraphRef="a2e9b" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec5e2">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aafc3"/>
      <Point GraphRef="bc4fd" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee122">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="da7bf"/>
      <Point GraphRef="e9c9c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee864">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="df988"/>
      <Point/>
      <Point GraphRef="d8e2a" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee8af">
    <Graphics>
      <Point GraphRef="a4395"/>
      <Point GraphRef="ff642" ArrowHead="Arrow"/>
      <Anchor Position="0.3990506329113924" Shape="None" GraphId="a8e32"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eec02">
    <Graphics>
      <Point GraphRef="d3b5a"/>
      <Point GraphRef="a53eb" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef21c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point/>
      <Point/>
      <Point GraphRef="fd41c" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f04d0">
    <Graphics Color="0000ff">
      <Point GraphRef="f44de"/>
      <Point GraphRef="b491c" ArrowHead="Arrow"/>
      <Anchor Position="0.45023696682464454" Shape="None" GraphId="d2e29"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f137d">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="caffc"/>
      <Point/>
      <Point GraphRef="cf4c8" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f47bf">
    <Graphics ConnectorType="Elbow" Color="00cc00">
      <Point GraphRef="a4680"/>
      <Point/>
      <Point GraphRef="cab62" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f586b">
    <Graphics ConnectorType="Elbow" Color="0000ff">
      <Point GraphRef="de8da"/>
      <Point/>
      <Point GraphRef="dc9f7" ArrowHead="Arrow"/>
      <Anchor Position="0.3763929338187532" Shape="None" GraphId="c3400"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6e02">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="aa73c"/>
      <Point/>
      <Point/>
      <Point GraphRef="cf4c8" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6f92">
    <Graphics Color="0000ff">
      <Point GraphRef="d832d"/>
      <Point GraphRef="e848a" ArrowHead="Arrow"/>
      <Anchor Position="0.5569803672044762" Shape="None" GraphId="f2942"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f7323">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0" ArrowHead="mim-necessary-stimulation"/>
      <Point GraphRef="f4293"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f7328">
    <Graphics>
      <Point GraphRef="b142a"/>
      <Point GraphRef="ee0d9" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3564236993885141" Shape="None" GraphId="be1cb"/>
      <Anchor Position="0.55525" Shape="None" GraphId="dc165"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8377">
    <Graphics ConnectorType="Elbow" Color="00cc00">
      <Point GraphRef="d16da"/>
      <Point/>
      <Point GraphRef="ee9d3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8a7c">
    <Graphics>
      <Point GraphRef="a2e9b"/>
      <Point GraphRef="a85a9" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fabc2">
    <Comment>inhibition through the reduction of lipid hydroperoxides  essential for the activation of 15-lipoxygenase</Comment>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ddf70"/>
      <Point GraphRef="b544e" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fcb12">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bc4fd"/>
      <Point/>
      <Point/>
      <Point GraphRef="dc165" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fcb64">
    <Graphics ConnectorType="Elbow" Color="0000ff">
      <Point GraphRef="a7bc6"/>
      <Point/>
      <Point GraphRef="b2775" ArrowHead="Arrow"/>
      <Anchor Position="0.7096213840726888" Shape="None" GraphId="c1821"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd3f9">
    <Comment>inhibition through the reduction of lipid hydroperoxides  essential for the activation of 5-lipoxygenase</Comment>
    <Graphics ConnectorType="Elbow">
      <Point/>
      <Point/>
      <Point/>
      <Point GraphRef="aaa29" ArrowHead="mim-inhibition"/>
      <Anchor Position="0.9244346784165718" Shape="None" GraphId="ddf70"/>
      <Anchor Position="0.4036074102595076" Shape="None" GraphId="f5c87"/>
      <Anchor Position="0.5736559874138658" Shape="None" GraphId="e91c9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd786">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c8be1"/>
      <Point GraphRef="ae520" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fee15">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="dd0e9" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fdfda">
    <Graphics>
      <Point GraphRef="aafc3"/>
      <Point GraphRef="f643c" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b5974">
    <Graphics>
      <Point GraphRef="ee8f2"/>
      <Point GraphRef="c9f82" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8a1a">
    <Graphics Color="0000ff">
      <Point GraphRef="ec17c"/>
      <Point GraphRef="bee4c" ArrowHead="Arrow"/>
      <Anchor Position="0.4430379746835443" Shape="None" GraphId="f1a5b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b9e9c">
    <Graphics>
      <Point GraphRef="a1433"/>
      <Point GraphRef="e9bbd" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5693">
    <Graphics Color="ffff00">
      <Point GraphRef="c50a9"/>
      <Point GraphRef="c8d5c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2555">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="e5057"/>
      <Point GraphRef="bc332" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b9e40">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a4395"/>
      <Point GraphRef="dd437" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d7f06">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="afaae"/>
      <Point GraphRef="dd4fd" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="de4e0">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="f5683"/>
      <Point/>
      <Point GraphRef="cb970" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0836">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="d0575"/>
      <Point GraphRef="f0bc8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b01cb">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="b142a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b3859">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b0fbe"/>
      <Point GraphRef="c9f82" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b65cd">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="d7661" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bbe25">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="ce7eb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bcf58">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="da7bf" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cdaae">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="a0196" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec245">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="b5726" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5ddd">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point/>
      <Point/>
      <Point GraphRef="a4395" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fee23">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="cc5ff"/>
      <Point GraphRef="ee0d9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ad457">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e262a"/>
      <Point/>
      <Point GraphRef="aaa29" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e92d6">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="f14eb"/>
      <Point/>
      <Point GraphRef="a473b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="caf51">
    <Graphics Color="0000ff">
      <Point GraphRef="fbb37"/>
      <Point GraphRef="ab5b9" ArrowHead="Arrow"/>
      <Anchor Position="0.4915254237288136" Shape="None" GraphId="fa480"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e5b0a">
    <Graphics>
      <Point GraphRef="a602e"/>
      <Point GraphRef="b39da" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a5e14">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="eaaa4"/>
      <Point/>
      <Point GraphRef="ef76d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7027">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="dd0e9"/>
      <Point GraphRef="a8632" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9ae9">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="caffc"/>
      <Point/>
      <Point GraphRef="abc88" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7a8f">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="aa73c"/>
      <Point GraphRef="c376b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0ea8">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="e3880"/>
      <Point GraphRef="b6504" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8a2b">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b9f06"/>
      <Point/>
      <Point GraphRef="c8c76" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a1bfb">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="bc4fd"/>
      <Point GraphRef="bd97d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2b92">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="d86b0"/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c9c40">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="e3718"/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cbe06">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="bc4fd"/>
      <Point/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df3cf">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="da423"/>
      <Point/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8ca3">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="fe319"/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f410f">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="de905"/>
      <Point/>
      <Point/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5e75">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="b83ab"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a312b">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="da423" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a3bea">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="e586f" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a3ced">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="d9bd5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ae194">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="e3718" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0566">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="f09fb" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bfc6e">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="b83ab" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="da9f4">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="de905" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db740">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="fad0c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e423b">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="d86b0" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea90b">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="d27a3" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5c44">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0"/>
      <Point/>
      <Point GraphRef="c35a9" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6201">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd96b"/>
      <Point GraphRef="fe319" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe065">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="f8b44" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="feddc">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0"/>
      <Point/>
      <Point/>
      <Point GraphRef="fe319" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6014">
    <Graphics Color="0000ff">
      <Point GraphRef="d35e0"/>
      <Point GraphRef="c6bbe" ArrowHead="Arrow"/>
      <Anchor Position="0.3877155172413793" Shape="None" GraphId="a391d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6d17">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b33c7"/>
      <Point/>
      <Point GraphRef="b91c3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e0d86">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b3e60"/>
      <Point GraphRef="fbbc3" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aaf9e">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="cb3e2"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a1bed">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="fd626"/>
      <Point/>
      <Point/>
      <Point GraphRef="e3d61" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2ea4">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="e848a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a805d">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b2db8"/>
      <Point GraphRef="d431b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa7a6">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="ffaea" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ae5d1">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point/>
      <Point GraphRef="ee0d9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aef3f">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="ceac0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0779">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="ea0e1"/>
      <Point GraphRef="da423" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2745">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="ea0e1"/>
      <Point GraphRef="b044b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2c47">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="a79b9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b32fb">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="b948f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b4359">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd97d"/>
      <Point/>
      <Point GraphRef="c3834" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b5d6f">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point/>
      <Point GraphRef="ba6f9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c06de">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="a7bc6" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6fc7">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b2db8"/>
      <Point GraphRef="f74e0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cfc1d">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="f7a72" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4418">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b35fd"/>
      <Point GraphRef="c8be1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d60ba">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b2db8"/>
      <Point GraphRef="c28d2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d64e9">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="bb33d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d998c">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="e3d61"/>
      <Point/>
      <Point/>
      <Point GraphRef="fd626" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dcf00">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b2db8"/>
      <Point GraphRef="c48de" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd5fe">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="ea849" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df3b2">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="dc9f7" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e1805">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b2db8"/>
      <Point GraphRef="b73ed" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea9eb">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="ce534" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec3aa">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="ec19f"/>
      <Point GraphRef="d86b0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec421">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="d78db" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ece9e">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="c468d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eed68">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b0fbe"/>
      <Point GraphRef="a2e6b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6062">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="e3d61"/>
      <Point GraphRef="c75f4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f79eb">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b56c2"/>
      <Point GraphRef="feb41" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8b89">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bd97d"/>
      <Point GraphRef="d832d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c3a53">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ca7e6"/>
      <Point/>
      <Point GraphRef="c4433" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7131">
    <Graphics>
      <Point GraphRef="eb9ae"/>
      <Point GraphRef="b0fbe" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b68d6">
    <Graphics Color="ffff00">
      <Point GraphRef="cdd46"/>
      <Point GraphRef="acd22"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d946d">
    <Graphics Color="0000ff">
      <Point GraphRef="c6bbe"/>
      <Point GraphRef="e2c9a" ArrowHead="Arrow"/>
      <Anchor Position="0.51975987993997" Shape="None" GraphId="df86f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f7c3e">
    <Graphics ConnectorType="Elbow" Color="0000ff">
      <Point GraphRef="ec17c"/>
      <Point GraphRef="d77b8" ArrowHead="Arrow"/>
      <Anchor Position="0.7877730470196221" Shape="None" GraphId="b1495"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b443e">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="affc1"/>
      <Point GraphRef="c5114" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4b94">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c7921"/>
      <Point GraphRef="aa67f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c5cf0">
    <Graphics>
      <Point GraphRef="ab5b9"/>
      <Point GraphRef="e87bc" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f322a">
    <Graphics Color="999999">
      <Point GraphRef="ef1e3"/>
      <Point GraphRef="a391d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ceea0">
    <Graphics Color="999999">
      <Point GraphRef="c4433"/>
      <Point GraphRef="f1a5b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7098">
    <Graphics Color="999999">
      <Point/>
      <Point GraphRef="df86f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1856">
    <Graphics Color="ffff00">
      <Point GraphRef="c4706"/>
      <Point GraphRef="cc501" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0595">
    <Graphics Color="ffff00">
      <Point GraphRef="f48db"/>
      <Point GraphRef="a391d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e4736">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="b39da"/>
      <Point GraphRef="cd332" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f18b1">
    <Comment>oxidation</Comment>
    <Graphics>
      <Point GraphRef="d77b8"/>
      <Point GraphRef="af991" ArrowHead="mim-conversion"/>
      <Anchor Position="0.05301204819277108" Shape="None" GraphId="b59ce"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bad67">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="ab5b9"/>
      <Point GraphRef="e6791" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c116a">
    <Graphics>
      <Point GraphRef="a48e8"/>
      <Point GraphRef="c4fa0" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b5ca1">
    <Comment>Requirement-Se incorporation in selenoproteins</Comment>
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="ddf81" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fcdc6">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ea38d"/>
      <Point/>
      <Point GraphRef="ac66d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6e8e">
    <Graphics Color="0000ff">
      <Point GraphRef="f14eb"/>
      <Point GraphRef="f643c" ArrowHead="Arrow"/>
      <Anchor Position="0.3743479594967781" Shape="None" GraphId="b6a6e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8824">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="b3ed6"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c72e8">
    <Graphics Color="0000ff">
      <Point GraphRef="ce455"/>
      <Point GraphRef="d431b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.45588235294117646" Shape="None" GraphId="ae2b3"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a21ba">
    <Graphics Color="0000ff">
      <Point GraphRef="e47b0"/>
      <Point GraphRef="ad687" ArrowHead="Arrow"/>
      <Anchor Position="0.6906924969028855" Shape="None" GraphId="a3662"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb520">
    <Graphics>
      <Point GraphRef="f643c"/>
      <Point GraphRef="bed05" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d3b86">
    <Comment>reduction</Comment>
    <Graphics Color="0000ff">
      <Point GraphRef="a81a0"/>
      <Point GraphRef="ac3f4" ArrowHead="Arrow"/>
      <Anchor Position="0.490163387795932" Shape="None" GraphId="c4706"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cee8a">
    <Graphics Color="0000ff">
      <Point GraphRef="e48d3"/>
      <Point GraphRef="e572e" ArrowHead="Arrow"/>
      <Anchor Position="0.2254065838602702" Shape="None" GraphId="ff2aa"/>
      <Anchor Position="0.23865844981124965" Shape="None"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ac065">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="cf0a6"/>
      <Point/>
      <Point/>
      <Point GraphRef="d5f27" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b31e3">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="ec17c"/>
      <Point GraphRef="a4680" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd009">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b142a"/>
      <Point/>
      <Point GraphRef="f2302" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eba73">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ee0d9"/>
      <Point/>
      <Point/>
      <Point GraphRef="de60a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fefb8">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a0196"/>
      <Point/>
      <Point/>
      <Point GraphRef="d4079" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba3b6">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="dfa65"/>
      <Point GraphRef="ef1e3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bc1a1">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="e1aaf"/>
      <Point GraphRef="affc1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d20d9">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="e1aaf"/>
      <Point GraphRef="acb03" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2c56">
    <Graphics Color="0000ff">
      <Point GraphRef="d1e46"/>
      <Point GraphRef="e47b0" ArrowHead="Arrow"/>
      <Anchor Position="0.46808510638297873" Shape="None" GraphId="cc9de"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb2ba">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="ddf81"/>
      <Point/>
      <Point/>
      <Point GraphRef="be1cb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd0ee">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="d3b5a"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cd937">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="bed05"/>
      <Point GraphRef="d58ca" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa5e0">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="ab5b9"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb9e3">
    <Graphics Color="ffff00">
      <Point GraphRef="c0b2d"/>
      <Point GraphRef="ff2aa"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe5fe">
    <Graphics Color="ffff00">
      <Point/>
      <Point GraphRef="c4706"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb8ca">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="d147c"/>
      <Point GraphRef="eb649" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f80d3">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a48e8"/>
      <Point GraphRef="d4f38" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dda4e">
    <Graphics Color="ffff00">
      <Point/>
      <Point GraphRef="e83e0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ade6e">
    <Graphics>
      <Point GraphRef="bb0ab"/>
      <Point GraphRef="d554b" ArrowHead="mim-necessary-stimulation"/>
      <Anchor Position="0.6515367387181878" Shape="None" GraphId="ae42a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee7f5">
    <Graphics Color="999999">
      <Point GraphRef="ff2aa" ArrowHead="mim-catalysis"/>
      <Point GraphRef="d554b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dbac1">
    <Graphics Color="ffff00">
      <Point GraphRef="c15fb"/>
      <Point GraphRef="a67f4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1ad8">
    <Graphics Color="999999">
      <Point GraphRef="d17e4"/>
      <Point GraphRef="fa480" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4e1d">
    <Graphics>
      <Point GraphRef="eaeb5"/>
      <Point GraphRef="aaa29" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ca029">
    <Graphics>
      <Point GraphRef="acb03"/>
      <Point GraphRef="e40b9" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e614a">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ee8f2"/>
      <Point GraphRef="c4433" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f673c">
    <Graphics>
      <Point GraphRef="bed05"/>
      <Point GraphRef="b59ce" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.43012123979797756" Shape="None" GraphId="e40b9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8c88">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e87bc" ArrowHead="mim-binding"/>
      <Point/>
      <Point GraphRef="a48e8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b57b7">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="b3ed6" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5f62">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="fca10" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8ce4">
    <Graphics>
      <Point GraphRef="aafc3"/>
      <Point GraphRef="f14eb" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bda19">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a1433"/>
      <Point GraphRef="db9da" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f7e6f">
    <Graphics Color="999999">
      <Point GraphRef="ef45b"/>
      <Point GraphRef="a3662" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ece06">
    <Graphics>
      <Point GraphRef="d17e4"/>
      <Point GraphRef="bed05" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb21a">
    <Graphics Color="ffff00">
      <Point GraphRef="e83e0"/>
      <Point GraphRef="c9ee6" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a0980">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="dc9f7"/>
      <Point GraphRef="ae558" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7391">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ea849"/>
      <Point/>
      <Point/>
      <Point GraphRef="e6845" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9f86">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b2775"/>
      <Point GraphRef="d985f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ad793">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c4512"/>
      <Point GraphRef="ea35e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b3003">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="af9f8"/>
      <Point GraphRef="e744d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b43c4">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="cb799"/>
      <Point GraphRef="b71db" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b63b3">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="ce534"/>
      <Point GraphRef="c8c2d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b742d">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="d78db"/>
      <Point GraphRef="d16da" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bcccb">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b044b"/>
      <Point GraphRef="eddfc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c141b">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="b8717"/>
      <Point GraphRef="e6f1f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c5dd9">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="d8e2a"/>
      <Point GraphRef="a5609" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c5e92">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="c358a"/>
      <Point GraphRef="a438a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c60e4">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c468d"/>
      <Point/>
      <Point GraphRef="d3705" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cc294">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="e3718"/>
      <Point GraphRef="d929a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cee56">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a7bc6"/>
      <Point GraphRef="c2c40" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d845c">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a79b9"/>
      <Point GraphRef="d8720" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e59ab">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="f7a72"/>
      <Point GraphRef="d6ac0" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e784d">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="fd626"/>
      <Point GraphRef="cda46" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7c2d">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="bb33d"/>
      <Point GraphRef="dc083" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0503">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="ceac0"/>
      <Point GraphRef="c8082" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fbcb7">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="df988"/>
      <Point GraphRef="c80df" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c513b">
    <Graphics Color="0000ff">
      <Point/>
      <Point GraphRef="fbb37" ArrowHead="Arrow"/>
      <Anchor Position="0.691819213249115" Shape="None" GraphId="e746d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c86be">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="c0b2d"/>
      <Point GraphRef="b96ba" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c1271">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ca7e6"/>
      <Point/>
      <Point GraphRef="c7ac2" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f707c">
    <Graphics>
      <Point GraphRef="ca7e6"/>
      <Point GraphRef="cf958" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e189b">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="d77b8"/>
      <Point GraphRef="e297e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3eeb">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="aafc3"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e87d2">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="dbe9f"/>
      <Point GraphRef="f28e8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cbd8b">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ee8f2"/>
      <Point GraphRef="c1b4b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f7cf4">
    <Graphics>
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="a3dd8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea208">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e572e"/>
      <Point GraphRef="a3dd8" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f060a">
    <Graphics Color="0000ff">
      <Point GraphRef="cc97b"/>
      <Point GraphRef="a602e" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="e3510"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0080">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="ac3f4"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9f62">
    <Graphics Color="ffff00">
      <Point GraphRef="acd22"/>
      <Point GraphRef="bfa7a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf170">
    <Graphics>
      <Point GraphRef="c7921"/>
      <Point GraphRef="d2293" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cc5a9">
    <Graphics Color="0000ff">
      <Point GraphRef="d3307"/>
      <Point GraphRef="ce4a7" ArrowHead="mim-conversion"/>
      <Anchor Position="0.48066312765262903" Shape="None" GraphId="c8d5c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fddf2">
    <Graphics Color="999999">
      <Point GraphRef="fba72"/>
      <Point GraphRef="b1495" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec39f">
    <Graphics Color="ffff00">
      <Point GraphRef="a67f4"/>
      <Point GraphRef="e0652" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d06a7">
    <Graphics Color="999999">
      <Point GraphRef="faed3"/>
      <Point GraphRef="c8d5c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b710c">
    <Graphics Color="0000ff">
      <Point GraphRef="bee4c"/>
      <Point GraphRef="e5057" ArrowHead="Arrow"/>
      <Anchor Position="0.4" Shape="None" GraphId="a2976"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3240">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c2267"/>
      <Point/>
      <Point GraphRef="af4b3" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fec27">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a81a0"/>
      <Point GraphRef="c8e06" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d187b">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e572e"/>
      <Point/>
      <Point GraphRef="d431b" ArrowHead="mim-binding"/>
      <Anchor Position="0.8827217367180081" Shape="None" GraphId="fc144"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a314e">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="b2e47"/>
      <Point GraphRef="a7d41" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e03de">
    <Graphics>
      <Point GraphRef="b2e47"/>
      <Point GraphRef="f1a5b" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c543e">
    <Comment>reduction</Comment>
    <Graphics Color="0000ff">
      <Point GraphRef="b3e60"/>
      <Point GraphRef="aa8a1" ArrowHead="Arrow"/>
      <Anchor Position="0.5217807563427477" Shape="None" GraphId="e83e0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d2d4b">
    <Graphics Color="ffff00">
      <Point GraphRef="a391d"/>
      <Point GraphRef="fbaf7" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa645">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b5519"/>
      <Point GraphRef="c6e4f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ac6d6">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c7ac2"/>
      <Point GraphRef="faa3d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c71f5">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="eb3d6"/>
      <Point GraphRef="bcf2e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2b37">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a3827"/>
      <Point GraphRef="f6e0b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6fa9">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a760e"/>
      <Point/>
      <Point/>
      <Point GraphRef="dbec3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1abe">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="cfea7"/>
      <Point GraphRef="c10cb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd613">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c57e3"/>
      <Point GraphRef="d595a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fec39">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cc5e0"/>
      <Point GraphRef="fe0eb" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8e48">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="b0fbe"/>
      <Point GraphRef="cc807" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b316a">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="aafc3"/>
      <Point GraphRef="fca86" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a407a">
    <Comment>Negative effect</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff9900">
      <Point GraphRef="ddf81"/>
      <Point/>
      <Point GraphRef="bd97d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0b00">
    <Comment>Negative effect</Comment>
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point GraphRef="a3dd8"/>
      <Point GraphRef="bed05" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9a72">
    <Graphics>
      <Point GraphRef="a2e6b"/>
      <Point GraphRef="e76c5" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2c5a">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="dddb6"/>
      <Point/>
      <Point GraphRef="fe319" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c7903">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="d5fa1"/>
      <Point GraphRef="b83ab" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e43f1">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="dddb6"/>
      <Point/>
      <Point GraphRef="de905" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef875">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="dddb6"/>
      <Point GraphRef="fca10" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f047b">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="d5fa1"/>
      <Point GraphRef="e572e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa744">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="e76c5"/>
      <Point GraphRef="cc97b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec8ad">
    <Graphics Color="999999">
      <Point GraphRef="d17e4"/>
      <Point GraphRef="e746d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9e80">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="e572e"/>
      <Point GraphRef="a9d07" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b4ee8">
    <Graphics Color="0000ff">
      <Point GraphRef="a7bc6"/>
      <Point GraphRef="ce455" ArrowHead="Arrow"/>
      <Anchor Position="0.4024866589646249" Shape="None" GraphId="b7af4"/>
      <Anchor Position="0.5015129009187431" Shape="None" GraphId="b3935"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2ef9">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="c0e80"/>
      <Point GraphRef="ea88d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b61b2">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="aec7a"/>
      <Point GraphRef="c0e80" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba7ca">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="aec7a"/>
      <Point GraphRef="a3827" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bc5b4">
    <Comment>is composed of</Comment>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="aec7a"/>
      <Point GraphRef="c2d04" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e1288">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point GraphRef="bed05"/>
      <Point GraphRef="acb03" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cba00">
    <Comment>reduction</Comment>
    <Graphics ConnectorType="Elbow" Color="0000ff">
      <Point GraphRef="af991"/>
      <Point/>
      <Point/>
      <Point GraphRef="d77b8" ArrowHead="Arrow"/>
      <Anchor Position="0.4796380090497738" Shape="None" GraphId="ef8df"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b3199">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="d3b5a"/>
      <Point GraphRef="c4d7d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b9bea">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="c2267"/>
      <Point GraphRef="a37df" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9c8a">
    <Graphics Color="0000ff">
      <Point GraphRef="a9cb3"/>
      <Point GraphRef="ee8f2" ArrowHead="Arrow"/>
      <Anchor Position="0.4405609146455994" Shape="None" GraphId="ecd33"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a52f9">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e262a"/>
      <Point GraphRef="a7bc6" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2827">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b73ed"/>
      <Point GraphRef="a9427" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6bdf">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="c28d2"/>
      <Point GraphRef="ff750" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa10b">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="d832d"/>
      <Point/>
      <Point GraphRef="f3cc5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="abe88">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a2e9b"/>
      <Point/>
      <Point GraphRef="e887f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afa69">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ee4b4"/>
      <Point/>
      <Point GraphRef="ce144" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b427a">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="a9b63" ArrowHead="Arrow"/>
      <Point GraphRef="f74e0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b639c">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="f4722"/>
      <Point GraphRef="d6714" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="baad2">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="eaeb5"/>
      <Point/>
      <Point GraphRef="beae1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bff65">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="b491c"/>
      <Point/>
      <Point GraphRef="c4a3d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c88cf">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="eea23"/>
      <Point GraphRef="e8b87" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c9298">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="c48de"/>
      <Point GraphRef="edda5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb67e">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="ae520"/>
      <Point GraphRef="e2257" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cbbac">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="bd650"/>
      <Point/>
      <Point/>
      <Point GraphRef="bf4fe" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0ab7">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="ea7fa"/>
      <Point/>
      <Point/>
      <Point GraphRef="e063c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d65cf">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="e3d61"/>
      <Point GraphRef="c38a5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d90fc">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="fcf18"/>
      <Point GraphRef="ab76c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e4693">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="bc4fd"/>
      <Point GraphRef="ce5f2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e92ea">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a7107"/>
      <Point/>
      <Point GraphRef="f6b17" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e93a2">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="a85a9"/>
      <Point/>
      <Point GraphRef="e223c" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="efc9e">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="e93f4" ArrowHead="Arrow"/>
      <Point/>
      <Point GraphRef="c75f4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f569c">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics ConnectorType="Elbow" Color="ff0070">
      <Point GraphRef="f3dd1"/>
      <Point/>
      <Point GraphRef="f2509" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb9df">
    <Comment>From intracellular part to the plasma</Comment>
    <Graphics Color="ff0070">
      <Point GraphRef="b220a" ArrowHead="Arrow"/>
      <Point GraphRef="d58ca"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b5c74">
    <Graphics Color="0000ff">
      <Point GraphRef="bc30c"/>
      <Point GraphRef="fa566" ArrowHead="Arrow"/>
      <Anchor Position="0.4816753926701571" Shape="None" GraphId="a67f4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bba83">
    <Graphics Color="0000ff">
      <Point GraphRef="ce4a7"/>
      <Point GraphRef="bb0ab" ArrowHead="mim-conversion"/>
      <Anchor Position="0.48662386302835786" Shape="None" GraphId="acd22"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b9e2b">
    <Graphics Color="999999">
      <Point GraphRef="f560b"/>
      <Point GraphRef="acd22" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff22b">
    <Graphics Color="999999">
      <Point GraphRef="fe0eb"/>
      <Point GraphRef="b6a6e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ed7d8">
    <Graphics Color="999999">
      <Point GraphRef="cf958"/>
      <Point GraphRef="a59f4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8082">
    <Graphics Color="999999">
      <Point GraphRef="d1714"/>
      <Point GraphRef="e3510" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf918">
    <Graphics Color="999998">
      <Point GraphRef="cc807"/>
      <Point GraphRef="a67f4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c85b7">
    <Graphics Color="999899">
      <Point GraphRef="bed9f"/>
      <Point GraphRef="a2976" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="acb1e">
    <Graphics Color="999999">
      <Point GraphRef="e87bc"/>
      <Point GraphRef="cc9de" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="de54b">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="c4fa0"/>
      <Point/>
      <Point GraphRef="ef8df" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c8612">
    <Graphics Color="999999">
      <Point GraphRef="cbf20"/>
      <Point GraphRef="ecd33" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd43b">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="aaa29"/>
      <Point/>
      <Point GraphRef="ae2b3" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec499">
    <Graphics Color="999999">
      <Point GraphRef="b59a0"/>
      <Point GraphRef="ef45b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bfb6d">
    <Graphics Color="999999">
      <Point GraphRef="fe0eb"/>
      <Point GraphRef="c4706" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e995d">
    <Graphics Color="999999">
      <Point GraphRef="fe0eb"/>
      <Point GraphRef="e83e0" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba45e">
    <Graphics>
      <Point GraphRef="b3e60"/>
      <Point GraphRef="b6a6e" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6d5c">
    <Graphics>
      <Point GraphRef="fd89b"/>
      <Point GraphRef="fa480" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf4d0">
    <Graphics>
      <Point GraphRef="ff44e"/>
      <Point GraphRef="a391d" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f40b5">
    <Graphics>
      <Point GraphRef="a0653"/>
      <Point GraphRef="ecd33" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dca1c">
    <Graphics>
      <Point GraphRef="d9733"/>
      <Point GraphRef="a67f4" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6619">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="ddf81"/>
      <Point/>
      <Point GraphRef="c347a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e723b">
    <Graphics Color="999999">
      <Point GraphRef="b544e"/>
      <Point GraphRef="c1821" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df367">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="aaa29"/>
      <Point/>
      <Point GraphRef="f8c27" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f529f">
    <Graphics>
      <Point GraphRef="bb33d"/>
      <Point GraphRef="a7bc6" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="be877">
    <Graphics Color="999999">
      <Point GraphRef="d63c5"/>
      <Point GraphRef="d677d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c56c0">
    <Graphics Color="999999">
      <Point GraphRef="d657b"/>
      <Point GraphRef="d677d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f9a75">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b2db8" ArrowHead="mim-binding"/>
      <Point GraphRef="fc144"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a54cf">
    <Graphics Color="999999">
      <Point GraphRef="d63c5"/>
      <Point GraphRef="f2942" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db907">
    <Graphics Color="999999">
      <Point GraphRef="d657b"/>
      <Point GraphRef="f2942" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c897b">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="d63c5"/>
      <Point GraphRef="a79d6" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6b05">
    <Graphics Color="999999">
      <Point GraphRef="f74ca"/>
      <Point GraphRef="fb7f1" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c8a3a">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="f09fb"/>
      <Point GraphRef="c03f1" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db0bd">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="f09fb"/>
      <Point/>
      <Point GraphRef="f8635" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b065c">
    <Graphics>
      <Point GraphRef="ae2b3" ArrowHead="mim-stimulation"/>
      <Point GraphRef="b044b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c4a79">
    <Graphics Color="999999">
      <Point GraphRef="c35a9"/>
      <Point GraphRef="d31ab" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d19f4">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="c7ac2"/>
      <Point GraphRef="b64d9" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e0c8f">
    <Graphics>
      <Point GraphRef="b5519"/>
      <Point GraphRef="b64d9" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2df0">
    <Graphics>
      <Point GraphRef="a760e"/>
      <Point GraphRef="b64d9" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb456">
    <Graphics Color="999999">
      <Point GraphRef="c7ac2"/>
      <Point GraphRef="fcb14" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e50af">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="b7af4" ArrowHead="mim-catalysis"/>
      <Point/>
      <Point GraphRef="aaa29"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7408">
    <Graphics>
      <Point GraphRef="b044b"/>
      <Point GraphRef="b3935" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fde01">
    <Graphics ConnectorType="Elbow" Color="999999">
      <Point GraphRef="d63c5"/>
      <Point/>
      <Point GraphRef="c3400" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d1426">
    <Graphics Color="999999">
      <Point GraphRef="a85a9"/>
      <Point GraphRef="d2e29" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e790d">
    <Graphics Color="999999">
      <Point GraphRef="ea7fa"/>
      <Point GraphRef="ede30" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="a14cc">
    <Graphics Color="999999">
      <Point/>
      <Point ArrowHead="mim-catalysis"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a5409">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-cleavage"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b0734">
    <Graphics>
      <Point GraphRef="d58ca"/>
      <Point ArrowHead="LigandRound"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b7751">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c5bc7">
    <Comment>is composed of</Comment>
    <Graphics Color="00cc00">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c744f">
    <Comment>is composed of</Comment>
    <Graphics LineStyle="Broken" Color="ff99ff">
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c74f0">
    <Graphics>
      <Point GraphRef="b142a"/>
      <Point ArrowHead="LigandRound"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cae92">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e1567">
    <Graphics>
      <Point/>
      <Point ArrowHead="Receptor"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e9801">
    <Graphics>
      <Point GraphRef="bddef"/>
      <Point ArrowHead="Receptor"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eabc2">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-inhibition"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ec031">
    <Graphics LineStyle="Broken" Color="ff9900">
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="edff3">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eec28">
    <Graphics Color="0000ff">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f117c">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-binding"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f5574">
    <Comment>is composed of</Comment>
    <Graphics Color="ff0070">
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fc626">
    <Graphics Color="ffff00">
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c85b6">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e3c96">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Metabolic stress" GraphId="a02f1">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Cofactor conversion" GraphId="a059f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Necessary stimulation" GraphId="a3dea">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Micronutrients" GraphId="a474b">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Oxidative stress" GraphId="a6b86">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Selenoproteins" GraphId="a7eb9">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Transcription factor" GraphId="ab21a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Leukotriene metabolism" GraphId="b1e69">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Other proteins" GraphId="b3726">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Reaction" GraphId="b4c83">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Overarching process" GraphId="b93b5">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="From intracellular part to the plasma" GraphId="b95dd">
    <Comment>is composed of</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Lipoprotein melabolism" GraphId="b9c59">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Prostaglandins metabolism" GraphId="ba375">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Protein tyrosine nitration" GraphId="bda98">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Process or metabolism involved in Se Pathway" GraphId="c17a5">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Inhibition" GraphId="c28a1">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Enzymes" GraphId="c4091">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Status" GraphId="ccadd">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Cleavage" GraphId="d6499">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Cofactors" GraphId="d7108">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Glycogenesis" GraphId="d8262">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Inflammation and &#10;immune response" GraphId="da61c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Binding" GraphId="dd8c9">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Catalysis" GraphId="dfa68">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Negative Effect" GraphId="e280f">
    <Comment>Negative Effect</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Conversion" GraphId="e2f08">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Metabolites" GraphId="e5b27">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Stimulation" GraphId="eba9a">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Ca++ metabolism" GraphId="ec19f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Lipid peroxidation" GraphId="ec849">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="LEGEND" GraphId="ed694">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Tryptophan metabolism" GraphId="f0219">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Biomarker for" GraphId="f9360">
    <Comment>is composed of</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Selenium status" GraphId="fd8c3">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="is composed of" GraphId="fe6f7">
    <Comment>is composed of</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Intracellular" GraphId="dc21c">
    <Graphics FillColor="ffffff" Color="993300"/>
  </Label>
  <Label TextLabel="NAD+ metabolism" GraphId="aebfc">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="ER protein folding" GraphId="dde74">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Glutathione metabolism" GraphId="e925f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Folate metabolism" GraphId="ec374" GroupRef="ee6ab">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="DNA oxidation" GraphId="eeb3d">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Plasma" GraphId="ca5e5">
    <Graphics FillColor="ffffff" Color="993300"/>
  </Label>
  <Shape GraphId="acb03">
    <BiopaxRef>aff</BiopaxRef>
    <BiopaxRef>fec</BiopaxRef>
    <BiopaxRef>a89</BiopaxRef>
    <BiopaxRef>c2b</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="ea88d">
    <BiopaxRef>fec</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="f5c78">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="a1e8b">
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="a796c">
    <Graphics FillColor="ff3333" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="aec7a">
    <BiopaxRef>f11</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="b0fbe">
    <BiopaxRef>d0b</BiopaxRef>
    <BiopaxRef>bf9</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="b2db8">
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="b35fd">
    <BiopaxRef>b59</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="b56c2">
    <BiopaxRef>b53</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="bd97d">
    <BiopaxRef>d63</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="cab62">
    <Graphics FillColor="ffff00" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="cc5ff">
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>e99</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="cf0a1">
    <Graphics FillColor="ff0000" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="ea0e1">
    <BiopaxRef>c83</BiopaxRef>
    <BiopaxRef>b76</BiopaxRef>
    <BiopaxRef>d6f</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="ee9d3">
    <Graphics FillColor="ffff00" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="f533a">
    <Graphics FillColor="ffff00" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="fb442">
    <Comment>overarching p</Comment>
    <Graphics FillColor="ffff00" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="d5fa1">
    <BiopaxRef>ae3</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="dddb6">
    <BiopaxRef>f4c</BiopaxRef>
    <BiopaxRef>a89</BiopaxRef>
    <BiopaxRef>fb2</BiopaxRef>
    <BiopaxRef>d09</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="e76c5">
    <BiopaxRef>d0b</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="d2293" GroupRef="ee6ab">
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="e1aaf">
    <BiopaxRef>be4</BiopaxRef>
    <Graphics FillColor="99ccff" ShapeType="Oval"/>
  </Shape>
  <Shape GraphId="a9813">
    <Graphics ShapeType="Rectangle" Color="ff0000"/>
  </Shape>
  <Shape GraphId="afaa4">
    <Graphics ShapeType="Rectangle" Color="ffff00"/>
  </Shape>
  <Shape GraphId="b520d">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="bff80">
    <Graphics ShapeType="Rectangle" Color="ff00ff"/>
  </Shape>
  <Shape GraphId="c40f8">
    <Graphics ShapeType="Rectangle" Color="ffcc00"/>
  </Shape>
  <Shape GraphId="cf019">
    <Graphics ShapeType="Rectangle" Color="999999"/>
  </Shape>
  <Shape GraphId="ea338">
    <Graphics ShapeType="Rectangle" Color="009933"/>
  </Shape>
  <Group GroupId="c57bc" GraphId="bd96b" Style="Complex">
    <BiopaxRef>ad3</BiopaxRef>
  </Group>
  <Group GroupId="afe71" GraphId="ddf81" Style="Group">
    <BiopaxRef>f4a</BiopaxRef>
    <BiopaxRef>e64</BiopaxRef>
    <BiopaxRef>a4c</BiopaxRef>
    <BiopaxRef>fad</BiopaxRef>
    <BiopaxRef>b30</BiopaxRef>
    <BiopaxRef>c82</BiopaxRef>
    <BiopaxRef>ad3</BiopaxRef>
    <BiopaxRef>ade</BiopaxRef>
    <BiopaxRef>eec</BiopaxRef>
    <BiopaxRef>da2</BiopaxRef>
    <BiopaxRef>a9f</BiopaxRef>
    <BiopaxRef>a40</BiopaxRef>
  </Group>
  <Group GroupId="ee6ab" GraphId="dfa65" Style="Group">
    <BiopaxRef>c2d</BiopaxRef>
  </Group>
  <Group GroupId="ae815" GraphId="e87bc" Style="Group">
    <BiopaxRef>ae2</BiopaxRef>
    <BiopaxRef>f84</BiopaxRef>
  </Group>
  <Group GroupId="e46d6" GraphId="f44de" Style="Complex">
    <BiopaxRef>af4</BiopaxRef>
  </Group>
  <Group GroupId="c1ae6" GraphId="fbbc3" Style="Group">
    <BiopaxRef>f1f</BiopaxRef>
  </Group>
  <Group GroupId="e0614" GraphId="fe0eb" Style="Group">
    <BiopaxRef>a3f</BiopaxRef>
    <BiopaxRef>f1f</BiopaxRef>
    <BiopaxRef>abc</BiopaxRef>
    <BiopaxRef>f97</BiopaxRef>
  </Group>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a6d">
      <bp:ID >218223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Needleman P</bp:AUTHORS>
      <bp:AUTHORS >Raz A</bp:AUTHORS>
      <bp:AUTHORS >Minkes MS</bp:AUTHORS>
      <bp:AUTHORS >Ferrendelli JA</bp:AUTHORS>
      <bp:AUTHORS >Sprecher H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af0">
      <bp:ID >16962588</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Lu C</bp:AUTHORS>
      <bp:AUTHORS >Qiu F</bp:AUTHORS>
      <bp:AUTHORS >Zhou H</bp:AUTHORS>
      <bp:AUTHORS >Peng Y</bp:AUTHORS>
      <bp:AUTHORS >Hao W</bp:AUTHORS>
      <bp:AUTHORS >Xu J</bp:AUTHORS>
      <bp:AUTHORS >Yuan J</bp:AUTHORS>
      <bp:AUTHORS >Wang S</bp:AUTHORS>
      <bp:AUTHORS >Qiang B</bp:AUTHORS>
      <bp:AUTHORS >Xu C</bp:AUTHORS>
      <bp:AUTHORS >Peng X</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f15">
      <bp:ID >8846925</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Free radicals, uric acid, and human disease.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med.</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8846925</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Free radicals, uric acid, and human disease.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med.</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Proctor PH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c47">
      <bp:ID >19014349</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification and characterization of human phosphatidylserine synthase 1 and 2.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Tomohiro S</bp:AUTHORS>
      <bp:AUTHORS >Kawaguti A</bp:AUTHORS>
      <bp:AUTHORS >Kawabe Y</bp:AUTHORS>
      <bp:AUTHORS >Kitada S</bp:AUTHORS>
      <bp:AUTHORS >Kuge O</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce5">
      <bp:ID >1730245</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:AUTHORS >Franken PA</bp:AUTHORS>
      <bp:AUTHORS >Van den Berg L</bp:AUTHORS>
      <bp:AUTHORS >Huang J</bp:AUTHORS>
      <bp:AUTHORS >Gunyuzlu P</bp:AUTHORS>
      <bp:AUTHORS >Lugtigheid RB</bp:AUTHORS>
      <bp:AUTHORS >Verheij HM</bp:AUTHORS>
      <bp:AUTHORS >De Haas GH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbd">
      <bp:ID >11731805</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Domain alternation switches B(12)-dependent methionine synthase to the activation conformation.</bp:TITLE>
      <bp:SOURCE >Nat Struct Biol.</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Bandarian V</bp:AUTHORS>
      <bp:AUTHORS >Pattridge KA</bp:AUTHORS>
      <bp:AUTHORS >Lennon BW</bp:AUTHORS>
      <bp:AUTHORS >Huddler DP</bp:AUTHORS>
      <bp:AUTHORS >Matthews RG</bp:AUTHORS>
      <bp:AUTHORS >Ludwig ML.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a53">
      <bp:ID >17508906</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >From selenium to selenoproteins: synthesis, identity, and their role in human health.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:ID >17508906</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >From selenium to selenoproteins: synthesis, identity, and their role in human health.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Papp LV</bp:AUTHORS>
      <bp:AUTHORS >Lu J</bp:AUTHORS>
      <bp:AUTHORS >Holmgren A</bp:AUTHORS>
      <bp:AUTHORS >Khanna KK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd7">
      <bp:ID >17477829</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assay.</bp:TITLE>
      <bp:SOURCE >Assay Drug Dev Technol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Glickman JF</bp:AUTHORS>
      <bp:AUTHORS >Schmid A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f11">
      <bp:ID >19415921</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins.</bp:TITLE>
      <bp:SOURCE >J Proteome Res</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Abello N</bp:AUTHORS>
      <bp:AUTHORS >Kerstjens HA</bp:AUTHORS>
      <bp:AUTHORS >Postma DS</bp:AUTHORS>
      <bp:AUTHORS >Bischoff R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a96">
      <bp:ID >18541719</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Semnani RT</bp:AUTHORS>
      <bp:AUTHORS >Venugopal PG</bp:AUTHORS>
      <bp:AUTHORS >Leifer CA</bp:AUTHORS>
      <bp:AUTHORS >Mostb&#195;&#402;&#198;&#8217;&#195;&#8218;&#226;&#8364;&#185;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#226;&#8364;&#160;ck S</bp:AUTHORS>
      <bp:AUTHORS >Sabzevari H</bp:AUTHORS>
      <bp:AUTHORS >Nutman TB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd5">
      <bp:ID >15670717</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.</bp:TITLE>
      <bp:SOURCE >Mol Genet Metab</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Correa-Cerro LS</bp:AUTHORS>
      <bp:AUTHORS >Porter FD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a05">
      <bp:ID >15063746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress - SelS is a novel glucose-regulated protein.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Gao Y</bp:AUTHORS>
      <bp:AUTHORS >Feng HC</bp:AUTHORS>
      <bp:AUTHORS >Walder K</bp:AUTHORS>
      <bp:AUTHORS >Bolton K</bp:AUTHORS>
      <bp:AUTHORS >Sunderland T</bp:AUTHORS>
      <bp:AUTHORS >Bishara N</bp:AUTHORS>
      <bp:AUTHORS >Quick M</bp:AUTHORS>
      <bp:AUTHORS >Kantham L</bp:AUTHORS>
      <bp:AUTHORS >Collier GR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b5c">
      <bp:ID >17296604</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Johnson J</bp:AUTHORS>
      <bp:AUTHORS >Albarani V</bp:AUTHORS>
      <bp:AUTHORS >Nguyen M</bp:AUTHORS>
      <bp:AUTHORS >Goldman M</bp:AUTHORS>
      <bp:AUTHORS >Willems F</bp:AUTHORS>
      <bp:AUTHORS >Aksoy E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e66">
      <bp:ID >17049925</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.</bp:TITLE>
      <bp:SOURCE >Trends Mol Med</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Videla LA</bp:AUTHORS>
      <bp:AUTHORS >Rodrigo R</bp:AUTHORS>
      <bp:AUTHORS >Araya J</bp:AUTHORS>
      <bp:AUTHORS >Poniachik J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf3">
      <bp:ID >10448523</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Homocysteine metabolism.</bp:TITLE>
      <bp:SOURCE >Annu Rev Nutr</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Selhub J.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d34">
      <bp:ID >190267</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >1977</bp:YEAR>
      <bp:AUTHORS >Minkes M</bp:AUTHORS>
      <bp:AUTHORS >Stanford N</bp:AUTHORS>
      <bp:AUTHORS >Chi MM</bp:AUTHORS>
      <bp:AUTHORS >Roth GJ</bp:AUTHORS>
      <bp:AUTHORS >Raz A</bp:AUTHORS>
      <bp:AUTHORS >Needleman P</bp:AUTHORS>
      <bp:AUTHORS >Majerus PW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed4">
      <bp:ID >16951403</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >16951403</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Spassieva S</bp:AUTHORS>
      <bp:AUTHORS >Seo JG</bp:AUTHORS>
      <bp:AUTHORS >Jiang JC</bp:AUTHORS>
      <bp:AUTHORS >Bielawski J</bp:AUTHORS>
      <bp:AUTHORS >Alvarez-Vasquez F</bp:AUTHORS>
      <bp:AUTHORS >Jazwinski SM</bp:AUTHORS>
      <bp:AUTHORS >Hannun YA</bp:AUTHORS>
      <bp:AUTHORS >Obeid LM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="abc">
      <bp:ID >8769129</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Arn&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169;r ES</bp:AUTHORS>
      <bp:AUTHORS >Nordberg J</bp:AUTHORS>
      <bp:AUTHORS >Holmgren A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b76">
      <bp:ID >19769461</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signalling and calcium homeostasis.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Sandrine A</bp:AUTHORS>
      <bp:AUTHORS >Ferreiro A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1f">
      <bp:ID >11264458</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Properties and biological activities of thioredoxins.</bp:TITLE>
      <bp:SOURCE >Annu Rev Pharmacol Toxicol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11264458</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Properties and biological activities of thioredoxins.</bp:TITLE>
      <bp:SOURCE >Annu Rev Pharmacol Toxicol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Powis G</bp:AUTHORS>
      <bp:AUTHORS >Montfort WR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3c">
      <bp:ID >1708392</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Cali JJ</bp:AUTHORS>
      <bp:AUTHORS >Russell DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dab">
      <bp:ID >6295699</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin B12 binders (transcobalamins) in serum.</bp:TITLE>
      <bp:SOURCE >Crit Rev Clin Lab Sci.</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Fernandes-Costa F: Metz J.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c89">
      <bp:ID >4386961</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >4386961</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Biosynthesis of dihydrosphingosine in vitro.</bp:TITLE>
      <bp:SOURCE >Hoppe Seylers Z Physiol Chem</bp:SOURCE>
      <bp:YEAR >1968</bp:YEAR>
      <bp:AUTHORS >Stoffel W</bp:AUTHORS>
      <bp:AUTHORS >LeKim D</bp:AUTHORS>
      <bp:AUTHORS >Sticht G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3f">
      <bp:ID >18757362</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoproteins.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Lu J</bp:AUTHORS>
      <bp:AUTHORS >Holmgren A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb6">
      <bp:ID >12062442</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein W is a glutathione-dependent antioxidant in vivo.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Jeong D</bp:AUTHORS>
      <bp:AUTHORS >Kim TS</bp:AUTHORS>
      <bp:AUTHORS >Chung YW</bp:AUTHORS>
      <bp:AUTHORS >Lee BJ</bp:AUTHORS>
      <bp:AUTHORS >Kim IY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d74">
      <bp:ID >15536089</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CTP: Phosphocholine cytidylyltransferase: paving the way from gene to membrane.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Jackowski S</bp:AUTHORS>
      <bp:AUTHORS >Fagone P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e1b">
      <bp:ID >25935</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sphingomyelinase in pig and human epidermis.</bp:TITLE>
      <bp:SOURCE >J Invest Dermatol</bp:SOURCE>
      <bp:YEAR >1978</bp:YEAR>
      <bp:AUTHORS >Bowser PA</bp:AUTHORS>
      <bp:AUTHORS >Gray GM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e44">
      <bp:ID >2174886</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Leukotriene E4 elimination and metabolism in normal human subjects.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1990</bp:YEAR>
      <bp:AUTHORS >Sala A</bp:AUTHORS>
      <bp:AUTHORS >Voelkel N</bp:AUTHORS>
      <bp:AUTHORS >Maclouf J</bp:AUTHORS>
      <bp:AUTHORS >Murphy RC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3e">
      <bp:ID >16698314</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Malle E</bp:AUTHORS>
      <bp:AUTHORS >Marsche G</bp:AUTHORS>
      <bp:AUTHORS >Arnhold J</bp:AUTHORS>
      <bp:AUTHORS >Davies MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc6">
      <bp:ID >9873062</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Liu YY</bp:AUTHORS>
      <bp:AUTHORS >Han TY</bp:AUTHORS>
      <bp:AUTHORS >Giuliano AE</bp:AUTHORS>
      <bp:AUTHORS >Cabot MC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb3">
      <bp:ID >9730949</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E.</bp:TITLE>
      <bp:SOURCE >Am J Physiol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Wu D</bp:AUTHORS>
      <bp:AUTHORS >Mura C</bp:AUTHORS>
      <bp:AUTHORS >Beharka AA</bp:AUTHORS>
      <bp:AUTHORS >Han SN</bp:AUTHORS>
      <bp:AUTHORS >Paulson KE</bp:AUTHORS>
      <bp:AUTHORS >Hwang D</bp:AUTHORS>
      <bp:AUTHORS >Meydani SN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b37">
      <bp:ID >11412116</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Pikuleva IA</bp:AUTHORS>
      <bp:AUTHORS >Puchkaev A</bp:AUTHORS>
      <bp:AUTHORS >Bj&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;rkhem I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de0">
      <bp:ID >18498226</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evolution of catalases from bacteria to humans.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Zamocky M</bp:AUTHORS>
      <bp:AUTHORS >Furtm&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;ller PG</bp:AUTHORS>
      <bp:AUTHORS >Obinger C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dac">
      <bp:ID >2246616</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >2246616</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serine-palmitoyl transferase activity in cultured human keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1990</bp:YEAR>
      <bp:AUTHORS >Holleran WM</bp:AUTHORS>
      <bp:AUTHORS >Williams ML</bp:AUTHORS>
      <bp:AUTHORS >Gao WN</bp:AUTHORS>
      <bp:AUTHORS >Elias PM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f38">
      <bp:ID >17912575</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis.</bp:TITLE>
      <bp:SOURCE >Clin Rheumatol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Kalpakcioglu B</bp:AUTHORS>
      <bp:AUTHORS >Senel K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ffd">
      <bp:ID >17389926</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation.</bp:TITLE>
      <bp:SOURCE >Int J Biol Sci</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Ben Jilani KE</bp:AUTHORS>
      <bp:AUTHORS >Panee J</bp:AUTHORS>
      <bp:AUTHORS >He Q</bp:AUTHORS>
      <bp:AUTHORS >Berry MJ</bp:AUTHORS>
      <bp:AUTHORS >Li PA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a00">
      <bp:ID >19413181</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?</bp:TITLE>
      <bp:SOURCE >Pol Arch Med Wewn</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Wu C</bp:AUTHORS>
      <bp:AUTHORS >Bates SM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c9c">
      <bp:ID >12627223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mechanism of metal activation of human hematopoietic prostaglandin D synthase.</bp:TITLE>
      <bp:SOURCE >Nat Struct Biol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Inoue T</bp:AUTHORS>
      <bp:AUTHORS >Irikura D</bp:AUTHORS>
      <bp:AUTHORS >Okazaki N</bp:AUTHORS>
      <bp:AUTHORS >Kinugasa S</bp:AUTHORS>
      <bp:AUTHORS >Matsumura H</bp:AUTHORS>
      <bp:AUTHORS >Uodome N</bp:AUTHORS>
      <bp:AUTHORS >Yamamoto M</bp:AUTHORS>
      <bp:AUTHORS >Kumasaka T</bp:AUTHORS>
      <bp:AUTHORS >Miyano M</bp:AUTHORS>
      <bp:AUTHORS >Kai Y</bp:AUTHORS>
      <bp:AUTHORS >Urade Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a48">
      <bp:ID >9789062</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Ghosh J</bp:AUTHORS>
      <bp:AUTHORS >Myers CE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c7a">
      <bp:ID >19403638</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials.</bp:TITLE>
      <bp:SOURCE >Am J Clin Nutr</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Hoey L</bp:AUTHORS>
      <bp:AUTHORS >Strain JJ</bp:AUTHORS>
      <bp:AUTHORS >McNulty H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc0">
      <bp:ID >19464347</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein expression and function-Selenoprotein W.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Whanger PD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b93">
      <bp:ID >8386626</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Generation of phosphatidic acid during calcium-loading of human erythrocytes. Evidence for a phosphatidylcholine-hydrolyzing phospholipase D.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >B&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;tikofer P</bp:AUTHORS>
      <bp:AUTHORS >Yee MC</bp:AUTHORS>
      <bp:AUTHORS >Schott MA</bp:AUTHORS>
      <bp:AUTHORS >Lubin BH</bp:AUTHORS>
      <bp:AUTHORS >Kuypers FA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd0">
      <bp:ID >11215511</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein W: a review.</bp:TITLE>
      <bp:SOURCE >Cell Mol Life Sci</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Whanger PD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfe">
      <bp:ID >5637427</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lipogenesis in human adipose tissue.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1968</bp:YEAR>
      <bp:AUTHORS >Galton DJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1f">
      <bp:ID >11939906</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Levin G</bp:AUTHORS>
      <bp:AUTHORS >Duffin KL</bp:AUTHORS>
      <bp:AUTHORS >Obukowicz MG</bp:AUTHORS>
      <bp:AUTHORS >Hummert SL</bp:AUTHORS>
      <bp:AUTHORS >Fujiwara H</bp:AUTHORS>
      <bp:AUTHORS >Needleman P</bp:AUTHORS>
      <bp:AUTHORS >Raz A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aeb">
      <bp:ID >9407135</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Lykidis A</bp:AUTHORS>
      <bp:AUTHORS >Jackson PD</bp:AUTHORS>
      <bp:AUTHORS >Rock CO</bp:AUTHORS>
      <bp:AUTHORS >Jackowski S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc7">
      <bp:ID >19674315</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants.</bp:TITLE>
      <bp:SOURCE >Nephrology (Carlton)</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Adams RL</bp:AUTHORS>
      <bp:AUTHORS >Bird RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d29">
      <bp:ID >10653827</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes.</bp:TITLE>
      <bp:SOURCE >Circulation</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Al-Obaidi MK</bp:AUTHORS>
      <bp:AUTHORS >Philippou H</bp:AUTHORS>
      <bp:AUTHORS >Stubbs PJ</bp:AUTHORS>
      <bp:AUTHORS >Adami A</bp:AUTHORS>
      <bp:AUTHORS >Amersey R</bp:AUTHORS>
      <bp:AUTHORS >Noble MM</bp:AUTHORS>
      <bp:AUTHORS >Lane DA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b4a">
      <bp:ID >9368067</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Paz K</bp:AUTHORS>
      <bp:AUTHORS >Hemi R</bp:AUTHORS>
      <bp:AUTHORS >LeRoith D</bp:AUTHORS>
      <bp:AUTHORS >Karasik A</bp:AUTHORS>
      <bp:AUTHORS >Elhanany E</bp:AUTHORS>
      <bp:AUTHORS >Kanety H</bp:AUTHORS>
      <bp:AUTHORS >Zick Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aea">
      <bp:ID >7288293</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholesterol 7 alpha-hydroxylase from human liver: partial purification and reconstruction into defined phospholipid-cholesterol vesicles.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1981</bp:YEAR>
      <bp:AUTHORS >Erickson SK</bp:AUTHORS>
      <bp:AUTHORS >B&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;sterling B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af9">
      <bp:ID >15680232</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Heterogeneity and function of mammalian MSRs: enzymes for repair, protection and regulation.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Hansel A</bp:AUTHORS>
      <bp:AUTHORS >Heinemann SH</bp:AUTHORS>
      <bp:AUTHORS >Hoshi T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecb">
      <bp:ID >19013211</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.</bp:TITLE>
      <bp:SOURCE >Mol Cell Endocrinol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Lee WH</bp:AUTHORS>
      <bp:AUTHORS >Lukacik P</bp:AUTHORS>
      <bp:AUTHORS >Guo K</bp:AUTHORS>
      <bp:AUTHORS >Ugochukwu E</bp:AUTHORS>
      <bp:AUTHORS >Kavanagh KL</bp:AUTHORS>
      <bp:AUTHORS >Marsden B</bp:AUTHORS>
      <bp:AUTHORS >Oppermann U</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2d">
      <bp:ID >19450180</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of the MTHFR polymorphisms in cancer risk modification and treatment.</bp:TITLE>
      <bp:SOURCE >Future Oncol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:ID >19450180</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of the MTHFR polymorphisms in cancer risk modification and treatment.</bp:TITLE>
      <bp:SOURCE >Future Oncol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Kim YI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab8">
      <bp:ID >228272</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Faust JR</bp:AUTHORS>
      <bp:AUTHORS >Goldstein JL</bp:AUTHORS>
      <bp:AUTHORS >Brown MS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5f">
      <bp:ID >12895592</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-lipoxygenase and FLAP.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Leukot Essent Fatty Acids</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Peters-Golden M</bp:AUTHORS>
      <bp:AUTHORS >Brock TG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba4">
      <bp:ID >18927507</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >FoxO1 integrates insulin signaling to VLDL production.</bp:TITLE>
      <bp:SOURCE >Cell Cycle</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Kamagate A</bp:AUTHORS>
      <bp:AUTHORS >Dong HH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da3">
      <bp:ID >15851485</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Gautier G</bp:AUTHORS>
      <bp:AUTHORS >Humbert M</bp:AUTHORS>
      <bp:AUTHORS >Deauvieau F</bp:AUTHORS>
      <bp:AUTHORS >Scuiller M</bp:AUTHORS>
      <bp:AUTHORS >Hiscott J</bp:AUTHORS>
      <bp:AUTHORS >Bates EE</bp:AUTHORS>
      <bp:AUTHORS >Trinchieri G</bp:AUTHORS>
      <bp:AUTHORS >Caux C</bp:AUTHORS>
      <bp:AUTHORS >Garrone P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c9b">
      <bp:ID >6113262</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Acyl-CoA:cholesterol acyltransferase in human small intestine: its activity and some properties of the enzymic reaction.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1981</bp:YEAR>
      <bp:AUTHORS >Helgerud P</bp:AUTHORS>
      <bp:AUTHORS >Saarem K</bp:AUTHORS>
      <bp:AUTHORS >Norum KR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af4">
      <bp:ID >11251339</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Does inflammation contribute to thrombotic events?</bp:TITLE>
      <bp:SOURCE >Haemostasis</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Esmon CT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e11">
      <bp:ID >11878747</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over.</bp:TITLE>
      <bp:SOURCE >J Trace Elem Med Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Bates CJ</bp:AUTHORS>
      <bp:AUTHORS >Thane CW</bp:AUTHORS>
      <bp:AUTHORS >Prentice A</bp:AUTHORS>
      <bp:AUTHORS >Delves HT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9f">
      <bp:ID >11878747</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over.</bp:TITLE>
      <bp:SOURCE >J Trace Elem Med Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Bates CJ</bp:AUTHORS>
      <bp:AUTHORS >Thane CW</bp:AUTHORS>
      <bp:AUTHORS >Prentice A</bp:AUTHORS>
      <bp:AUTHORS >Delves HT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="be4">
      <bp:ID >2602371</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1989</bp:YEAR>
      <bp:AUTHORS >Shigenaga MK</bp:AUTHORS>
      <bp:AUTHORS >Gimeno CJ</bp:AUTHORS>
      <bp:AUTHORS >Ames BN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e34">
      <bp:ID >16202558</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy.</bp:TITLE>
      <bp:SOURCE >Biomed Pharmacother</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Kovacs E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2b">
      <bp:ID >15689384</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Myeloperoxidase: friend and foe.</bp:TITLE>
      <bp:SOURCE >J Leukoc Biol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Klebanoff SJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a4c">
      <bp:ID >9442035</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Imai H</bp:AUTHORS>
      <bp:AUTHORS >Narashima K</bp:AUTHORS>
      <bp:AUTHORS >Arai M</bp:AUTHORS>
      <bp:AUTHORS >Sakamoto H</bp:AUTHORS>
      <bp:AUTHORS >Chiba N</bp:AUTHORS>
      <bp:AUTHORS >Nakagawa Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ddc">
      <bp:ID >18680158</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pyridoxine 5'-phosphate oxidase, not pyridoxal kinase, involves in long-term potentiation induction in the rat dentate gyrus.</bp:TITLE>
      <bp:SOURCE >Hippocampus</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Kwak SE</bp:AUTHORS>
      <bp:AUTHORS >Kim JE</bp:AUTHORS>
      <bp:AUTHORS >Kim DW</bp:AUTHORS>
      <bp:AUTHORS >Kwon OS</bp:AUTHORS>
      <bp:AUTHORS >Choi SY</bp:AUTHORS>
      <bp:AUTHORS >Kang TC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f6c">
      <bp:ID >11964182</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of alpha-methylacyl-CoA racemase in bile acid synthesis.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Cuebas DA</bp:AUTHORS>
      <bp:AUTHORS >Phillips C</bp:AUTHORS>
      <bp:AUTHORS >Schmitz W</bp:AUTHORS>
      <bp:AUTHORS >Conzelmann E</bp:AUTHORS>
      <bp:AUTHORS >Novikov DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7d">
      <bp:ID >15940673</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.</bp:TITLE>
      <bp:SOURCE >Eur J Immunol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Aksoy E</bp:AUTHORS>
      <bp:AUTHORS >Vanden Berghe W</bp:AUTHORS>
      <bp:AUTHORS >Detienne S</bp:AUTHORS>
      <bp:AUTHORS >Amraoui Z</bp:AUTHORS>
      <bp:AUTHORS >Fitzgerald KA</bp:AUTHORS>
      <bp:AUTHORS >Haegeman G</bp:AUTHORS>
      <bp:AUTHORS >Goldman M</bp:AUTHORS>
      <bp:AUTHORS >Willems F</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d63">
      <bp:ID >10064852</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lipid peroxidation-DNA damage by malondialdehyde.</bp:TITLE>
      <bp:SOURCE >Mutat Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Marnett LJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7b">
      <bp:ID >230492</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Whitaker MO</bp:AUTHORS>
      <bp:AUTHORS >Wyche A</bp:AUTHORS>
      <bp:AUTHORS >Fitzpatrick F</bp:AUTHORS>
      <bp:AUTHORS >Sprecher H</bp:AUTHORS>
      <bp:AUTHORS >Needleman P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab5">
      <bp:ID >9242711</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Eberhardt C</bp:AUTHORS>
      <bp:AUTHORS >Gray PW</bp:AUTHORS>
      <bp:AUTHORS >Tjoelker LW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a62">
      <bp:ID >8534261</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The isoprostanes. Current knowledge and directions for future research.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol.</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Morrow JD</bp:AUTHORS>
      <bp:AUTHORS >Roberts LJ 2nd.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8d">
      <bp:ID >19660687</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Omega-3 polyunsaturated fatty acids and cardiovascular diseases.</bp:TITLE>
      <bp:SOURCE >J Am Coll Cardiol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Lavie CJ</bp:AUTHORS>
      <bp:AUTHORS >Milani RV</bp:AUTHORS>
      <bp:AUTHORS >Mehra MR</bp:AUTHORS>
      <bp:AUTHORS >Ventura HO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd4">
      <bp:ID >14726604</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide and superoxide in inflammation and immune regulation.</bp:TITLE>
      <bp:SOURCE >J Physiol Pharmacol.</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Guzik TJ</bp:AUTHORS>
      <bp:AUTHORS >Korbut R</bp:AUTHORS>
      <bp:AUTHORS >Adamek-Guzik T.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fad">
      <bp:ID >1848655</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Huwyler J</bp:AUTHORS>
      <bp:AUTHORS >B&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;rgin M</bp:AUTHORS>
      <bp:AUTHORS >Zeugin T</bp:AUTHORS>
      <bp:AUTHORS >Gut J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aac">
      <bp:ID >16698314</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Malle E</bp:AUTHORS>
      <bp:AUTHORS >Marsche G</bp:AUTHORS>
      <bp:AUTHORS >Arnhold J</bp:AUTHORS>
      <bp:AUTHORS >Davies MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6d">
      <bp:ID >7278682</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phospholipase D from rat brain.</bp:TITLE>
      <bp:SOURCE >Methods Enzymol</bp:SOURCE>
      <bp:YEAR >1981</bp:YEAR>
      <bp:AUTHORS >Taki T</bp:AUTHORS>
      <bp:AUTHORS >Kanfer JN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db6">
      <bp:ID >16911361</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.</bp:TITLE>
      <bp:SOURCE >Clin Exp Allergy</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Matsukura S</bp:AUTHORS>
      <bp:AUTHORS >Kokubu F</bp:AUTHORS>
      <bp:AUTHORS >Kurokawa M</bp:AUTHORS>
      <bp:AUTHORS >Kawaguchi M</bp:AUTHORS>
      <bp:AUTHORS >Ieki K</bp:AUTHORS>
      <bp:AUTHORS >Kuga H</bp:AUTHORS>
      <bp:AUTHORS >Odaka M</bp:AUTHORS>
      <bp:AUTHORS >Suzuki S</bp:AUTHORS>
      <bp:AUTHORS >Watanabe S</bp:AUTHORS>
      <bp:AUTHORS >Takeuchi H</bp:AUTHORS>
      <bp:AUTHORS >Kasama T</bp:AUTHORS>
      <bp:AUTHORS >Adachi M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cef">
      <bp:ID >11307174</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >11307174</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hemoglobin variants and determination of glycated hemoglobin (HbA1c).</bp:TITLE>
      <bp:SOURCE >Diabetes Metab Res Rev</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Schnedl WJ</bp:AUTHORS>
      <bp:AUTHORS >Liebminger A</bp:AUTHORS>
      <bp:AUTHORS >Roller RE</bp:AUTHORS>
      <bp:AUTHORS >Lipp RW</bp:AUTHORS>
      <bp:AUTHORS >Krejs GJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c37">
      <bp:ID >15925209</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Simultaneous determination of unbound thyroid hormones in human plasma using high performance frontal analysis with electrochemical detection.</bp:TITLE>
      <bp:SOURCE >J Pharm Biomed Anal</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Kimura T</bp:AUTHORS>
      <bp:AUTHORS >Nakanishi K</bp:AUTHORS>
      <bp:AUTHORS >Nakagawa T</bp:AUTHORS>
      <bp:AUTHORS >Shibukawa A</bp:AUTHORS>
      <bp:AUTHORS >Matsuzaki K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4f">
      <bp:ID >8386433</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fatty acid metabolism in health and disease: the role of delta-6-desaturase.</bp:TITLE>
      <bp:SOURCE >Am J Clin Nutr</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Horrobin DF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf5">
      <bp:ID >10216279</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Araya Z</bp:AUTHORS>
      <bp:AUTHORS >Wikvall K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b30">
      <bp:ID >18761324</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:ID >18761324</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Moreno JJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e37">
      <bp:ID >16219795</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Goriely S</bp:AUTHORS>
      <bp:AUTHORS >Molle C</bp:AUTHORS>
      <bp:AUTHORS >Nguyen M</bp:AUTHORS>
      <bp:AUTHORS >Albarani V</bp:AUTHORS>
      <bp:AUTHORS >Haddou NO</bp:AUTHORS>
      <bp:AUTHORS >Lin R</bp:AUTHORS>
      <bp:AUTHORS >De Wit D</bp:AUTHORS>
      <bp:AUTHORS >Flamand V</bp:AUTHORS>
      <bp:AUTHORS >Willems F</bp:AUTHORS>
      <bp:AUTHORS >Goldman M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae0">
      <bp:ID >1618328</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cloning of a human choline kinase cDNA by complementation of the yeast cki mutation.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:AUTHORS >Hosaka K</bp:AUTHORS>
      <bp:AUTHORS >Tanaka S</bp:AUTHORS>
      <bp:AUTHORS >Nikawa J</bp:AUTHORS>
      <bp:AUTHORS >Yamashita S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f43">
      <bp:ID >8440384</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-lipoxygenase-activating protein is an arachidonate binding protein.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:ID >8440384</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-lipoxygenase-activating protein is an arachidonate binding protein.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Mancini JA</bp:AUTHORS>
      <bp:AUTHORS >Abramovitz M</bp:AUTHORS>
      <bp:AUTHORS >Cox ME</bp:AUTHORS>
      <bp:AUTHORS >Wong E</bp:AUTHORS>
      <bp:AUTHORS >Charleson S</bp:AUTHORS>
      <bp:AUTHORS >Perrier H</bp:AUTHORS>
      <bp:AUTHORS >Wang Z</bp:AUTHORS>
      <bp:AUTHORS >Prasit P</bp:AUTHORS>
      <bp:AUTHORS >Vickers PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee5">
      <bp:ID >3099851</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >UDPgalactose:glucosylceramide beta 1----4-galactosyltransferase activity in human proximal tubular cells from normal and familial hypercholesterolemic homozygotes.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1987</bp:YEAR>
      <bp:AUTHORS >Chatterjee S</bp:AUTHORS>
      <bp:AUTHORS >Castiglione E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a40">
      <bp:ID >17960332</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serum selenium concentrations correlate significantly with inflammatory biomarker high-sensitive CRP levels in Hungarian gestational diabetic and healthy pregnant women at mid-pregnancy.</bp:TITLE>
      <bp:SOURCE >Biol Trace Elem Res</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Molnar J</bp:AUTHORS>
      <bp:AUTHORS >Garamvolgyi Z</bp:AUTHORS>
      <bp:AUTHORS >Herold M</bp:AUTHORS>
      <bp:AUTHORS >Adanyi N</bp:AUTHORS>
      <bp:AUTHORS >Somogyi A</bp:AUTHORS>
      <bp:AUTHORS >Rigo J Jr</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8c">
      <bp:ID >11413152</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Why there are two cyclooxygenase isozymes.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Smith WL</bp:AUTHORS>
      <bp:AUTHORS >Langenbach R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee3">
      <bp:ID >932041</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sphingolipid base metabolism. Stereospecific uptake of proton in the enzymatic conversion of sphinganine 1-phosphate to ethanolamine 1-phosphate.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Shimojo T</bp:AUTHORS>
      <bp:AUTHORS >Akino T</bp:AUTHORS>
      <bp:AUTHORS >Miura Y</bp:AUTHORS>
      <bp:AUTHORS >Schroepfer GJ Jr</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db9">
      <bp:ID >9535873</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A new human selenium-containing protein. Purification, characterization, and cDNA sequence.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Gladyshev VN</bp:AUTHORS>
      <bp:AUTHORS >Jeang KT</bp:AUTHORS>
      <bp:AUTHORS >Wootton JC</bp:AUTHORS>
      <bp:AUTHORS >Hatfield DL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e73">
      <bp:ID >18428149</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.</bp:TITLE>
      <bp:SOURCE >J Med Virol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Miyazaki M</bp:AUTHORS>
      <bp:AUTHORS >Kanto T</bp:AUTHORS>
      <bp:AUTHORS >Inoue M</bp:AUTHORS>
      <bp:AUTHORS >Itose I</bp:AUTHORS>
      <bp:AUTHORS >Miyatake H</bp:AUTHORS>
      <bp:AUTHORS >Sakakibara M</bp:AUTHORS>
      <bp:AUTHORS >Yakushijin T</bp:AUTHORS>
      <bp:AUTHORS >Kakita N</bp:AUTHORS>
      <bp:AUTHORS >Hiramatsu N</bp:AUTHORS>
      <bp:AUTHORS >Takehara T</bp:AUTHORS>
      <bp:AUTHORS >Kasahara A</bp:AUTHORS>
      <bp:AUTHORS >Hayashi N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ceb">
      <bp:ID >11090610</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide is a physiological substrate for mammalian peroxidases.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >11090610</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide is a physiological substrate for mammalian peroxidases.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Abu-Soud HM</bp:AUTHORS>
      <bp:AUTHORS >Hazen SL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea2">
      <bp:ID >4086942</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >Clifton PM</bp:AUTHORS>
      <bp:AUTHORS >Mackinnon AM</bp:AUTHORS>
      <bp:AUTHORS >Barter PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cdb">
      <bp:ID >14749265</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.</bp:TITLE>
      <bp:SOURCE >Diabetes</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Ferr&#233; P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="caf">
      <bp:ID >17311055</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study.</bp:TITLE>
      <bp:SOURCE >Eur J Clin Nutr</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Scheurig AC</bp:AUTHORS>
      <bp:AUTHORS >Thorand B</bp:AUTHORS>
      <bp:AUTHORS >Fischer B</bp:AUTHORS>
      <bp:AUTHORS >Heier M</bp:AUTHORS>
      <bp:AUTHORS >Koenig W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d99">
      <bp:ID >9099683</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cloning of a novel human diacylglycerol kinase (DGKtheta) containing three cysteine-rich domains, a proline-rich region, and a pleckstrin homology domain with an overlapping Ras-associating domain.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Houssa B</bp:AUTHORS>
      <bp:AUTHORS >Schaap D</bp:AUTHORS>
      <bp:AUTHORS >van der Wal J</bp:AUTHORS>
      <bp:AUTHORS >Goto K</bp:AUTHORS>
      <bp:AUTHORS >Kondo H</bp:AUTHORS>
      <bp:AUTHORS >Yamakawa A</bp:AUTHORS>
      <bp:AUTHORS >Shibata M</bp:AUTHORS>
      <bp:AUTHORS >Takenawa T</bp:AUTHORS>
      <bp:AUTHORS >van Blitterswijk WJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e68">
      <bp:ID >2448410</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >2448410</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Conversion of linoleic acid into arachidonic acid by cultured murine and human keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1987</bp:YEAR>
      <bp:AUTHORS >Isseroff RR</bp:AUTHORS>
      <bp:AUTHORS >Ziboh VA</bp:AUTHORS>
      <bp:AUTHORS >Chapkin RS</bp:AUTHORS>
      <bp:AUTHORS >Martinez DT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0b">
      <bp:ID >17016550</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Deiodinases: implications of the local control of thyroid hormone action.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Bianco AC</bp:AUTHORS>
      <bp:AUTHORS >Kim BW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb2">
      <bp:ID >16319061</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:ID >16319061</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Ferguson AD</bp:AUTHORS>
      <bp:AUTHORS >Labunskyy VM</bp:AUTHORS>
      <bp:AUTHORS >Fomenko DE</bp:AUTHORS>
      <bp:AUTHORS >Ara&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#167; D</bp:AUTHORS>
      <bp:AUTHORS >Chelliah Y</bp:AUTHORS>
      <bp:AUTHORS >Amezcua CA</bp:AUTHORS>
      <bp:AUTHORS >Rizo J</bp:AUTHORS>
      <bp:AUTHORS >Gladyshev VN</bp:AUTHORS>
      <bp:AUTHORS >Deisenhofer J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d98">
      <bp:ID >7429333</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Studies on long chain fatty acid:CoA ligase from human small intestine.</bp:TITLE>
      <bp:SOURCE >Gut</bp:SOURCE>
      <bp:YEAR >1980</bp:YEAR>
      <bp:AUTHORS >Bierbach H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed9">
      <bp:ID >2992548</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin E: interactions with free radicals and ascorbate.</bp:TITLE>
      <bp:SOURCE >Annu Rev Nutr</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >McCay PB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebb">
      <bp:ID >14726604</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide and superoxide in inflammation and immune regulation.</bp:TITLE>
      <bp:SOURCE >J Physiol Pharmacol.</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Guzik TJ</bp:AUTHORS>
      <bp:AUTHORS >Korbut R</bp:AUTHORS>
      <bp:AUTHORS >Adamek-Guzik T.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe6">
      <bp:ID >19825219</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study.</bp:TITLE>
      <bp:SOURCE >Br J Nutr</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Joensen AM</bp:AUTHORS>
      <bp:AUTHORS >Schmidt EB</bp:AUTHORS>
      <bp:AUTHORS >Dethlefsen C</bp:AUTHORS>
      <bp:AUTHORS >Johnsen SP</bp:AUTHORS>
      <bp:AUTHORS >Tj&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#184;nneland A</bp:AUTHORS>
      <bp:AUTHORS >Rasmussen LH</bp:AUTHORS>
      <bp:AUTHORS >Overvad K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb6">
      <bp:ID >12432931</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Prostaglandin E synthase.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Other Lipid Mediat</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Murakami M</bp:AUTHORS>
      <bp:AUTHORS >Nakatani Y</bp:AUTHORS>
      <bp:AUTHORS >Tanioka T</bp:AUTHORS>
      <bp:AUTHORS >Kudo I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b77">
      <bp:ID >18424738</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Bosschaerts T</bp:AUTHORS>
      <bp:AUTHORS >Guilliams M</bp:AUTHORS>
      <bp:AUTHORS >Noel W</bp:AUTHORS>
      <bp:AUTHORS >H&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169;rin M</bp:AUTHORS>
      <bp:AUTHORS >Burk RF</bp:AUTHORS>
      <bp:AUTHORS >Hill KE</bp:AUTHORS>
      <bp:AUTHORS >Brys L</bp:AUTHORS>
      <bp:AUTHORS >Raes G</bp:AUTHORS>
      <bp:AUTHORS >Ghassabeh GH</bp:AUTHORS>
      <bp:AUTHORS >De Baetselier P</bp:AUTHORS>
      <bp:AUTHORS >Beschin A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e15">
      <bp:ID >8806705</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human isopentenyl diphosphate: dimethylallyl diphosphate isomerase: overproduction, purification, and characterization.</bp:TITLE>
      <bp:SOURCE >Arch Biochem Biophys</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Hahn FM</bp:AUTHORS>
      <bp:AUTHORS >Xuan JW</bp:AUTHORS>
      <bp:AUTHORS >Chambers AF</bp:AUTHORS>
      <bp:AUTHORS >Poulter CD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e51">
      <bp:ID >12679481</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease.</bp:TITLE>
      <bp:SOURCE >J Clin Endocrinol Metab</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Cheng JB</bp:AUTHORS>
      <bp:AUTHORS >Jacquemin E</bp:AUTHORS>
      <bp:AUTHORS >Gerhardt M</bp:AUTHORS>
      <bp:AUTHORS >Nazer H</bp:AUTHORS>
      <bp:AUTHORS >Cresteil D</bp:AUTHORS>
      <bp:AUTHORS >Heubi JE</bp:AUTHORS>
      <bp:AUTHORS >Setchell KD</bp:AUTHORS>
      <bp:AUTHORS >Russell DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8b">
      <bp:ID >10666321</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cloning, heterologous expression, and enzymological characterization of human squalene monooxygenase.</bp:TITLE>
      <bp:SOURCE >Arch Biochem Biophys</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Laden BP</bp:AUTHORS>
      <bp:AUTHORS >Tang Y</bp:AUTHORS>
      <bp:AUTHORS >Porter TD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e88">
      <bp:ID >14993240</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Yang P</bp:AUTHORS>
      <bp:AUTHORS >Chan D</bp:AUTHORS>
      <bp:AUTHORS >Felix E</bp:AUTHORS>
      <bp:AUTHORS >Cartwright C</bp:AUTHORS>
      <bp:AUTHORS >Menter DG</bp:AUTHORS>
      <bp:AUTHORS >Madden T</bp:AUTHORS>
      <bp:AUTHORS >Klein RD</bp:AUTHORS>
      <bp:AUTHORS >Fischer SM</bp:AUTHORS>
      <bp:AUTHORS >Newman RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4a">
      <bp:ID >10569628</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Tissue-specific functions of individual glutathione peroxidases.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:ID >10569628</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Tissue-specific functions of individual glutathione peroxidases.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Brigelius-Floh&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d00">
      <bp:ID >9737710</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase in biology and disease.</bp:TITLE>
      <bp:SOURCE >FASEB J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Dubois RN</bp:AUTHORS>
      <bp:AUTHORS >Abramson SB</bp:AUTHORS>
      <bp:AUTHORS >Crofford L</bp:AUTHORS>
      <bp:AUTHORS >Gupta RA</bp:AUTHORS>
      <bp:AUTHORS >Simon LS</bp:AUTHORS>
      <bp:AUTHORS >Van De Putte LB</bp:AUTHORS>
      <bp:AUTHORS >Lipsky PE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f54">
      <bp:ID >9852097</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Lund EG</bp:AUTHORS>
      <bp:AUTHORS >Kerr TA</bp:AUTHORS>
      <bp:AUTHORS >Sakai J</bp:AUTHORS>
      <bp:AUTHORS >Li WP</bp:AUTHORS>
      <bp:AUTHORS >Russell DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b5e">
      <bp:ID >2870496</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Localization of the gene encoding 3-hydroxy-3-methylglutaryl-coenzyme A synthase to human chromosome 5.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1986</bp:YEAR>
      <bp:AUTHORS >Leonard S</bp:AUTHORS>
      <bp:AUTHORS >Arbogast D</bp:AUTHORS>
      <bp:AUTHORS >Geyer D</bp:AUTHORS>
      <bp:AUTHORS >Jones C</bp:AUTHORS>
      <bp:AUTHORS >Sinensky M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9b">
      <bp:ID >10048303</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease.</bp:TITLE>
      <bp:SOURCE >Bioessays</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Janciauskiene S</bp:AUTHORS>
      <bp:AUTHORS >Wright HT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca3">
      <bp:ID >8301225</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c52">
      <bp:ID >17439363</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin E regulatory mechanisms.</bp:TITLE>
      <bp:SOURCE >Annu Rev Nutr</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:ID >17439363</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin E regulatory mechanisms.</bp:TITLE>
      <bp:SOURCE >Annu Rev Nutr</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Traber MG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a64">
      <bp:ID >3046314</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin B-12: plant sources, requirements, and assay.</bp:TITLE>
      <bp:SOURCE >Am J Clin Nutr</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Herbert V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d2a">
      <bp:ID >4355366</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1973</bp:YEAR>
      <bp:AUTHORS >Goldstein JL</bp:AUTHORS>
      <bp:AUTHORS >Brown MS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7a">
      <bp:ID >11460480</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Elements of the fibrinolytic system.</bp:TITLE>
      <bp:SOURCE >Ann N Y Acad Sci</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lijnen HR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a9f">
      <bp:ID >9075838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients.</bp:TITLE>
      <bp:SOURCE >Transplantation</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Hussein O</bp:AUTHORS>
      <bp:AUTHORS >Rosenblat M</bp:AUTHORS>
      <bp:AUTHORS >Refael G</bp:AUTHORS>
      <bp:AUTHORS >Aviram M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf2">
      <bp:ID >11839807</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Korotkov KV</bp:AUTHORS>
      <bp:AUTHORS >Novoselov SV</bp:AUTHORS>
      <bp:AUTHORS >Hatfield DL</bp:AUTHORS>
      <bp:AUTHORS >Gladyshev VN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5d">
      <bp:ID >15189125</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases.</bp:TITLE>
      <bp:SOURCE >Annu Rev Nutr</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Nakamura MT</bp:AUTHORS>
      <bp:AUTHORS >Nara TY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d0b">
      <bp:ID >14704851</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Enzymology of NAD+ homeostasis in man.</bp:TITLE>
      <bp:SOURCE >Cell Mol Life Sci</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Magni G</bp:AUTHORS>
      <bp:AUTHORS >Amici A</bp:AUTHORS>
      <bp:AUTHORS >Emanuelli M</bp:AUTHORS>
      <bp:AUTHORS >Orsomando G</bp:AUTHORS>
      <bp:AUTHORS >Raffaelli N</bp:AUTHORS>
      <bp:AUTHORS >Ruggieri S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebc">
      <bp:ID >17283068</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Kraveka JM</bp:AUTHORS>
      <bp:AUTHORS >Li L</bp:AUTHORS>
      <bp:AUTHORS >Szulc ZM</bp:AUTHORS>
      <bp:AUTHORS >Bielawski J</bp:AUTHORS>
      <bp:AUTHORS >Ogretmen B</bp:AUTHORS>
      <bp:AUTHORS >Hannun YA</bp:AUTHORS>
      <bp:AUTHORS >Obeid LM</bp:AUTHORS>
      <bp:AUTHORS >Bielawska A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae5">
      <bp:ID >10191291</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Olivier LM</bp:AUTHORS>
      <bp:AUTHORS >Chambliss KL</bp:AUTHORS>
      <bp:AUTHORS >Gibson KM</bp:AUTHORS>
      <bp:AUTHORS >Krisans SK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cfc">
      <bp:ID >4690137</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Enzymic studies on phosphatidic acid synthesis in human platelets.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >1973</bp:YEAR>
      <bp:AUTHORS >Okuma M</bp:AUTHORS>
      <bp:AUTHORS >Yamashita S</bp:AUTHORS>
      <bp:AUTHORS >Numa S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f84">
      <bp:ID >12231557</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity.</bp:TITLE>
      <bp:SOURCE >Arterioscler Thromb Vasc Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hink HU</bp:AUTHORS>
      <bp:AUTHORS >Santanam N</bp:AUTHORS>
      <bp:AUTHORS >Dikalov S</bp:AUTHORS>
      <bp:AUTHORS >McCann L</bp:AUTHORS>
      <bp:AUTHORS >Nguyen AD</bp:AUTHORS>
      <bp:AUTHORS >Parthasarathy S</bp:AUTHORS>
      <bp:AUTHORS >Harrison DG</bp:AUTHORS>
      <bp:AUTHORS >Fukai T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b21">
      <bp:ID >19375431</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure and mechanism of a eukaryotic FMN adenylyltransferase.</bp:TITLE>
      <bp:SOURCE >J Mol Biol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Huerta C</bp:AUTHORS>
      <bp:AUTHORS >Borek D</bp:AUTHORS>
      <bp:AUTHORS >Machius M</bp:AUTHORS>
      <bp:AUTHORS >Grishin NV</bp:AUTHORS>
      <bp:AUTHORS >Zhang H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb8">
      <bp:ID >458381</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Goetzl EJ</bp:AUTHORS>
      <bp:AUTHORS >Sun FF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb6">
      <bp:ID >17534535</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Properties of an unusual heme cofactor in PLP-dependent cystathionine beta-synthase.</bp:TITLE>
      <bp:SOURCE >Nat Prod Rep</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:ID >17534535</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Properties of an unusual heme cofactor in PLP-dependent cystathionine beta-synthase.</bp:TITLE>
      <bp:SOURCE >Nat Prod Rep</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Singh S</bp:AUTHORS>
      <bp:AUTHORS >Madzelan P</bp:AUTHORS>
      <bp:AUTHORS >Banerjee R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="add">
      <bp:ID >12432932</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Prostaglandin F synthase.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Other Lipid Mediat</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Watanabe K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbd">
      <bp:ID >6300970</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone</bp:TITLE>
      <bp:SOURCE >Prostaglandins.</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:ID >6300970</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone</bp:TITLE>
      <bp:SOURCE >Prostaglandins.</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Denis D</bp:AUTHORS>
      <bp:AUTHORS >Charleson S</bp:AUTHORS>
      <bp:AUTHORS >Rackham A</bp:AUTHORS>
      <bp:AUTHORS >Jones TR</bp:AUTHORS>
      <bp:AUTHORS >Ford-Hutchinson AW</bp:AUTHORS>
      <bp:AUTHORS >Lord A, Cirino M</bp:AUTHORS>
      <bp:AUTHORS >Girard Y</bp:AUTHORS>
      <bp:AUTHORS >Larue M</bp:AUTHORS>
      <bp:AUTHORS >Rokach J.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4c">
      <bp:ID >11044454</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lykidis A</bp:AUTHORS>
      <bp:AUTHORS >Wang J</bp:AUTHORS>
      <bp:AUTHORS >Karim MA</bp:AUTHORS>
      <bp:AUTHORS >Jackowski S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb9">
      <bp:ID >1848582</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of human neutrophil superoxide generation by alpha 1-antichymotrypsin.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Kilpatrick L</bp:AUTHORS>
      <bp:AUTHORS >Johnson JL</bp:AUTHORS>
      <bp:AUTHORS >Nickbarg EB</bp:AUTHORS>
      <bp:AUTHORS >Wang ZM</bp:AUTHORS>
      <bp:AUTHORS >Clifford TF</bp:AUTHORS>
      <bp:AUTHORS >Banach M</bp:AUTHORS>
      <bp:AUTHORS >Cooperman BS</bp:AUTHORS>
      <bp:AUTHORS >Douglas SD</bp:AUTHORS>
      <bp:AUTHORS >Rubin H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4f">
      <bp:ID >9370338</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphatidylserine decarboxylase.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Voelker DR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e18">
      <bp:ID >10802064</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Functional characterization of human sphingosine kinase-1.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Nava VE</bp:AUTHORS>
      <bp:AUTHORS >Lacana E</bp:AUTHORS>
      <bp:AUTHORS >Poulton S</bp:AUTHORS>
      <bp:AUTHORS >Liu H</bp:AUTHORS>
      <bp:AUTHORS >Sugiura M</bp:AUTHORS>
      <bp:AUTHORS >Kono K</bp:AUTHORS>
      <bp:AUTHORS >Milstien S</bp:AUTHORS>
      <bp:AUTHORS >Kohama T</bp:AUTHORS>
      <bp:AUTHORS >Spiegel S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc2">
      <bp:ID >18522490</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18522490</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18522490</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Basu S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a41">
      <bp:ID >10101267</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of the GGPS1 genes encoding geranylgeranyl diphosphate synthases from mouse and human.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Kainou T</bp:AUTHORS>
      <bp:AUTHORS >Kawamura K</bp:AUTHORS>
      <bp:AUTHORS >Tanaka K</bp:AUTHORS>
      <bp:AUTHORS >Matsuda H</bp:AUTHORS>
      <bp:AUTHORS >Kawamukai M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6a">
      <bp:ID >6758698</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formation of ursodeoxycholic acid from chenodeoxycholic acid by a 7 beta-hydroxysteroid dehydrogenase-elaborating Eubacterium aerofaciens strain cocultured with 7 alpha-hydroxysteroid dehydrogenase-elaborating organisms.</bp:TITLE>
      <bp:SOURCE >Appl Environ Microbiol</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >MacDonald IA</bp:AUTHORS>
      <bp:AUTHORS >Rochon YP</bp:AUTHORS>
      <bp:AUTHORS >Hutchison DM</bp:AUTHORS>
      <bp:AUTHORS >Holdeman LV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e78">
      <bp:ID >8567691</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification and characterization of UDP-glucose:ceramide glucosyltransferase from rat liver Golgi membranes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Paul P</bp:AUTHORS>
      <bp:AUTHORS >Kamisaka Y</bp:AUTHORS>
      <bp:AUTHORS >Marks DL</bp:AUTHORS>
      <bp:AUTHORS >Pagano RE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ade">
      <bp:ID >16413410</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Blocking tumor cell eicosanoid synthesis by GP x 4 impedes tumor growth and malignancy.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Heirman I</bp:AUTHORS>
      <bp:AUTHORS >Ginneberge D</bp:AUTHORS>
      <bp:AUTHORS >Brigelius-Floh&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; R</bp:AUTHORS>
      <bp:AUTHORS >Hendrickx N</bp:AUTHORS>
      <bp:AUTHORS >Agostinis P</bp:AUTHORS>
      <bp:AUTHORS >Brouckaert P</bp:AUTHORS>
      <bp:AUTHORS >Rottiers P</bp:AUTHORS>
      <bp:AUTHORS >Grooten J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0f">
      <bp:ID >11861418</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Saavedra WF</bp:AUTHORS>
      <bp:AUTHORS >Paolocci N</bp:AUTHORS>
      <bp:AUTHORS >St John ME</bp:AUTHORS>
      <bp:AUTHORS >Skaf MW</bp:AUTHORS>
      <bp:AUTHORS >Stewart GC</bp:AUTHORS>
      <bp:AUTHORS >Xie JS</bp:AUTHORS>
      <bp:AUTHORS >Harrison RW</bp:AUTHORS>
      <bp:AUTHORS >Zeichner J</bp:AUTHORS>
      <bp:AUTHORS >Mudrick D</bp:AUTHORS>
      <bp:AUTHORS >Marb&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;n E</bp:AUTHORS>
      <bp:AUTHORS >Kass DA</bp:AUTHORS>
      <bp:AUTHORS >Hare JM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d18">
      <bp:ID >12432933</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Thromboxane synthase: structure and function of protein and gene.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Other Lipid Mediat</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Wang LH</bp:AUTHORS>
      <bp:AUTHORS >Kulmacz RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8e">
      <bp:ID >15780594</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenases, peroxide tone and the allure of fish oil.</bp:TITLE>
      <bp:SOURCE >Curr Opin Cell Biol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15780594</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenases, peroxide tone and the allure of fish oil.</bp:TITLE>
      <bp:SOURCE >Curr Opin Cell Biol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15780594</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenases, peroxide tone and the allure of fish oil.</bp:TITLE>
      <bp:SOURCE >Curr Opin Cell Biol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Smith WL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2c">
      <bp:ID >9767110</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Expression and characterization of human group V phospholipase A2.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Chen Y</bp:AUTHORS>
      <bp:AUTHORS >Dennis EA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2d">
      <bp:ID >9570154</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.</bp:TITLE>
      <bp:SOURCE >DNA Cell Biol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Leung DW</bp:AUTHORS>
      <bp:AUTHORS >Tompkins CK</bp:AUTHORS>
      <bp:AUTHORS >White T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b39">
      <bp:ID >11121721</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Abate A</bp:AUTHORS>
      <bp:AUTHORS >Yang G</bp:AUTHORS>
      <bp:AUTHORS >Dennery PA</bp:AUTHORS>
      <bp:AUTHORS >Oberle S</bp:AUTHORS>
      <bp:AUTHORS >Schr&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;der H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da2">
      <bp:ID >14642406</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants.</bp:TITLE>
      <bp:SOURCE >Atherosclerosis</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Sneddon AA</bp:AUTHORS>
      <bp:AUTHORS >Wu HC</bp:AUTHORS>
      <bp:AUTHORS >Farquharson A</bp:AUTHORS>
      <bp:AUTHORS >Grant I</bp:AUTHORS>
      <bp:AUTHORS >Arthur JR</bp:AUTHORS>
      <bp:AUTHORS >Rotondo D</bp:AUTHORS>
      <bp:AUTHORS >Choe SN</bp:AUTHORS>
      <bp:AUTHORS >Wahle KW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6f">
      <bp:ID >19557870</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment.</bp:TITLE>
      <bp:SOURCE >Ann Neurol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Arbogast S</bp:AUTHORS>
      <bp:AUTHORS >Beuvin M</bp:AUTHORS>
      <bp:AUTHORS >Fraysse B</bp:AUTHORS>
      <bp:AUTHORS >Zhou H</bp:AUTHORS>
      <bp:AUTHORS >Muntoni F</bp:AUTHORS>
      <bp:AUTHORS >Ferreiro A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec4">
      <bp:ID >18938145</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The controversial place of vitamin C in cancer treatment.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Verrax J</bp:AUTHORS>
      <bp:AUTHORS >Calderon PB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b60">
      <bp:ID >16547353</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1).</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Lu B</bp:AUTHORS>
      <bp:AUTHORS >Xu FY</bp:AUTHORS>
      <bp:AUTHORS >Jiang YJ</bp:AUTHORS>
      <bp:AUTHORS >Choy PC</bp:AUTHORS>
      <bp:AUTHORS >Hatch GM</bp:AUTHORS>
      <bp:AUTHORS >Grunfeld C</bp:AUTHORS>
      <bp:AUTHORS >Feingold KR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de8">
      <bp:ID >17511631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.</bp:TITLE>
      <bp:SOURCE >Biochem Soc Trans</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Karpe F</bp:AUTHORS>
      <bp:AUTHORS >Bickerton AS</bp:AUTHORS>
      <bp:AUTHORS >Hodson L</bp:AUTHORS>
      <bp:AUTHORS >Fielding BA</bp:AUTHORS>
      <bp:AUTHORS >Tan GD</bp:AUTHORS>
      <bp:AUTHORS >Frayn KN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c56">
      <bp:ID >3919061</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Bile acid synthesis during development. Mitochondrial 12 alpha-hydroxylation in human fetal liver.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >Gustafsson J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a2e">
      <bp:ID >7649494</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >alpha-Lipoic acid as a biological antioxidant.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Packer L</bp:AUTHORS>
      <bp:AUTHORS >Witt EH</bp:AUTHORS>
      <bp:AUTHORS >Tritschler HJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e71">
      <bp:ID >6311078</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Leukotrienes.</bp:TITLE>
      <bp:SOURCE >Annu Rev Biochem</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:ID >6311078</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Leukotrienes.</bp:TITLE>
      <bp:SOURCE >Annu Rev Biochem</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:AUTHORS >Hammarstr&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;m S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bac">
      <bp:ID >6884990</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification and characterization of amino-acid N-choloyltransferase from human liver.</bp:TITLE>
      <bp:SOURCE >Hoppe Seylers Z Physiol Chem</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:AUTHORS >Kimura M</bp:AUTHORS>
      <bp:AUTHORS >Okuno E</bp:AUTHORS>
      <bp:AUTHORS >Inada J</bp:AUTHORS>
      <bp:AUTHORS >Ohyama H</bp:AUTHORS>
      <bp:AUTHORS >Kido R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a89">
      <bp:ID >16174820</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenium, the thyroid, and the endocrine system.</bp:TITLE>
      <bp:SOURCE >Endocr Rev</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >16174820</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenium, the thyroid, and the endocrine system.</bp:TITLE>
      <bp:SOURCE >Endocr Rev</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >16174820</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenium, the thyroid, and the endocrine system.</bp:TITLE>
      <bp:SOURCE >Endocr Rev</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >K&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;hrle J</bp:AUTHORS>
      <bp:AUTHORS >Jakob F</bp:AUTHORS>
      <bp:AUTHORS >Contempr&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; B</bp:AUTHORS>
      <bp:AUTHORS >Dumont JE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d09">
      <bp:ID >15215856</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol.</bp:TITLE>
      <bp:SOURCE >Nature</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Ye Y</bp:AUTHORS>
      <bp:AUTHORS >Shibata Y</bp:AUTHORS>
      <bp:AUTHORS >Yun C</bp:AUTHORS>
      <bp:AUTHORS >Ron D</bp:AUTHORS>
      <bp:AUTHORS >Rapoport TA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd2">
      <bp:ID >9462665</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Bile acid synthesis in primary cultures of rat and human hepatocytes.</bp:TITLE>
      <bp:SOURCE >Hepatology</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Ellis E</bp:AUTHORS>
      <bp:AUTHORS >Goodwin B</bp:AUTHORS>
      <bp:AUTHORS >Abrahamsson A</bp:AUTHORS>
      <bp:AUTHORS >Liddle C</bp:AUTHORS>
      <bp:AUTHORS >Mode A</bp:AUTHORS>
      <bp:AUTHORS >Rudling M</bp:AUTHORS>
      <bp:AUTHORS >Bjorkhem I</bp:AUTHORS>
      <bp:AUTHORS >Einarsson C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bdc">
      <bp:ID >6814427</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Momoi T</bp:AUTHORS>
      <bp:AUTHORS >Ben-Yoseph Y</bp:AUTHORS>
      <bp:AUTHORS >Nadler HL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce6">
      <bp:ID >1848582</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of human neutrophil superoxide generation by alpha 1-antichymotrypsin.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Kilpatrick L</bp:AUTHORS>
      <bp:AUTHORS >Johnson JL</bp:AUTHORS>
      <bp:AUTHORS >Nickbarg EB</bp:AUTHORS>
      <bp:AUTHORS >Wang ZM</bp:AUTHORS>
      <bp:AUTHORS >Clifford TF</bp:AUTHORS>
      <bp:AUTHORS >Banach M</bp:AUTHORS>
      <bp:AUTHORS >Cooperman BS</bp:AUTHORS>
      <bp:AUTHORS >Douglas SD</bp:AUTHORS>
      <bp:AUTHORS >Rubin H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ad3">
      <bp:ID >17081103</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glutathione peroxidases and redox-regulated transcription factors.</bp:TITLE>
      <bp:SOURCE >Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Brigelius-Floh&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c68">
      <bp:ID >19268692</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protection against reactive oxygen species by selenoproteins.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Steinbrenner H</bp:AUTHORS>
      <bp:AUTHORS >Sies H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b59">
      <bp:ID >17713401</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glucose metabolism and catecholamines.</bp:TITLE>
      <bp:SOURCE >Crit Care Med</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Barth E</bp:AUTHORS>
      <bp:AUTHORS >Albuszies G</bp:AUTHORS>
      <bp:AUTHORS >Baumgart K</bp:AUTHORS>
      <bp:AUTHORS >Matejovic M</bp:AUTHORS>
      <bp:AUTHORS >Wachter U</bp:AUTHORS>
      <bp:AUTHORS >Vogt J</bp:AUTHORS>
      <bp:AUTHORS >Radermacher P</bp:AUTHORS>
      <bp:AUTHORS >Calzia E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eac">
      <bp:ID >18164739</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lathosterol side chain amides: a new class of human lathosterol oxidase inhibitors.</bp:TITLE>
      <bp:SOURCE >Steroids</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Giera M</bp:AUTHORS>
      <bp:AUTHORS >Renard D</bp:AUTHORS>
      <bp:AUTHORS >Pl&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;ssl F</bp:AUTHORS>
      <bp:AUTHORS >Bracher F</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b3f">
      <bp:ID >15585321</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of sphingosine and ceramide kinases in inflammatory responses.</bp:TITLE>
      <bp:SOURCE >Immunol Lett</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Baumruker T</bp:AUTHORS>
      <bp:AUTHORS >Bornancin F</bp:AUTHORS>
      <bp:AUTHORS >Billich A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebf">
      <bp:ID >17046972</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >NF-{kappa}B is required for STAT-4 expression during dendritic cell maturation.</bp:TITLE>
      <bp:SOURCE >J Leukoc Biol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Remoli ME</bp:AUTHORS>
      <bp:AUTHORS >Ragimbeau J</bp:AUTHORS>
      <bp:AUTHORS >Giacomini E</bp:AUTHORS>
      <bp:AUTHORS >Gafa V</bp:AUTHORS>
      <bp:AUTHORS >Severa M</bp:AUTHORS>
      <bp:AUTHORS >Lande R</bp:AUTHORS>
      <bp:AUTHORS >Pellegrini S</bp:AUTHORS>
      <bp:AUTHORS >Coccia EM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e3f">
      <bp:ID >18656701</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.</bp:TITLE>
      <bp:SOURCE >Immunobiology</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Ho AW</bp:AUTHORS>
      <bp:AUTHORS >Wong CK</bp:AUTHORS>
      <bp:AUTHORS >Lam CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a28">
      <bp:ID >11067870</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Schwarz M</bp:AUTHORS>
      <bp:AUTHORS >Wright AC</bp:AUTHORS>
      <bp:AUTHORS >Davis DL</bp:AUTHORS>
      <bp:AUTHORS >Nazer H</bp:AUTHORS>
      <bp:AUTHORS >Bj&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;rkhem I</bp:AUTHORS>
      <bp:AUTHORS >Russell DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a07">
      <bp:ID >10048303</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease.</bp:TITLE>
      <bp:SOURCE >Bioessays</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Janciauskiene S</bp:AUTHORS>
      <bp:AUTHORS >Wright HT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eed">
      <bp:ID >6418841</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:AUTHORS >Bailey JM</bp:AUTHORS>
      <bp:AUTHORS >Bryant RW</bp:AUTHORS>
      <bp:AUTHORS >Whiting J</bp:AUTHORS>
      <bp:AUTHORS >Salata K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fcb">
      <bp:ID >10471130</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >In vivo conversion of linoleic acid to arachidonic acid in human adults.</bp:TITLE>
      <bp:SOURCE >Prostaglandins Leukot Essent Fatty Acids</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Salem N Jr</bp:AUTHORS>
      <bp:AUTHORS >Pawlosky R</bp:AUTHORS>
      <bp:AUTHORS >Wegher B</bp:AUTHORS>
      <bp:AUTHORS >Hibbeln J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >classic metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000002</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="afb">
      <bp:ID >1377680</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:AUTHORS >Schafer BL</bp:AUTHORS>
      <bp:AUTHORS >Bishop RW</bp:AUTHORS>
      <bp:AUTHORS >Kratunis VJ</bp:AUTHORS>
      <bp:AUTHORS >Kalinowski SS</bp:AUTHORS>
      <bp:AUTHORS >Mosley ST</bp:AUTHORS>
      <bp:AUTHORS >Gibson KM</bp:AUTHORS>
      <bp:AUTHORS >Tanaka RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae3">
      <bp:ID >17526492</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >17526492</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein H is a redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Panee J</bp:AUTHORS>
      <bp:AUTHORS >Stoytcheva ZR</bp:AUTHORS>
      <bp:AUTHORS >Liu W</bp:AUTHORS>
      <bp:AUTHORS >Berry MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f70">
      <bp:ID >8656081</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Moore SA</bp:AUTHORS>
      <bp:AUTHORS >Hurt E</bp:AUTHORS>
      <bp:AUTHORS >Yoder E</bp:AUTHORS>
      <bp:AUTHORS >Sprecher H</bp:AUTHORS>
      <bp:AUTHORS >Spector AA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="adb">
      <bp:ID >14976195</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Yamaoka S</bp:AUTHORS>
      <bp:AUTHORS >Miyaji M</bp:AUTHORS>
      <bp:AUTHORS >Kitano T</bp:AUTHORS>
      <bp:AUTHORS >Umehara H</bp:AUTHORS>
      <bp:AUTHORS >Okazaki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d95">
      <bp:ID >9112289</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?</bp:TITLE>
      <bp:SOURCE >Prostaglandins</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9112289</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?</bp:TITLE>
      <bp:SOURCE >Prostaglandins</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Serhan CN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c9e">
      <bp:ID >19521349</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Basal and Fasting/Refeeding-regulated Tissue Levels of Endogenous PPAR-alpha Ligands in Zucker Rats.</bp:TITLE>
      <bp:SOURCE >Obesity (Silver Spring)</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Izzo AA</bp:AUTHORS>
      <bp:AUTHORS >Piscitelli F</bp:AUTHORS>
      <bp:AUTHORS >Capasso R</bp:AUTHORS>
      <bp:AUTHORS >Marini P</bp:AUTHORS>
      <bp:AUTHORS >Cristino L</bp:AUTHORS>
      <bp:AUTHORS >Petrosino S</bp:AUTHORS>
      <bp:AUTHORS >Di Marzo V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a87">
      <bp:ID >11519011</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Waterham HR</bp:AUTHORS>
      <bp:AUTHORS >Koster J</bp:AUTHORS>
      <bp:AUTHORS >Romeijn GJ</bp:AUTHORS>
      <bp:AUTHORS >Hennekam RC</bp:AUTHORS>
      <bp:AUTHORS >Vreken P</bp:AUTHORS>
      <bp:AUTHORS >Andersson HC</bp:AUTHORS>
      <bp:AUTHORS >FitzPatrick DR</bp:AUTHORS>
      <bp:AUTHORS >Kelley RI</bp:AUTHORS>
      <bp:AUTHORS >Wanders RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8e">
      <bp:ID >9683613</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Waterham HR</bp:AUTHORS>
      <bp:AUTHORS >Wijburg FA</bp:AUTHORS>
      <bp:AUTHORS >Hennekam RC</bp:AUTHORS>
      <bp:AUTHORS >Vreken P</bp:AUTHORS>
      <bp:AUTHORS >Poll-The BT</bp:AUTHORS>
      <bp:AUTHORS >Dorland L</bp:AUTHORS>
      <bp:AUTHORS >Duran M</bp:AUTHORS>
      <bp:AUTHORS >Jira PE</bp:AUTHORS>
      <bp:AUTHORS >Smeitink JA</bp:AUTHORS>
      <bp:AUTHORS >Wevers RA</bp:AUTHORS>
      <bp:AUTHORS >Wanders RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b05">
      <bp:ID >2876046</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Influence of the amino acid moiety on deconjugation of bile acid amidates by cholylglycine hydrolase or human fecal cultures.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1986</bp:YEAR>
      <bp:AUTHORS >Huijghebaert SM</bp:AUTHORS>
      <bp:AUTHORS >Hofmann AF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af3">
      <bp:ID >11761328</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The covalent FAD of monoamine oxidase: structural and functional role and mechanism of the flavinylation reaction.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Edmondson DE</bp:AUTHORS>
      <bp:AUTHORS >Newton-Vinson P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2b">
      <bp:ID >17927969</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.</bp:TITLE>
      <bp:SOURCE >Cell Immunol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Bohnenkamp HR</bp:AUTHORS>
      <bp:AUTHORS >Papazisis KT</bp:AUTHORS>
      <bp:AUTHORS >Burchell JM</bp:AUTHORS>
      <bp:AUTHORS >Taylor-Papadimitriou J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fec">
      <bp:ID >10842581</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Free radicals and hearing. Cause, consequence, and criteria.</bp:TITLE>
      <bp:SOURCE >Ann N Y Acad Sci</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Evans P</bp:AUTHORS>
      <bp:AUTHORS >Halliwell B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf9">
      <bp:ID >16251722</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Absorption and lipoprotein transport of sphingomyelin.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Nilsson A</bp:AUTHORS>
      <bp:AUTHORS >Duan RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e85">
      <bp:ID >16564093</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fatty acid elongases in mammals: their regulation and roles in metabolism.</bp:TITLE>
      <bp:SOURCE >Prog Lipid Res</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Jakobsson A</bp:AUTHORS>
      <bp:AUTHORS >Westerberg R</bp:AUTHORS>
      <bp:AUTHORS >Jacobsson A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5c">
      <bp:ID >11716958</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of type 2,5'-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue.</bp:TITLE>
      <bp:SOURCE >Immunol Lett</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Moln&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;r I</bp:AUTHORS>
      <bp:AUTHORS >Bal&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#161;zs C</bp:AUTHORS>
      <bp:AUTHORS >Szegedi G</bp:AUTHORS>
      <bp:AUTHORS >Sipka S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c25">
      <bp:ID >7577714</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cytochrome P450 CYP27-catalyzed oxidation of C27-steroid into C27-acid.</bp:TITLE>
      <bp:SOURCE >J Steroid Biochem Mol Biol</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Betsholtz IH</bp:AUTHORS>
      <bp:AUTHORS >Wikvall K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f17">
      <bp:ID >15837518</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fibrinogen and fibrin.</bp:TITLE>
      <bp:SOURCE >Adv Protein Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Weisel JW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4c">
      <bp:ID >17365173</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum.</bp:TITLE>
      <bp:SOURCE >IUBMB Life</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Labunskyy VM</bp:AUTHORS>
      <bp:AUTHORS >Hatfield DL</bp:AUTHORS>
      <bp:AUTHORS >Gladyshev VN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd2">
      <bp:ID >6300970</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone.</bp:TITLE>
      <bp:SOURCE >Prostaglandins.</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Denis D</bp:AUTHORS>
      <bp:AUTHORS >Charleson S</bp:AUTHORS>
      <bp:AUTHORS >Rackham A</bp:AUTHORS>
      <bp:AUTHORS >Jones TR</bp:AUTHORS>
      <bp:AUTHORS >Ford-Hutchinson AW</bp:AUTHORS>
      <bp:AUTHORS >Lord A</bp:AUTHORS>
      <bp:AUTHORS >Cirino M</bp:AUTHORS>
      <bp:AUTHORS >Girard Y</bp:AUTHORS>
      <bp:AUTHORS >Larue M</bp:AUTHORS>
      <bp:AUTHORS >Rokach J.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b35">
      <bp:ID >10880336</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sphingosine 1-phosphate signalling in mammalian cells.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Pyne S</bp:AUTHORS>
      <bp:AUTHORS >Pyne NJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c82">
      <bp:ID >8617728</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Schnurr K</bp:AUTHORS>
      <bp:AUTHORS >Belkner J</bp:AUTHORS>
      <bp:AUTHORS >Ursini F</bp:AUTHORS>
      <bp:AUTHORS >Schewe T</bp:AUTHORS>
      <bp:AUTHORS >K&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;hn H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c65">
      <bp:ID >15314690</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Zheng L</bp:AUTHORS>
      <bp:AUTHORS >Nukuna B</bp:AUTHORS>
      <bp:AUTHORS >Brennan ML</bp:AUTHORS>
      <bp:AUTHORS >Sun M</bp:AUTHORS>
      <bp:AUTHORS >Goormastic M</bp:AUTHORS>
      <bp:AUTHORS >Settle M</bp:AUTHORS>
      <bp:AUTHORS >Schmitt D</bp:AUTHORS>
      <bp:AUTHORS >Fu X</bp:AUTHORS>
      <bp:AUTHORS >Thomson L</bp:AUTHORS>
      <bp:AUTHORS >Fox PL</bp:AUTHORS>
      <bp:AUTHORS >Ischiropoulos H</bp:AUTHORS>
      <bp:AUTHORS >Smith JD</bp:AUTHORS>
      <bp:AUTHORS >Kinter M</bp:AUTHORS>
      <bp:AUTHORS >Hazen SL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f18">
      <bp:ID >18718914</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Ho TC</bp:AUTHORS>
      <bp:AUTHORS >Chen SL</bp:AUTHORS>
      <bp:AUTHORS >Yang YC</bp:AUTHORS>
      <bp:AUTHORS >Chen CY</bp:AUTHORS>
      <bp:AUTHORS >Feng FP</bp:AUTHORS>
      <bp:AUTHORS >Hsieh JW</bp:AUTHORS>
      <bp:AUTHORS >Cheng HC</bp:AUTHORS>
      <bp:AUTHORS >Tsao YP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c24">
      <bp:ID >15026176</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins.</bp:TITLE>
      <bp:SOURCE >Mol Cell Endocrinol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Penning TM</bp:AUTHORS>
      <bp:AUTHORS >Jin Y</bp:AUTHORS>
      <bp:AUTHORS >Steckelbroeck S</bp:AUTHORS>
      <bp:AUTHORS >Lanisnik Rizner T</bp:AUTHORS>
      <bp:AUTHORS >Lewis M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="efa">
      <bp:ID >7276750</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cofactor requiremets for 7 alpha-dehydroxylation of cholic and chenodeoxycholic acid in cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 13708.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1981</bp:YEAR>
      <bp:AUTHORS >White BA</bp:AUTHORS>
      <bp:AUTHORS >Cacciapuoti AF</bp:AUTHORS>
      <bp:AUTHORS >Fricke RJ</bp:AUTHORS>
      <bp:AUTHORS >Whitehead TR</bp:AUTHORS>
      <bp:AUTHORS >Mosbach EH</bp:AUTHORS>
      <bp:AUTHORS >Hylemon PB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed1">
      <bp:ID >19803417</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proinflammatory cytokines in CRP baseline regulation.</bp:TITLE>
      <bp:SOURCE >Adv Clin Chem</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Eklund CM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f21">
      <bp:ID >3790723</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >1987</bp:YEAR>
      <bp:AUTHORS >Reilly IA</bp:AUTHORS>
      <bp:AUTHORS >FitzGerald GA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab2">
      <bp:ID >17612623</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2).</bp:TITLE>
      <bp:SOURCE >Biochem Cell Biol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Bakovic M</bp:AUTHORS>
      <bp:AUTHORS >Fullerton MD</bp:AUTHORS>
      <bp:AUTHORS >Michel V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ef6">
      <bp:ID >2167130</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Isolation and characterization of the human liver ethanolamine kinase.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1990</bp:YEAR>
      <bp:AUTHORS >Draus E</bp:AUTHORS>
      <bp:AUTHORS >Niefind J</bp:AUTHORS>
      <bp:AUTHORS >Vietor K</bp:AUTHORS>
      <bp:AUTHORS >Havsteen B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b91">
      <bp:ID >3918580</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formation of 11-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid in human umbilical arteries is catalyzed by cyclooxygenase.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1985</bp:YEAR>
      <bp:AUTHORS >Setty BN</bp:AUTHORS>
      <bp:AUTHORS >Stuart MJ</bp:AUTHORS>
      <bp:AUTHORS >Walenga RW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eec">
      <bp:ID >18479189</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Banning A</bp:AUTHORS>
      <bp:AUTHORS >Florian S</bp:AUTHORS>
      <bp:AUTHORS >Deubel S</bp:AUTHORS>
      <bp:AUTHORS >Thalmann S</bp:AUTHORS>
      <bp:AUTHORS >M&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;ller-Schmehl K</bp:AUTHORS>
      <bp:AUTHORS >Jacobasch G</bp:AUTHORS>
      <bp:AUTHORS >Brigelius-Floh&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b63">
      <bp:ID >18987785</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative modification of LDL: its pathological role in atherosclerosis.</bp:TITLE>
      <bp:SOURCE >Clin Rev Allergy Immunol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Itabe H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca9">
      <bp:ID >19403631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Studies of biomarker responses to intervention with riboflavin: a systematic review.</bp:TITLE>
      <bp:SOURCE >Am J Clin Nutr</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:ID >19403631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Studies of biomarker responses to intervention with riboflavin: a systematic review.</bp:TITLE>
      <bp:SOURCE >Am J Clin Nutr</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Hoey L</bp:AUTHORS>
      <bp:AUTHORS >McNulty H</bp:AUTHORS>
      <bp:AUTHORS >Strain JJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f82">
      <bp:ID >16858407</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Johnsen IB</bp:AUTHORS>
      <bp:AUTHORS >Nguyen TT</bp:AUTHORS>
      <bp:AUTHORS >Ringdal M</bp:AUTHORS>
      <bp:AUTHORS >Tryggestad AM</bp:AUTHORS>
      <bp:AUTHORS >Bakke O</bp:AUTHORS>
      <bp:AUTHORS >Lien E</bp:AUTHORS>
      <bp:AUTHORS >Espevik T</bp:AUTHORS>
      <bp:AUTHORS >Anthonsen MW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf9">
      <bp:ID >6371429</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Biochemistry of tryptophan in health and disease.</bp:TITLE>
      <bp:SOURCE >Mol Aspects Med</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:ID >6371429</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Biochemistry of tryptophan in health and disease.</bp:TITLE>
      <bp:SOURCE >Mol Aspects Med</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Bender DA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e06">
      <bp:ID >9627909</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Anxiety and adipose essential fatty acid precursors for prostaglandin E1 and E2.</bp:TITLE>
      <bp:SOURCE >J Am Coll Nutr</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Mamalakis G</bp:AUTHORS>
      <bp:AUTHORS >Kafatos A</bp:AUTHORS>
      <bp:AUTHORS >Tornaritis M</bp:AUTHORS>
      <bp:AUTHORS >Alevizos B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b53">
      <bp:ID >18032380</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18032380</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Li YC</bp:AUTHORS>
      <bp:AUTHORS >Chiang CW</bp:AUTHORS>
      <bp:AUTHORS >Yeh HC</bp:AUTHORS>
      <bp:AUTHORS >Hsu PY</bp:AUTHORS>
      <bp:AUTHORS >Whitby FG</bp:AUTHORS>
      <bp:AUTHORS >Wang LH</bp:AUTHORS>
      <bp:AUTHORS >Chan NL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e99">
      <bp:ID >15976321</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >New insights into the regulation of HDL metabolism and reverse cholesterol transport.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Lewis GF</bp:AUTHORS>
      <bp:AUTHORS >Rader DJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e7f">
      <bp:ID >9584338</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacological inhibition of leukotriene actions.</bp:TITLE>
      <bp:SOURCE >Pharm World Sci</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Engels F</bp:AUTHORS>
      <bp:AUTHORS >Nijkamp FP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aff">
      <bp:ID >15680219</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15680219</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sch&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;neich C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c92">
      <bp:ID >3013986</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phospholipid transmethylation and choline phosphotransferase in microsomal fraction of human diseased liver.</bp:TITLE>
      <bp:SOURCE >J Hepatol</bp:SOURCE>
      <bp:YEAR >1986</bp:YEAR>
      <bp:AUTHORS >Niwa Y</bp:AUTHORS>
      <bp:AUTHORS >Sakane T</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa M</bp:AUTHORS>
      <bp:AUTHORS >Kondo T</bp:AUTHORS>
      <bp:AUTHORS >Taniguchi S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c28">
      <bp:ID >16339544</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Yasutomi M</bp:AUTHORS>
      <bp:AUTHORS >Ohshima Y</bp:AUTHORS>
      <bp:AUTHORS >Omata N</bp:AUTHORS>
      <bp:AUTHORS >Yamada A</bp:AUTHORS>
      <bp:AUTHORS >Iwasaki H</bp:AUTHORS>
      <bp:AUTHORS >Urasaki Y</bp:AUTHORS>
      <bp:AUTHORS >Mayumi M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c06">
      <bp:ID >12775843</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of mammalian selenoproteomes.</bp:TITLE>
      <bp:SOURCE >Science</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Kryukov GV</bp:AUTHORS>
      <bp:AUTHORS >Castellano S</bp:AUTHORS>
      <bp:AUTHORS >Novoselov SV</bp:AUTHORS>
      <bp:AUTHORS >Lobanov AV</bp:AUTHORS>
      <bp:AUTHORS >Zehtab O</bp:AUTHORS>
      <bp:AUTHORS >Guig&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#179; R</bp:AUTHORS>
      <bp:AUTHORS >Gladyshev VN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c51">
      <bp:ID >16430221</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Myeloperoxidase metabolizes thiocyanate in a reaction driven by nitric oxide.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Galijasevic S</bp:AUTHORS>
      <bp:AUTHORS >Saed GM</bp:AUTHORS>
      <bp:AUTHORS >Hazen SL</bp:AUTHORS>
      <bp:AUTHORS >Abu-Soud HM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edb">
      <bp:ID >10914032</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Measurement of ceramide synthase activity.</bp:TITLE>
      <bp:SOURCE >Methods Enzymol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Bose R</bp:AUTHORS>
      <bp:AUTHORS >Kolesnick R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3f">
      <bp:ID >17463087</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Hasan UA</bp:AUTHORS>
      <bp:AUTHORS >Caux C</bp:AUTHORS>
      <bp:AUTHORS >Perrot I</bp:AUTHORS>
      <bp:AUTHORS >Doffin AC</bp:AUTHORS>
      <bp:AUTHORS >Menetrier-Caux C</bp:AUTHORS>
      <bp:AUTHORS >Trinchieri G</bp:AUTHORS>
      <bp:AUTHORS >Tommasino M</bp:AUTHORS>
      <bp:AUTHORS >Vlach J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a22">
      <bp:ID >14580199</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ligand binding-induced conformational changes in riboflavin kinase: structural basis for the ordered mechanism.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Karthikeyan S</bp:AUTHORS>
      <bp:AUTHORS >Zhou Q</bp:AUTHORS>
      <bp:AUTHORS >Osterman AL</bp:AUTHORS>
      <bp:AUTHORS >Zhang H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e74">
      <bp:ID >12815058</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Johnson KR</bp:AUTHORS>
      <bp:AUTHORS >Johnson KY</bp:AUTHORS>
      <bp:AUTHORS >Becker KP</bp:AUTHORS>
      <bp:AUTHORS >Bielawski J</bp:AUTHORS>
      <bp:AUTHORS >Mao C</bp:AUTHORS>
      <bp:AUTHORS >Obeid LM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da1">
      <bp:ID >17916561</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Plasma membrane rafts complete cholesterol synthesis by participating in retrograde movement of precursor sterols.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Yamauchi Y</bp:AUTHORS>
      <bp:AUTHORS >Reid PC</bp:AUTHORS>
      <bp:AUTHORS >Sperry JB</bp:AUTHORS>
      <bp:AUTHORS >Furukawa K</bp:AUTHORS>
      <bp:AUTHORS >Takeya M</bp:AUTHORS>
      <bp:AUTHORS >Chang CC</bp:AUTHORS>
      <bp:AUTHORS >Chang TY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f92">
      <bp:ID >18583509</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Deo AK</bp:AUTHORS>
      <bp:AUTHORS >Bandiera SM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f03">
      <bp:ID >18420277</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18420277</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18420277</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18420277</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18420277</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Cipollone F</bp:AUTHORS>
      <bp:AUTHORS >Cicolini G</bp:AUTHORS>
      <bp:AUTHORS >Bucci M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb5">
      <bp:ID >11325678</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route.</bp:TITLE>
      <bp:SOURCE >Am J Kidney Dis</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Maccarrone M</bp:AUTHORS>
      <bp:AUTHORS >Meloni C</bp:AUTHORS>
      <bp:AUTHORS >Manca-di-Villahermosa S</bp:AUTHORS>
      <bp:AUTHORS >Cococcetta N</bp:AUTHORS>
      <bp:AUTHORS >Casciani CU</bp:AUTHORS>
      <bp:AUTHORS >Finazzi-Agr&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#178; A</bp:AUTHORS>
      <bp:AUTHORS >Taccone-Gallucci M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb5">
      <bp:ID >15317910</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.</bp:TITLE>
      <bp:SOURCE >Pharmacol Rev</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Simmons DL</bp:AUTHORS>
      <bp:AUTHORS >Botting RM</bp:AUTHORS>
      <bp:AUTHORS >Hla T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e58">
      <bp:ID >10980461</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Conradi-H&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#188;nermann-Happle syndrome is caused by mutations in the gene that encodes a 8- 7 sterol isomerase and is biochemically related to the CHILD syndrome.</bp:TITLE>
      <bp:SOURCE >Eur J Dermatol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Traupe H</bp:AUTHORS>
      <bp:AUTHORS >Has C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a4a">
      <bp:ID >19747065</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structure-function relationships, physiological roles and evolution of mammalian ER-resident selenoproteins.</bp:TITLE>
      <bp:SOURCE >Antioxid Redox Signal</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Shchedrina VA</bp:AUTHORS>
      <bp:AUTHORS >Zhang Y</bp:AUTHORS>
      <bp:AUTHORS >Labunskyy VM</bp:AUTHORS>
      <bp:AUTHORS >Hatfield DL</bp:AUTHORS>
      <bp:AUTHORS >Gladyshev V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd5">
      <bp:ID >698243</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Enzymatic sulphation of bile salts in human liver.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1978</bp:YEAR>
      <bp:AUTHORS >L&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;f L</bp:AUTHORS>
      <bp:AUTHORS >Wengle B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed6">
      <bp:ID >874074</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >1977</bp:YEAR>
      <bp:AUTHORS >Bills TK</bp:AUTHORS>
      <bp:AUTHORS >Smith JB</bp:AUTHORS>
      <bp:AUTHORS >Silver MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1e">
      <bp:ID >12730456</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P.</bp:TITLE>
      <bp:SOURCE >J Nutr</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12730456</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P.</bp:TITLE>
      <bp:SOURCE >J Nutr</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Burk RF</bp:AUTHORS>
      <bp:AUTHORS >Hill KE</bp:AUTHORS>
      <bp:AUTHORS >Motley AK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba9">
      <bp:ID >4387676</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolism of sphingosine bases. 8. Distribution, isolation and properties of D-3-oxosphinganine reductase. Stereospecificity of the NADPH-dependent reaction of 3-oxodihydrospingosine (2-amino-1-hydroxyoctadecane-3-one).</bp:TITLE>
      <bp:SOURCE >Hoppe Seylers Z Physiol Chem</bp:SOURCE>
      <bp:YEAR >1968</bp:YEAR>
      <bp:AUTHORS >Stoffel W</bp:AUTHORS>
      <bp:AUTHORS >LeKim D</bp:AUTHORS>
      <bp:AUTHORS >Sticht G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d42">
      <bp:ID >16574427</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells.</bp:TITLE>
      <bp:SOURCE >Cytokine</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:ID >16574427</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells.</bp:TITLE>
      <bp:SOURCE >Cytokine</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Gao Y</bp:AUTHORS>
      <bp:AUTHORS >Hannan NR</bp:AUTHORS>
      <bp:AUTHORS >Wanyonyi S</bp:AUTHORS>
      <bp:AUTHORS >Konstantopolous N</bp:AUTHORS>
      <bp:AUTHORS >Pagnon J</bp:AUTHORS>
      <bp:AUTHORS >Feng HC</bp:AUTHORS>
      <bp:AUTHORS >Jowett JB</bp:AUTHORS>
      <bp:AUTHORS >Kim KH</bp:AUTHORS>
      <bp:AUTHORS >Walder K</bp:AUTHORS>
      <bp:AUTHORS >Collier GR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1c">
      <bp:ID >18987785</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative modification of LDL: its pathological role in atherosclerosis.</bp:TITLE>
      <bp:SOURCE >Clin Rev Allergy Immunol</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Itabe H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c7d">
      <bp:ID >16120612</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >van der Westhuyzen DR</bp:AUTHORS>
      <bp:AUTHORS >Cai L</bp:AUTHORS>
      <bp:AUTHORS >de Beer MC</bp:AUTHORS>
      <bp:AUTHORS >de Beer FC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e64">
      <bp:ID >4774123</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Acyl-donor specificities of partially purified 1-acylglycerophosphate acyltransferase, 2-acylglycerophosphate acyltransferase and 1-acylglycerophosphorylcholine acyltransferase from rat-liver microsomes.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1973</bp:YEAR>
      <bp:AUTHORS >Yamashita S</bp:AUTHORS>
      <bp:AUTHORS >Hosaka K</bp:AUTHORS>
      <bp:AUTHORS >Numa S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c53">
      <bp:ID >17392543</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serum selenium and diabetes in U.S. adults.</bp:TITLE>
      <bp:SOURCE >Diabetes Care</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Bleys J</bp:AUTHORS>
      <bp:AUTHORS >Navas-Acien A</bp:AUTHORS>
      <bp:AUTHORS >Guallar E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd0">
      <bp:ID >14677018</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A study on soluble intercellular adhesion molecule-1 and selenium in patients with rheumatoid arthritis complicated by vasculitis.</bp:TITLE>
      <bp:SOURCE >Clin Rheumatol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >14677018</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A study on soluble intercellular adhesion molecule-1 and selenium in patients with rheumatoid arthritis complicated by vasculitis.</bp:TITLE>
      <bp:SOURCE >Clin Rheumatol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Witkowska AM</bp:AUTHORS>
      <bp:AUTHORS >Kuryliszyn-Moskal A</bp:AUTHORS>
      <bp:AUTHORS >Borawska MH</bp:AUTHORS>
      <bp:AUTHORS >Huka&#195;&#402;&#198;&#8217;&#195;&#8218;&#226;&#8364;&#166;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#226;&#8364;&#353;owicz K</bp:AUTHORS>
      <bp:AUTHORS >Markiewicz R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e14">
      <bp:ID >12431977</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane topography of human phosphatidylethanolamine N-methyltransferase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Shields DJ</bp:AUTHORS>
      <bp:AUTHORS >Lehner R</bp:AUTHORS>
      <bp:AUTHORS >Agellon LB</bp:AUTHORS>
      <bp:AUTHORS >Vance DE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a46">
      <bp:ID >14726604</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide and superoxide in inflammation and immune regulation.</bp:TITLE>
      <bp:SOURCE >J Physiol Pharmacol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Guzik TJ</bp:AUTHORS>
      <bp:AUTHORS >Korbut R</bp:AUTHORS>
      <bp:AUTHORS >Adamek-Guzik T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >selenoamino acid metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000133</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe7">
      <bp:ID >9587024</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The metabolism of homocysteine: pathways and regulation.</bp:TITLE>
      <bp:SOURCE >Eur J Pediatr</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Finkelstein JD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af6">
      <bp:ID >11972054</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Peters KL</bp:AUTHORS>
      <bp:AUTHORS >Smith HL</bp:AUTHORS>
      <bp:AUTHORS >Stark GR</bp:AUTHORS>
      <bp:AUTHORS >Sen GC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2b">
      <bp:ID >374662</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Ahlberg J</bp:AUTHORS>
      <bp:AUTHORS >Angelin B</bp:AUTHORS>
      <bp:AUTHORS >Bj&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;rkhem I</bp:AUTHORS>
      <bp:AUTHORS >Einarsson K</bp:AUTHORS>
      <bp:AUTHORS >Leijd B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c69">
      <bp:ID >17276401</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The death domain of IRAK-1: an oligomerization domain mediating interactions with MyD88, Tollip, IRAK-1, and IRAK-4.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Neumann D</bp:AUTHORS>
      <bp:AUTHORS >Kollewe C</bp:AUTHORS>
      <bp:AUTHORS >Resch K</bp:AUTHORS>
      <bp:AUTHORS >Martin MU.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c0f">
      <bp:ID >16716149</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Chen D</bp:AUTHORS>
      <bp:AUTHORS >Zhang XY</bp:AUTHORS>
      <bp:AUTHORS >Shi Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d97">
      <bp:ID >10100195</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activity of phosphatidylethanolamine-N-methyltransferase in brain affected by Alzheimer's disease.</bp:TITLE>
      <bp:SOURCE >Neurochem Int</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Guan ZZ</bp:AUTHORS>
      <bp:AUTHORS >Wang YN</bp:AUTHORS>
      <bp:AUTHORS >Xiao KQ</bp:AUTHORS>
      <bp:AUTHORS >Hu PS</bp:AUTHORS>
      <bp:AUTHORS >Liu JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4e">
      <bp:ID >8325534</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Towards the physiological function of uric acid.</bp:TITLE>
      <bp:SOURCE >Free Radic Biol Med</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Becker BF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f97">
      <bp:ID >9278416</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >May JM</bp:AUTHORS>
      <bp:AUTHORS >Mendiratta S</bp:AUTHORS>
      <bp:AUTHORS >Hill KE</bp:AUTHORS>
      <bp:AUTHORS >Burk RF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2d">
      <bp:ID >10705969</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2.</bp:TITLE>
      <bp:SOURCE >Biofactors</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Hesse-B&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#164;hr K</bp:AUTHORS>
      <bp:AUTHORS >Dreher I</bp:AUTHORS>
      <bp:AUTHORS >K&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#182;hrle J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e1e">
      <bp:ID >7639730</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of the human gene encoding lanosterol synthase from a liver cDNA library.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Baker CH</bp:AUTHORS>
      <bp:AUTHORS >Matsuda SP</bp:AUTHORS>
      <bp:AUTHORS >Liu DR</bp:AUTHORS>
      <bp:AUTHORS >Corey EJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fbb">
      <bp:ID >9325339</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Substrate specificities of 3-oxoacyl-CoA thiolase A and sterol carrier protein 2/3-oxoacyl-CoA thiolase purified from normal rat liver peroxisomes. Sterol carrier protein 2/3-oxoacyl-CoA thiolase is involved in the metabolism of 2-methyl-branched fatty acids and bile acid intermediates.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Antonenkov VD</bp:AUTHORS>
      <bp:AUTHORS >Van Veldhoven PP</bp:AUTHORS>
      <bp:AUTHORS >Waelkens E</bp:AUTHORS>
      <bp:AUTHORS >Mannaerts GP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f9c">
      <bp:ID >10544287</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification and characterization of rat sterol 14-demethylase P450 (CYP51) expressed in Escherichia coli.</bp:TITLE>
      <bp:SOURCE >J Biochem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Nitahara Y</bp:AUTHORS>
      <bp:AUTHORS >Aoyama Y</bp:AUTHORS>
      <bp:AUTHORS >Horiuchi T</bp:AUTHORS>
      <bp:AUTHORS >Noshiro M</bp:AUTHORS>
      <bp:AUTHORS >Yoshida Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0e">
      <bp:ID >15704532</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication.</bp:TITLE>
      <bp:SOURCE >Clin Cardiol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Doo YC</bp:AUTHORS>
      <bp:AUTHORS >Han SJ</bp:AUTHORS>
      <bp:AUTHORS >Park WJ</bp:AUTHORS>
      <bp:AUTHORS >Kim SM</bp:AUTHORS>
      <bp:AUTHORS >Choi SH</bp:AUTHORS>
      <bp:AUTHORS >Cho GY</bp:AUTHORS>
      <bp:AUTHORS >Hong KS</bp:AUTHORS>
      <bp:AUTHORS >Han KR</bp:AUTHORS>
      <bp:AUTHORS >Lee NH</bp:AUTHORS>
      <bp:AUTHORS >Oh DJ</bp:AUTHORS>
      <bp:AUTHORS >Ryu KH</bp:AUTHORS>
      <bp:AUTHORS >Rhim CY</bp:AUTHORS>
      <bp:AUTHORS >Lee KH</bp:AUTHORS>
      <bp:AUTHORS >Lee Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df7">
      <bp:ID >2610352</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Radioassay of bile acid coenzyme A:glycine/taurine: N-acyltransferase using an n-butanol solvent extraction procedure.</bp:TITLE>
      <bp:SOURCE >Anal Biochem</bp:SOURCE>
      <bp:YEAR >1989</bp:YEAR>
      <bp:AUTHORS >Johnson MR</bp:AUTHORS>
      <bp:AUTHORS >Barnes S</bp:AUTHORS>
      <bp:AUTHORS >Diasio RB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbc">
      <bp:ID >8986768</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism?</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Guimar&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#163;es MJ</bp:AUTHORS>
      <bp:AUTHORS >Peterson D</bp:AUTHORS>
      <bp:AUTHORS >Vicari A</bp:AUTHORS>
      <bp:AUTHORS >Cocks BG</bp:AUTHORS>
      <bp:AUTHORS >Copeland NG</bp:AUTHORS>
      <bp:AUTHORS >Gilbert DJ</bp:AUTHORS>
      <bp:AUTHORS >Jenkins NA</bp:AUTHORS>
      <bp:AUTHORS >Ferrick DA</bp:AUTHORS>
      <bp:AUTHORS >Kastelein RA</bp:AUTHORS>
      <bp:AUTHORS >Bazan JF</bp:AUTHORS>
      <bp:AUTHORS >Zlotnik A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ff7">
      <bp:ID >9133619</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiological role of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein.</bp:TITLE>
      <bp:SOURCE >J Biochem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Jiang LL</bp:AUTHORS>
      <bp:AUTHORS >Kurosawa T</bp:AUTHORS>
      <bp:AUTHORS >Sato M</bp:AUTHORS>
      <bp:AUTHORS >Suzuki Y</bp:AUTHORS>
      <bp:AUTHORS >Hashimoto T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c31">
      <bp:ID >19024248</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fructosamine--an underutilized tool in diabetes management: case report and literature review.</bp:TITLE>
      <bp:SOURCE >Tenn Med</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Youssef D</bp:AUTHORS>
      <bp:AUTHORS >El Abbassi A</bp:AUTHORS>
      <bp:AUTHORS >Jordan RM</bp:AUTHORS>
      <bp:AUTHORS >Peiris AN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9c">
      <bp:ID >218223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1979</bp:YEAR>
      <bp:AUTHORS >Needleman P</bp:AUTHORS>
      <bp:AUTHORS >Raz A</bp:AUTHORS>
      <bp:AUTHORS >Minkes MS</bp:AUTHORS>
      <bp:AUTHORS >Ferrendelli JA</bp:AUTHORS>
      <bp:AUTHORS >Sprecher H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c99">
      <bp:ID >8652655</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phospholipase A(2) activity in non-glycated and glycated low density lipoproteins.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Sakurai T</bp:AUTHORS>
      <bp:AUTHORS >Yamamoto Y</bp:AUTHORS>
      <bp:AUTHORS >Baba N</bp:AUTHORS>
      <bp:AUTHORS >Nakano M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db4">
      <bp:ID >2175712</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification, cDNA-cloning and expression of human diacylglycerol kinase.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1990</bp:YEAR>
      <bp:AUTHORS >Schaap D</bp:AUTHORS>
      <bp:AUTHORS >de Widt J</bp:AUTHORS>
      <bp:AUTHORS >van der Wal J</bp:AUTHORS>
      <bp:AUTHORS >Vandekerckhove J</bp:AUTHORS>
      <bp:AUTHORS >van Damme J</bp:AUTHORS>
      <bp:AUTHORS >Gussow D</bp:AUTHORS>
      <bp:AUTHORS >Ploegh HL</bp:AUTHORS>
      <bp:AUTHORS >van Blitterswijk WJ</bp:AUTHORS>
      <bp:AUTHORS >van der Bend RL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf6">
      <bp:ID >6122208</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1982</bp:YEAR>
      <bp:AUTHORS >Anderson ME</bp:AUTHORS>
      <bp:AUTHORS >Allison RD</bp:AUTHORS>
      <bp:AUTHORS >Meister A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a86">
      <bp:ID >18354163</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Shen W</bp:AUTHORS>
      <bp:AUTHORS >Stone K</bp:AUTHORS>
      <bp:AUTHORS >Jales A</bp:AUTHORS>
      <bp:AUTHORS >Leitenberg D</bp:AUTHORS>
      <bp:AUTHORS >Ladisch S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e72">
      <bp:ID >16887964</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Agaugu&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; S</bp:AUTHORS>
      <bp:AUTHORS >Perrin-Cocon L</bp:AUTHORS>
      <bp:AUTHORS >Coutant F</bp:AUTHORS>
      <bp:AUTHORS >Andr&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169; P</bp:AUTHORS>
      <bp:AUTHORS >Lotteau V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID >18394665</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Homology modelling of human DHCR24 (seladin-1) and analysis of its binding properties through molecular docking and dynamics simulations.</bp:TITLE>
      <bp:SOURCE >Steroids</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Pedretti A</bp:AUTHORS>
      <bp:AUTHORS >Bocci E</bp:AUTHORS>
      <bp:AUTHORS >Maggi R</bp:AUTHORS>
      <bp:AUTHORS >Vistoli G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae2">
      <bp:ID >18617006</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative stress in normal and impaired wound repair.</bp:TITLE>
      <bp:SOURCE >Pharmacol Res</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:ID >18617006</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative stress in normal and impaired wound repair.</bp:TITLE>
      <bp:SOURCE >Pharmacol Res</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Sch&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#164;fer M</bp:AUTHORS>
      <bp:AUTHORS >Werner S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c83">
      <bp:ID >18198219</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion.</bp:TITLE>
      <bp:SOURCE >FASEB J</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Grumolato L</bp:AUTHORS>
      <bp:AUTHORS >Ghzili H</bp:AUTHORS>
      <bp:AUTHORS >Montero-Hadjadje M</bp:AUTHORS>
      <bp:AUTHORS >Gasman S</bp:AUTHORS>
      <bp:AUTHORS >Lesage J</bp:AUTHORS>
      <bp:AUTHORS >Tanguy Y</bp:AUTHORS>
      <bp:AUTHORS >Galas L</bp:AUTHORS>
      <bp:AUTHORS >Ait-Ali D</bp:AUTHORS>
      <bp:AUTHORS >Leprince J</bp:AUTHORS>
      <bp:AUTHORS >Gu&#195;&#402;&#198;&#8217;&#195;&#8218;&#198;&#8217;&#195;&#402;&#226;&#8364;&#353;&#195;&#8218;&#194;&#169;rineau NC</bp:AUTHORS>
      <bp:AUTHORS >Elkahloun AG</bp:AUTHORS>
      <bp:AUTHORS >Fournier A</bp:AUTHORS>
      <bp:AUTHORS >Vieau D</bp:AUTHORS>
      <bp:AUTHORS >Vaudry H</bp:AUTHORS>
      <bp:AUTHORS >Anouar Y</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>